id	sid	tid	token	lemma	pos
mkg-25034	1	1	82	82	NUM
mkg-25034	1	2	dental	dental	ADJ
mkg-25034	1	3	journal	journal	NOUN
mkg-25034	1	4	(	(	PUNCT
mkg-25034	1	5	majalah	majalah	PROPN
mkg-25034	1	6	kedokteran	kedokteran	PROPN
mkg-25034	1	7	gigi	gigi	PROPN
mkg-25034	1	8	)	)	PUNCT
mkg-25034	1	9	2021	2021	NUM
mkg-25034	1	10	june	june	PROPN
mkg-25034	1	11	;	;	PUNCT
mkg-25034	1	12	54(2	54(2	NUM
mkg-25034	1	13	):	):	PUNCT
mkg-25034	1	14	82–86	82–86	NUM
mkg-25034	1	15	original	original	ADJ
mkg-25034	1	16	article	article	NOUN
mkg-25034	1	17	the	the	DET
mkg-25034	1	18	antifungal	antifungal	ADJ
mkg-25034	1	19	susceptibility	susceptibility	NOUN
mkg-25034	1	20	of	of	ADP
mkg-25034	1	21	candida	candida	NOUN
mkg-25034	1	22	albicans	albican	NOUN
mkg-25034	1	23	isolated	isolate	VERB
mkg-25034	1	24	from	from	ADP
mkg-25034	1	25	hiv	hiv	PROPN
mkg-25034	1	26	/	/	SYM
mkg-25034	1	27	aids	aids	PROPN
mkg-25034	1	28	patients	patient	NOUN
mkg-25034	1	29	sri	sri	VERB
mkg-25034	1	30	rezeki1	rezeki1	PROPN
mkg-25034	1	31	,	,	PUNCT
mkg-25034	1	32	siti	siti	PROPN
mkg-25034	1	33	aliyah	aliyah	PROPN
mkg-25034	1	34	pradono2	pradono2	PROPN
mkg-25034	1	35	,	,	PUNCT
mkg-25034	1	36	gus	gus	PROPN
mkg-25034	1	37	permana	permana	PROPN
mkg-25034	1	38	subita2	subita2	PROPN
mkg-25034	1	39	,	,	PUNCT
mkg-25034	1	40	yeva	yeva	ADJ
mkg-25034	1	41	rosana3	rosana3	NOUN
mkg-25034	1	42	,	,	PUNCT
mkg-25034	1	43	sunnati4	sunnati4	NOUN
mkg-25034	1	44	and	and	CCONJ
mkg-25034	1	45	basri	basri	ADJ
mkg-25034	1	46	a.	a.	NOUN
mkg-25034	1	47	gani5	gani5	NOUN
mkg-25034	1	48	1	1	NUM
mkg-25034	1	49	department	department	NOUN
mkg-25034	1	50	of	of	ADP
mkg-25034	1	51	oral	oral	ADJ
mkg-25034	1	52	medicine	medicine	NOUN
mkg-25034	1	53	,	,	PUNCT
mkg-25034	1	54	faculty	faculty	NOUN
mkg-25034	1	55	of	of	ADP
mkg-25034	1	56	dentistry	dentistry	NOUN
mkg-25034	1	57	,	,	PUNCT
mkg-25034	1	58	universitas	universita	NOUN
mkg-25034	1	59	syiah	syiah	PROPN
mkg-25034	1	60	kuala	kuala	PROPN
mkg-25034	1	61	,	,	PUNCT
mkg-25034	1	62	banda	banda	PROPN
mkg-25034	1	63	aceh	aceh	PROPN
mkg-25034	1	64	,	,	PUNCT
mkg-25034	1	65	indonesia	indonesia	PROPN
mkg-25034	1	66	2	2	NUM
mkg-25034	1	67	department	department	NOUN
mkg-25034	1	68	of	of	ADP
mkg-25034	1	69	oral	oral	ADJ
mkg-25034	1	70	medicine	medicine	NOUN
mkg-25034	1	71	,	,	PUNCT
mkg-25034	1	72	faculty	faculty	NOUN
mkg-25034	1	73	of	of	ADP
mkg-25034	1	74	dentistry	dentistry	NOUN
mkg-25034	1	75	,	,	PUNCT
mkg-25034	1	76	universitas	universitas	PROPN
mkg-25034	1	77	indonesia	indonesia	PROPN
mkg-25034	1	78	,	,	PUNCT
mkg-25034	1	79	jakarta	jakarta	PROPN
mkg-25034	1	80	,	,	PUNCT
mkg-25034	1	81	indonesia	indonesia	PROPN
mkg-25034	1	82	3	3	NUM
mkg-25034	1	83	department	department	PROPN
mkg-25034	1	84	of	of	ADP
mkg-25034	1	85	microbiology	microbiology	NOUN
mkg-25034	1	86	,	,	PUNCT
mkg-25034	1	87	faculty	faculty	NOUN
mkg-25034	1	88	of	of	ADP
mkg-25034	1	89	medicine	medicine	NOUN
mkg-25034	1	90	,	,	PUNCT
mkg-25034	1	91	universitas	universitas	PROPN
mkg-25034	1	92	indonesia	indonesia	PROPN
mkg-25034	1	93	,	,	PUNCT
mkg-25034	1	94	jakarta	jakarta	PROPN
mkg-25034	1	95	,	,	PUNCT
mkg-25034	1	96	indonesia	indonesia	PROPN
mkg-25034	1	97	4	4	NUM
mkg-25034	1	98	department	department	NOUN
mkg-25034	1	99	of	of	ADP
mkg-25034	1	100	periodontics	periodontic	NOUN
mkg-25034	1	101	,	,	PUNCT
mkg-25034	1	102	faculty	faculty	NOUN
mkg-25034	1	103	of	of	ADP
mkg-25034	1	104	dentistry	dentistry	NOUN
mkg-25034	1	105	,	,	PUNCT
mkg-25034	1	106	universitas	universita	NOUN
mkg-25034	1	107	syiah	syiah	PROPN
mkg-25034	1	108	kuala	kuala	PROPN
mkg-25034	1	109	,	,	PUNCT
mkg-25034	1	110	banda	banda	PROPN
mkg-25034	1	111	aceh	aceh	PROPN
mkg-25034	1	112	,	,	PUNCT
mkg-25034	1	113	indonesia	indonesia	PROPN
mkg-25034	1	114	5	5	NUM
mkg-25034	1	115	department	department	NOUN
mkg-25034	1	116	of	of	ADP
mkg-25034	1	117	oral	oral	ADJ
mkg-25034	1	118	biology	biology	NOUN
mkg-25034	1	119	,	,	PUNCT
mkg-25034	1	120	faculty	faculty	NOUN
mkg-25034	1	121	of	of	ADP
mkg-25034	1	122	dentistry	dentistry	NOUN
mkg-25034	1	123	,	,	PUNCT
mkg-25034	1	124	universitas	universita	NOUN
mkg-25034	1	125	syiah	syiah	PROPN
mkg-25034	1	126	kuala	kuala	PROPN
mkg-25034	1	127	,	,	PUNCT
mkg-25034	1	128	banda	banda	PROPN
mkg-25034	1	129	aceh	aceh	PROPN
mkg-25034	1	130	,	,	PUNCT
mkg-25034	1	131	indonesia	indonesia	PROPN
mkg-25034	1	132	abstract	abstract	ADJ
mkg-25034	1	133	background	background	NOUN
mkg-25034	1	134	:	:	PUNCT
mkg-25034	1	135	candida	candida	NOUN
mkg-25034	1	136	albicans	albican	NOUN
mkg-25034	1	137	was	be	AUX
mkg-25034	1	138	found	find	VERB
mkg-25034	1	139	to	to	PART
mkg-25034	1	140	be	be	AUX
mkg-25034	1	141	dominant	dominant	ADJ
mkg-25034	1	142	in	in	ADP
mkg-25034	1	143	patients	patient	NOUN
mkg-25034	1	144	with	with	ADP
mkg-25034	1	145	human	human	ADJ
mkg-25034	1	146	immunodeficiency	immunodeficiency	NOUN
mkg-25034	1	147	virus	virus	NOUN
mkg-25034	1	148	/	/	SYM
mkg-25034	1	149	acquired	acquire	VERB
mkg-25034	1	150	immunodeficiency	immunodeficiency	NOUN
mkg-25034	1	151	syndrome	syndrome	NOUN
mkg-25034	1	152	(	(	PUNCT
mkg-25034	1	153	hiv	hiv	PROPN
mkg-25034	1	154	/	/	SYM
mkg-25034	1	155	aids	aids	PROPN
mkg-25034	1	156	)	)	PUNCT
mkg-25034	1	157	.	.	PUNCT
mkg-25034	2	1	the	the	DET
mkg-25034	2	2	antifungals	antifungal	NOUN
mkg-25034	2	3	fluconazole	fluconazole	NOUN
mkg-25034	2	4	,	,	PUNCT
mkg-25034	2	5	ketoconazole	ketoconazole	NOUN
mkg-25034	2	6	,	,	PUNCT
mkg-25034	2	7	and	and	CCONJ
mkg-25034	2	8	nystatin	nystatin	NOUN
mkg-25034	2	9	were	be	AUX
mkg-25034	2	10	used	use	VERB
mkg-25034	2	11	as	as	ADP
mkg-25034	2	12	oral	oral	ADJ
mkg-25034	2	13	candidiasis	candidiasis	NOUN
mkg-25034	2	14	therapy	therapy	NOUN
mkg-25034	2	15	for	for	ADP
mkg-25034	2	16	hiv	hiv	PROPN
mkg-25034	2	17	/	/	SYM
mkg-25034	2	18	aids	aids	PROPN
mkg-25034	2	19	,	,	PUNCT
mkg-25034	2	20	each	each	PRON
mkg-25034	2	21	of	of	ADP
mkg-25034	2	22	which	which	PRON
mkg-25034	2	23	has	have	AUX
mkg-25034	2	24	differing	differ	VERB
mkg-25034	2	25	susceptibility	susceptibility	NOUN
mkg-25034	2	26	in	in	ADP
mkg-25034	2	27	oral	oral	ADJ
mkg-25034	2	28	candidiasis	candidiasis	NOUN
mkg-25034	2	29	therapy	therapy	NOUN
mkg-25034	2	30	.	.	PUNCT
mkg-25034	3	1	purpose	purpose	NOUN
mkg-25034	3	2	:	:	PUNCT
mkg-25034	3	3	the	the	DET
mkg-25034	3	4	present	present	ADJ
mkg-25034	3	5	study	study	NOUN
mkg-25034	3	6	aimed	aim	VERB
mkg-25034	3	7	to	to	PART
mkg-25034	3	8	evaluate	evaluate	VERB
mkg-25034	3	9	the	the	DET
mkg-25034	3	10	susceptibility	susceptibility	NOUN
mkg-25034	3	11	and	and	CCONJ
mkg-25034	3	12	antifungal	antifungal	ADJ
mkg-25034	3	13	resistance	resistance	NOUN
mkg-25034	3	14	to	to	ADP
mkg-25034	3	15	oral	oral	ADJ
mkg-25034	3	16	c.	c.	NOUN
mkg-25034	3	17	albicans	albican	NOUN
mkg-25034	3	18	in	in	ADP
mkg-25034	3	19	hiv	hiv	PROPN
mkg-25034	3	20	/	/	SYM
mkg-25034	3	21	aids	aids	PROPN
mkg-25034	3	22	patients	patient	NOUN
mkg-25034	3	23	.	.	PUNCT
mkg-25034	4	1	methods	method	NOUN
mkg-25034	4	2	:	:	PUNCT
mkg-25034	4	3	the	the	DET
mkg-25034	4	4	subjects	subject	NOUN
mkg-25034	4	5	followed	follow	VERB
mkg-25034	4	6	the	the	DET
mkg-25034	4	7	universal	universal	ADJ
mkg-25034	4	8	precaution	precaution	NOUN
mkg-25034	4	9	principles	principle	NOUN
mkg-25034	4	10	.	.	PUNCT
mkg-25034	5	1	oral	oral	ADJ
mkg-25034	5	2	candida	candida	PROPN
mkg-25034	5	3	species	specie	NOUN
mkg-25034	5	4	were	be	AUX
mkg-25034	5	5	isolated	isolate	VERB
mkg-25034	5	6	from	from	ADP
mkg-25034	5	7	the	the	DET
mkg-25034	5	8	saliva	saliva	NOUN
mkg-25034	5	9	of	of	ADP
mkg-25034	5	10	98	98	NUM
mkg-25034	5	11	hiv	hiv	NOUN
mkg-25034	5	12	/	/	SYM
mkg-25034	5	13	aids	aids	PROPN
mkg-25034	5	14	subjects	subject	NOUN
mkg-25034	5	15	.	.	PUNCT
mkg-25034	6	1	identification	identification	NOUN
mkg-25034	6	2	of	of	ADP
mkg-25034	6	3	candida	candida	PROPN
mkg-25034	6	4	species	specie	NOUN
mkg-25034	6	5	was	be	AUX
mkg-25034	6	6	carried	carry	VERB
mkg-25034	6	7	out	out	ADP
mkg-25034	6	8	by	by	ADP
mkg-25034	6	9	the	the	DET
mkg-25034	6	10	mycobiotic	mycobiotic	ADJ
mkg-25034	6	11	agar	agar	NOUN
mkg-25034	6	12	of	of	ADP
mkg-25034	6	13	api	api	NOUN
mkg-25034	6	14	20	20	NUM
mkg-25034	6	15	c	c	PROPN
mkg-25034	6	16	aux	aux	PROPN
mkg-25034	6	17	system	system	NOUN
mkg-25034	6	18	.	.	PUNCT
mkg-25034	7	1	susceptibility	susceptibility	NOUN
mkg-25034	7	2	and	and	CCONJ
mkg-25034	7	3	resistance	resistance	NOUN
mkg-25034	7	4	antifungal	antifungal	ADJ
mkg-25034	7	5	tests	test	VERB
mkg-25034	7	6	on	on	ADP
mkg-25034	7	7	the	the	DET
mkg-25034	7	8	candida	candida	PROPN
mkg-25034	7	9	species	specie	NOUN
mkg-25034	7	10	were	be	AUX
mkg-25034	7	11	performed	perform	VERB
mkg-25034	7	12	using	use	VERB
mkg-25034	7	13	a	a	DET
mkg-25034	7	14	fungus	fungus	NOUN
mkg-25034	7	15	atb	atb	PROPN
mkg-25034	7	16	kit	kit	PROPN
mkg-25034	7	17	.	.	PUNCT
mkg-25034	8	1	results	result	NOUN
mkg-25034	8	2	:	:	PUNCT
mkg-25034	8	3	candida	candida	NOUN
mkg-25034	8	4	albicans	albican	NOUN
mkg-25034	8	5	was	be	AUX
mkg-25034	8	6	the	the	DET
mkg-25034	8	7	most	most	ADV
mkg-25034	8	8	dominant	dominant	ADJ
mkg-25034	8	9	species	specie	NOUN
mkg-25034	8	10	found	find	VERB
mkg-25034	8	11	from	from	ADP
mkg-25034	8	12	98	98	NUM
mkg-25034	8	13	subjects	subject	NOUN
mkg-25034	8	14	(	(	PUNCT
mkg-25034	8	15	95	95	NUM
mkg-25034	8	16	%	%	NOUN
mkg-25034	8	17	)	)	PUNCT
mkg-25034	8	18	.	.	PUNCT
mkg-25034	9	1	the	the	DET
mkg-25034	9	2	rest	rest	NOUN
mkg-25034	9	3	were	be	AUX
mkg-25034	9	4	other	other	ADJ
mkg-25034	9	5	candida	candida	PROPN
mkg-25034	9	6	species	specie	NOUN
mkg-25034	9	7	.	.	PUNCT
mkg-25034	10	1	there	there	PRON
mkg-25034	10	2	are	be	VERB
mkg-25034	10	3	41	41	NUM
mkg-25034	10	4	subjects	subject	NOUN
mkg-25034	10	5	(	(	PUNCT
mkg-25034	10	6	42	42	NUM
mkg-25034	10	7	%	%	NOUN
mkg-25034	10	8	)	)	PUNCT
mkg-25034	10	9	with	with	ADP
mkg-25034	10	10	a	a	DET
mkg-25034	10	11	history	history	NOUN
mkg-25034	10	12	of	of	ADP
mkg-25034	10	13	oral	oral	ADJ
mkg-25034	10	14	candidiasis	candidiasis	NOUN
mkg-25034	10	15	,	,	PUNCT
mkg-25034	10	16	and	and	CCONJ
mkg-25034	10	17	57	57	NUM
mkg-25034	10	18	subjects	subject	NOUN
mkg-25034	10	19	(	(	PUNCT
mkg-25034	10	20	58	58	NUM
mkg-25034	10	21	%	%	NOUN
mkg-25034	10	22	)	)	PUNCT
mkg-25034	10	23	without	without	ADP
mkg-25034	10	24	.	.	PUNCT
mkg-25034	11	1	the	the	DET
mkg-25034	11	2	history	history	NOUN
mkg-25034	11	3	of	of	ADP
mkg-25034	11	4	those	those	PRON
mkg-25034	11	5	who	who	PRON
mkg-25034	11	6	used	use	VERB
mkg-25034	11	7	antifungals	antifungal	NOUN
mkg-25034	11	8	were	be	AUX
mkg-25034	11	9	:	:	PUNCT
mkg-25034	11	10	nystatin	nystatin	NOUN
mkg-25034	11	11	=	=	SYM
mkg-25034	11	12	60	60	NUM
mkg-25034	11	13	subjects	subject	NOUN
mkg-25034	11	14	(	(	PUNCT
mkg-25034	11	15	61	61	NUM
mkg-25034	11	16	%	%	NOUN
mkg-25034	11	17	)	)	PUNCT
mkg-25034	11	18	,	,	PUNCT
mkg-25034	11	19	fluconazole	fluconazole	NOUN
mkg-25034	11	20	=	=	SYM
mkg-25034	11	21	39	39	NUM
mkg-25034	11	22	subjects	subject	NOUN
mkg-25034	11	23	(	(	PUNCT
mkg-25034	11	24	40	40	NUM
mkg-25034	11	25	%	%	NOUN
mkg-25034	11	26	)	)	PUNCT
mkg-25034	11	27	,	,	PUNCT
mkg-25034	11	28	and	and	CCONJ
mkg-25034	11	29	ketoconazole	ketoconazole	NOUN
mkg-25034	11	30	=	=	SYM
mkg-25034	11	31	two	two	NUM
mkg-25034	11	32	subjects	subject	NOUN
mkg-25034	11	33	(	(	PUNCT
mkg-25034	11	34	2	2	NUM
mkg-25034	11	35	%	%	NOUN
mkg-25034	11	36	)	)	PUNCT
mkg-25034	11	37	.	.	PUNCT
mkg-25034	12	1	these	these	DET
mkg-25034	12	2	antifungals	antifungal	NOUN
mkg-25034	12	3	have	have	VERB
mkg-25034	12	4	a	a	DET
mkg-25034	12	5	susceptibility	susceptibility	NOUN
mkg-25034	12	6	above	above	ADP
mkg-25034	12	7	80	80	NUM
mkg-25034	12	8	%	%	NOUN
mkg-25034	12	9	against	against	ADP
mkg-25034	12	10	c.	c.	NOUN
mkg-25034	12	11	albicans	albican	NOUN
mkg-25034	12	12	,	,	PUNCT
mkg-25034	12	13	except	except	SCONJ
mkg-25034	12	14	the	the	DET
mkg-25034	12	15	nystatin	nystatin	PROPN
mkg-25034	12	16	group	group	NOUN
mkg-25034	12	17	(	(	PUNCT
mkg-25034	12	18	79	79	NUM
mkg-25034	12	19	%	%	NOUN
mkg-25034	12	20	)	)	PUNCT
mkg-25034	12	21	(	(	PUNCT
mkg-25034	12	22	p>0.05	p>0.05	NOUN
mkg-25034	12	23	;	;	PUNCT
mkg-25034	12	24	0.628	0.628	NUM
mkg-25034	12	25	)	)	PUNCT
mkg-25034	12	26	,	,	PUNCT
mkg-25034	12	27	but	but	CCONJ
mkg-25034	12	28	fluconazole	fluconazole	NOUN
mkg-25034	12	29	has	have	VERB
mkg-25034	12	30	a	a	DET
mkg-25034	12	31	strong	strong	ADJ
mkg-25034	12	32	correlation	correlation	NOUN
mkg-25034	12	33	(	(	PUNCT
mkg-25034	12	34	r=0.820	r=0.820	NOUN
mkg-25034	12	35	)	)	PUNCT
mkg-25034	12	36	to	to	ADP
mkg-25034	12	37	susceptibility	susceptibility	NOUN
mkg-25034	12	38	,	,	PUNCT
mkg-25034	12	39	susceptibility	susceptibility	NOUN
mkg-25034	12	40	-	-	PUNCT
mkg-25034	12	41	dependent	dependent	ADJ
mkg-25034	12	42	dose	dose	NOUN
mkg-25034	12	43	,	,	PUNCT
mkg-25034	12	44	and	and	CCONJ
mkg-25034	12	45	resistance	resistance	NOUN
mkg-25034	12	46	.	.	PUNCT
mkg-25034	13	1	conclusion	conclusion	NOUN
mkg-25034	13	2	:	:	PUNCT
mkg-25034	13	3	candida	candida	NOUN
mkg-25034	13	4	albicans	albican	NOUN
mkg-25034	13	5	was	be	AUX
mkg-25034	13	6	dominant	dominant	ADJ
mkg-25034	13	7	in	in	ADP
mkg-25034	13	8	the	the	DET
mkg-25034	13	9	saliva	saliva	NOUN
mkg-25034	13	10	of	of	ADP
mkg-25034	13	11	hiv	hiv	PROPN
mkg-25034	13	12	/	/	SYM
mkg-25034	13	13	aids	aids	PROPN
mkg-25034	13	14	patients	patient	NOUN
mkg-25034	13	15	.	.	PUNCT
mkg-25034	14	1	this	this	DET
mkg-25034	14	2	fungus	fungus	NOUN
mkg-25034	14	3	was	be	AUX
mkg-25034	14	4	effectively	effectively	ADV
mkg-25034	14	5	treated	treat	VERB
mkg-25034	14	6	by	by	ADP
mkg-25034	14	7	fluconazole	fluconazole	NOUN
mkg-25034	14	8	,	,	PUNCT
mkg-25034	14	9	ketoconazole	ketoconazole	NOUN
mkg-25034	14	10	and	and	CCONJ
mkg-25034	14	11	nystatin	nystatin	NOUN
mkg-25034	14	12	.	.	PUNCT
mkg-25034	15	1	these	these	DET
mkg-25034	15	2	antifungals	antifungal	NOUN
mkg-25034	15	3	had	have	VERB
mkg-25034	15	4	a	a	DET
mkg-25034	15	5	high	high	ADJ
mkg-25034	15	6	susceptibility	susceptibility	NOUN
mkg-25034	15	7	at	at	ADP
mkg-25034	15	8	≤	≤	NOUN
mkg-25034	15	9	8	8	NUM
mkg-25034	15	10	μg	μg	NOUN
mkg-25034	15	11	/	/	SYM
mkg-25034	15	12	ml	ml	NOUN
mkg-25034	15	13	to	to	ADP
mkg-25034	15	14	c.	c.	NOUN
mkg-25034	15	15	albicans	albican	NOUN
mkg-25034	15	16	.	.	PUNCT
mkg-25034	16	1	keywords	keyword	NOUN
mkg-25034	16	2	:	:	PUNCT
mkg-25034	16	3	antifungal	antifungal	ADJ
mkg-25034	16	4	;	;	PUNCT
mkg-25034	16	5	candida	candida	NOUN
mkg-25034	16	6	albicans	albican	NOUN
mkg-25034	16	7	;	;	PUNCT
mkg-25034	16	8	hiv	hiv	PROPN
mkg-25034	16	9	/	/	SYM
mkg-25034	16	10	aids	aids	PROPN
mkg-25034	16	11	;	;	PUNCT
mkg-25034	16	12	susceptibility	susceptibility	NOUN
mkg-25034	16	13	and	and	CCONJ
mkg-25034	16	14	resistance	resistance	NOUN
mkg-25034	16	15	correspondence	correspondence	NOUN
mkg-25034	16	16	:	:	PUNCT
mkg-25034	16	17	sri	sri	PROPN
mkg-25034	16	18	rezeki	rezeki	PROPN
mkg-25034	16	19	,	,	PUNCT
mkg-25034	16	20	department	department	NOUN
mkg-25034	16	21	of	of	ADP
mkg-25034	16	22	oral	oral	ADJ
mkg-25034	16	23	medicine	medicine	NOUN
mkg-25034	16	24	,	,	PUNCT
mkg-25034	16	25	faculty	faculty	NOUN
mkg-25034	16	26	of	of	ADP
mkg-25034	16	27	dentistry	dentistry	NOUN
mkg-25034	16	28	,	,	PUNCT
mkg-25034	16	29	universitas	universita	NOUN
mkg-25034	16	30	syiah	syiah	PROPN
mkg-25034	16	31	kuala	kuala	PROPN
mkg-25034	16	32	.	.	PUNCT
mkg-25034	17	1	jl	jl	PROPN
mkg-25034	17	2	.	.	PUNCT
mkg-25034	18	1	teuku	teuku	PRON
mkg-25034	18	2	nyak	nyak	PROPN
mkg-25034	18	3	arief	arief	PROPN
mkg-25034	18	4	darussalam	darussalam	PROPN
mkg-25034	18	5	,	,	PUNCT
mkg-25034	18	6	banda	banda	PROPN
mkg-25034	18	7	aceh	aceh	PROPN
mkg-25034	18	8	,	,	PUNCT
mkg-25034	18	9	23111	23111	NUM
mkg-25034	18	10	indonesia	indonesia	PROPN
mkg-25034	18	11	email	email	NOUN
mkg-25034	18	12	:	:	PUNCT
mkg-25034	18	13	iy_99fkg@unsyiah.ac.id	iy_99fkg@unsyiah.ac.id	PROPN
mkg-25034	18	14	introduction	introduction	NOUN
mkg-25034	18	15	in	in	ADP
mkg-25034	18	16	indonesia	indonesia	PROPN
mkg-25034	18	17	(	(	PUNCT
mkg-25034	18	18	data	datum	NOUN
mkg-25034	18	19	2005–2019	2005–2019	NUM
mkg-25034	18	20	)	)	PUNCT
mkg-25034	18	21	,	,	PUNCT
mkg-25034	18	22	the	the	DET
mkg-25034	18	23	number	number	NOUN
mkg-25034	18	24	of	of	ADP
mkg-25034	18	25	people	people	NOUN
mkg-25034	18	26	living	live	VERB
mkg-25034	18	27	with	with	ADP
mkg-25034	18	28	human	human	ADJ
mkg-25034	18	29	immunodeficiency	immunodeficiency	NOUN
mkg-25034	18	30	virus	virus	NOUN
mkg-25034	18	31	(	(	PUNCT
mkg-25034	18	32	hiv	hiv	PROPN
mkg-25034	18	33	)	)	PUNCT
mkg-25034	18	34	was	be	AUX
mkg-25034	18	35	338,363	338,363	NUM
mkg-25034	18	36	.	.	PUNCT
mkg-25034	19	1	meanwhile	meanwhile	ADV
mkg-25034	19	2	,	,	PUNCT
mkg-25034	19	3	an	an	DET
mkg-25034	19	4	acquired	acquire	VERB
mkg-25034	19	5	immunodeficiency	immunodeficiency	NOUN
mkg-25034	19	6	syndrome	syndrome	NOUN
mkg-25034	19	7	(	(	PUNCT
mkg-25034	19	8	aids	aids	PROPN
mkg-25034	19	9	)	)	PUNCT
mkg-25034	19	10	was	be	AUX
mkg-25034	19	11	reported	report	VERB
mkg-25034	19	12	in	in	ADP
mkg-25034	19	13	115,601	115,601	NUM
mkg-25034	19	14	cases.1	cases.1	NOUN
mkg-25034	19	15	one	one	NUM
mkg-25034	19	16	of	of	ADP
mkg-25034	19	17	the	the	DET
mkg-25034	19	18	conditions	condition	NOUN
mkg-25034	19	19	experienced	experience	VERB
mkg-25034	19	20	by	by	ADP
mkg-25034	19	21	people	people	NOUN
mkg-25034	19	22	with	with	ADP
mkg-25034	19	23	hiv	hiv	PROPN
mkg-25034	19	24	/	/	SYM
mkg-25034	19	25	aids	aids	PROPN
mkg-25034	19	26	is	be	AUX
mkg-25034	19	27	mucosal	mucosal	ADJ
mkg-25034	19	28	candidiasis	candidiasis	NOUN
mkg-25034	19	29	in	in	ADP
mkg-25034	19	30	the	the	DET
mkg-25034	19	31	oral	oral	ADJ
mkg-25034	19	32	,	,	PUNCT
mkg-25034	19	33	esophageal	esophageal	ADJ
mkg-25034	19	34	,	,	PUNCT
mkg-25034	19	35	or	or	CCONJ
mkg-25034	19	36	vaginal	vaginal	ADJ
mkg-25034	19	37	regions	region	NOUN
mkg-25034	19	38	.	.	PUNCT
mkg-25034	20	1	the	the	DET
mkg-25034	20	2	circumstances	circumstance	NOUN
mkg-25034	20	3	of	of	ADP
mkg-25034	20	4	oral	oral	ADJ
mkg-25034	20	5	candidiasis	candidiasis	NOUN
mkg-25034	20	6	in	in	ADP
mkg-25034	20	7	hiv	hiv	PROPN
mkg-25034	20	8	infections	infection	NOUN
mkg-25034	20	9	vary	vary	VERB
mkg-25034	20	10	from	from	ADP
mkg-25034	20	11	7	7	NUM
mkg-25034	20	12	%	%	NOUN
mkg-25034	20	13	to	to	ADP
mkg-25034	20	14	93	93	NUM
mkg-25034	20	15	%	%	NOUN
mkg-25034	20	16	,	,	PUNCT
mkg-25034	20	17	depending	depend	VERB
mkg-25034	20	18	on	on	ADP
mkg-25034	20	19	the	the	DET
mkg-25034	20	20	patient	patient	ADJ
mkg-25034	20	21	mix	mix	NOUN
mkg-25034	20	22	,	,	PUNCT
mkg-25034	20	23	diagnostic	diagnostic	ADJ
mkg-25034	20	24	criteria	criterion	NOUN
mkg-25034	20	25	,	,	PUNCT
mkg-25034	20	26	and	and	CCONJ
mkg-25034	20	27	research	research	NOUN
mkg-25034	20	28	methods.2	methods.2	PROPN
mkg-25034	20	29	it	it	PRON
mkg-25034	20	30	is	be	AUX
mkg-25034	20	31	considered	consider	VERB
mkg-25034	20	32	an	an	DET
mkg-25034	20	33	important	important	ADJ
mkg-25034	20	34	marker	marker	NOUN
mkg-25034	20	35	of	of	ADP
mkg-25034	20	36	immune	immune	ADJ
mkg-25034	20	37	decline	decline	NOUN
mkg-25034	20	38	as	as	ADP
mkg-25034	20	39	an	an	DET
mkg-25034	20	40	early	early	ADJ
mkg-25034	20	41	manifestation	manifestation	NOUN
mkg-25034	20	42	of	of	ADP
mkg-25034	20	43	hiv	hiv	PROPN
mkg-25034	20	44	infection	infection	NOUN
mkg-25034	20	45	.	.	PUNCT
mkg-25034	21	1	in	in	ADP
mkg-25034	21	2	addition	addition	NOUN
mkg-25034	21	3	,	,	PUNCT
mkg-25034	21	4	there	there	PRON
mkg-25034	21	5	is	be	VERB
mkg-25034	21	6	a	a	DET
mkg-25034	21	7	decrease	decrease	NOUN
mkg-25034	21	8	in	in	ADP
mkg-25034	21	9	cd4	cd4	PROPN
mkg-25034	21	10	lymphocyte	lymphocyte	ADJ
mkg-25034	21	11	cells	cell	NOUN
mkg-25034	21	12	<	<	X
mkg-25034	21	13	200.3	200.3	NUM
mkg-25034	21	14	oropharyngeal	oropharyngeal	ADJ
mkg-25034	21	15	and	and	CCONJ
mkg-25034	21	16	esophageal	esophageal	ADJ
mkg-25034	21	17	candidiasis	candidiasis	NOUN
mkg-25034	21	18	are	be	AUX
mkg-25034	21	19	common	common	ADJ
mkg-25034	21	20	manifestation	manifestation	NOUN
mkg-25034	21	21	in	in	ADP
mkg-25034	21	22	hiv	hiv	PROPN
mkg-25034	21	23	patients	patient	NOUN
mkg-25034	21	24	.	.	PUNCT
mkg-25034	22	1	the	the	DET
mkg-25034	22	2	disease	disease	NOUN
mkg-25034	22	3	is	be	AUX
mkg-25034	22	4	caused	cause	VERB
mkg-25034	22	5	by	by	ADP
mkg-25034	22	6	c.	c.	NOUN
mkg-25034	22	7	albicans	albican	NOUN
mkg-25034	22	8	and	and	CCONJ
mkg-25034	22	9	other	other	ADJ
mkg-25034	22	10	oral	oral	ADJ
mkg-25034	22	11	candida	candida	PROPN
mkg-25034	22	12	species	specie	NOUN
mkg-25034	22	13	.	.	PUNCT
mkg-25034	23	1	antiretroviral	antiretroviral	ADJ
mkg-25034	23	2	therapy	therapy	NOUN
mkg-25034	23	3	(	(	PUNCT
mkg-25034	23	4	art	art	NOUN
mkg-25034	23	5	)	)	PUNCT
mkg-25034	23	6	can	can	AUX
mkg-25034	23	7	reduce	reduce	VERB
mkg-25034	23	8	the	the	DET
mkg-25034	23	9	prevalence	prevalence	NOUN
mkg-25034	23	10	of	of	ADP
mkg-25034	23	11	oropharyngeal	oropharyngeal	ADJ
mkg-25034	23	12	and	and	CCONJ
mkg-25034	23	13	esophageal	esophageal	ADJ
mkg-25034	23	14	candidiasis	candidiasis	NOUN
mkg-25034	23	15	in	in	ADP
mkg-25034	23	16	refractory	refractory	NOUN
mkg-25034	23	17	disease.4	disease.4	PROPN
mkg-25034	23	18	the	the	DET
mkg-25034	23	19	resistance	resistance	NOUN
mkg-25034	23	20	of	of	ADP
mkg-25034	23	21	fluconazole	fluconazole	NOUN
mkg-25034	23	22	or	or	CCONJ
mkg-25034	23	23	azole	azole	NOUN
mkg-25034	23	24	is	be	AUX
mkg-25034	23	25	influenced	influence	VERB
mkg-25034	23	26	by	by	ADP
mkg-25034	23	27	repeated	repeat	VERB
mkg-25034	23	28	long	long	ADJ
mkg-25034	23	29	-	-	PUNCT
mkg-25034	23	30	term	term	NOUN
mkg-25034	23	31	exposure	exposure	NOUN
mkg-25034	23	32	.	.	PUNCT
mkg-25034	24	1	in	in	ADP
mkg-25034	24	2	this	this	DET
mkg-25034	24	3	permutation	permutation	NOUN
mkg-25034	24	4	,	,	PUNCT
mkg-25034	24	5	the	the	DET
mkg-25034	24	6	majority	majority	NOUN
mkg-25034	24	7	of	of	ADP
mkg-25034	24	8	cases	case	NOUN
mkg-25034	24	9	relate	relate	VERB
mkg-25034	24	10	to	to	ADP
mkg-25034	24	11	the	the	DET
mkg-25034	24	12	acquisition	acquisition	NOUN
mkg-25034	24	13	of	of	ADP
mkg-25034	24	14	resistance	resistance	NOUN
mkg-25034	24	15	to	to	ADP
mkg-25034	24	16	c.	c.	PROPN
mkg-25034	24	17	albicans.5	albicans.5	PROPN
mkg-25034	24	18	both	both	CCONJ
mkg-25034	24	19	local	local	ADJ
mkg-25034	24	20	and	and	CCONJ
mkg-25034	24	21	systemic	systemic	ADJ
mkg-25034	24	22	predisposing	predispose	VERB
mkg-25034	24	23	factors	factor	NOUN
mkg-25034	24	24	lead	lead	VERB
mkg-25034	24	25	to	to	ADP
mkg-25034	24	26	candida	candida	PROPN
mkg-25034	24	27	’s	’s	PART
mkg-25034	24	28	commensal	commensal	NOUN
mkg-25034	24	29	changes	change	NOUN
mkg-25034	24	30	,	,	PUNCT
mkg-25034	24	31	developing	develop	VERB
mkg-25034	24	32	into	into	ADP
mkg-25034	24	33	oral	oral	ADJ
mkg-25034	24	34	candidiasis	candidiasis	NOUN
mkg-25034	24	35	.	.	PUNCT
mkg-25034	25	1	these	these	DET
mkg-25034	25	2	infections	infection	NOUN
mkg-25034	25	3	of	of	ADP
mkg-25034	25	4	esophageal	esophageal	ADJ
mkg-25034	25	5	candidiasis	candidiasis	NOUN
mkg-25034	25	6	,	,	PUNCT
mkg-25034	25	7	as	as	ADV
mkg-25034	25	8	well	well	ADV
mkg-25034	25	9	as	as	ADP
mkg-25034	25	10	morbidity	morbidity	NOUN
mkg-25034	25	11	,	,	PUNCT
mkg-25034	25	12	and	and	CCONJ
mkg-25034	25	13	even	even	ADV
mkg-25034	25	14	mortality	mortality	NOUN
mkg-25034	25	15	,	,	PUNCT
mkg-25034	25	16	were	be	AUX
mkg-25034	25	17	reported	report	VERB
mkg-25034	25	18	as	as	ADP
mkg-25034	25	19	secondary	secondary	ADJ
mkg-25034	25	20	complications.6	complications.6	PROPN
mkg-25034	25	21	dental	dental	ADJ
mkg-25034	25	22	journal	journal	NOUN
mkg-25034	25	23	(	(	PUNCT
mkg-25034	25	24	majalah	majalah	PROPN
mkg-25034	25	25	kedokteran	kedokteran	PROPN
mkg-25034	25	26	gigi	gigi	PROPN
mkg-25034	25	27	)	)	PUNCT
mkg-25034	25	28	p	p	X
mkg-25034	25	29	-	-	PUNCT
mkg-25034	25	30	issn	issn	NOUN
mkg-25034	25	31	:	:	PUNCT
mkg-25034	25	32	1978	1978	NUM
mkg-25034	25	33	-	-	SYM
mkg-25034	25	34	3728	3728	NUM
mkg-25034	25	35	;	;	PUNCT
mkg-25034	25	36	e	e	X
mkg-25034	25	37	-	-	PUNCT
mkg-25034	25	38	issn	issn	ADJ
mkg-25034	25	39	:	:	PUNCT
mkg-25034	25	40	2442	2442	NUM
mkg-25034	25	41	-	-	SYM
mkg-25034	25	42	9740	9740	NUM
mkg-25034	25	43	.	.	PUNCT
mkg-25034	26	1	accredited	accredit	VERB
mkg-25034	26	2	no	no	PRON
mkg-25034	26	3	.	.	PUNCT
mkg-25034	26	4	32a	32a	NOUN
mkg-25034	26	5	/	/	SYM
mkg-25034	26	6	e	e	NOUN
mkg-25034	26	7	/	/	SYM
mkg-25034	26	8	kpt/2017	kpt/2017	X
mkg-25034	26	9	.	.	PUNCT
mkg-25034	27	1	open	open	ADJ
mkg-25034	27	2	access	access	NOUN
mkg-25034	27	3	under	under	ADP
mkg-25034	27	4	cc	cc	NOUN
mkg-25034	27	5	-	-	PUNCT
mkg-25034	27	6	by	by	ADP
mkg-25034	27	7	-	-	PUNCT
mkg-25034	27	8	sa	sa	NOUN
mkg-25034	27	9	license	license	NOUN
mkg-25034	27	10	.	.	PUNCT
mkg-25034	28	1	available	available	ADJ
mkg-25034	28	2	at	at	ADP
mkg-25034	28	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	28	4	doi	doi	NOUN
mkg-25034	28	5	:	:	PUNCT
mkg-25034	28	6	10.20473	10.20473	NUM
mkg-25034	28	7	/	/	SYM
mkg-25034	28	8	j.djmkg.v54.i2.p82–86	j.djmkg.v54.i2.p82–86	ADJ
mkg-25034	28	9	mailto:iy_99fkg@unsyiah.ac.id	mailto:iy_99fkg@unsyiah.ac.id	PROPN
mkg-25034	28	10	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	28	11	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	NOUN
mkg-25034	28	12	83rezeki	83rezeki	NUM
mkg-25034	28	13	et	et	PROPN
mkg-25034	28	14	al./dent	al./dent	PROPN
mkg-25034	28	15	.	.	PUNCT
mkg-25034	29	1	j.	j.	PROPN
mkg-25034	29	2	(	(	PUNCT
mkg-25034	29	3	majalah	majalah	PROPN
mkg-25034	29	4	kedokteran	kedokteran	PROPN
mkg-25034	29	5	gigi	gigi	PROPN
mkg-25034	29	6	)	)	PUNCT
mkg-25034	29	7	2021	2021	NUM
mkg-25034	29	8	june	june	PROPN
mkg-25034	29	9	;	;	PUNCT
mkg-25034	29	10	54(2	54(2	NUM
mkg-25034	29	11	):	):	PUNCT
mkg-25034	29	12	82–86	82–86	NUM
mkg-25034	29	13	the	the	DET
mkg-25034	29	14	antifungal	antifungal	ADJ
mkg-25034	29	15	drugs	drug	NOUN
mkg-25034	29	16	fluconazole	fluconazole	NOUN
mkg-25034	29	17	,	,	PUNCT
mkg-25034	29	18	ketoconazole	ketoconazole	NOUN
mkg-25034	29	19	,	,	PUNCT
mkg-25034	29	20	and	and	CCONJ
mkg-25034	29	21	nystatin	nystatin	NOUN
mkg-25034	29	22	effectively	effectively	ADV
mkg-25034	29	23	treat	treat	VERB
mkg-25034	29	24	hiv	hiv	PROPN
mkg-25034	29	25	oropharyngeal	oropharyngeal	NOUN
mkg-25034	29	26	and	and	CCONJ
mkg-25034	29	27	esophageal	esophageal	ADJ
mkg-25034	29	28	candidiasis	candidiasis	NOUN
mkg-25034	29	29	.	.	PUNCT
mkg-25034	30	1	therefore	therefore	ADV
mkg-25034	30	2	,	,	PUNCT
mkg-25034	30	3	their	their	PRON
mkg-25034	30	4	widespread	widespread	ADJ
mkg-25034	30	5	use	use	NOUN
mkg-25034	30	6	has	have	VERB
mkg-25034	30	7	the	the	DET
mkg-25034	30	8	potential	potential	NOUN
mkg-25034	30	9	to	to	PART
mkg-25034	30	10	increase	increase	VERB
mkg-25034	30	11	c.	c.	NOUN
mkg-25034	30	12	albicans	albican	NOUN
mkg-25034	30	13	resistance	resistance	NOUN
mkg-25034	30	14	.	.	PUNCT
mkg-25034	31	1	these	these	DET
mkg-25034	31	2	antifungals	antifungal	NOUN
mkg-25034	31	3	,	,	PUNCT
mkg-25034	31	4	when	when	SCONJ
mkg-25034	31	5	observed	observe	VERB
mkg-25034	31	6	in	in	ADP
mkg-25034	31	7	different	different	ADJ
mkg-25034	31	8	groups	group	NOUN
mkg-25034	31	9	of	of	ADP
mkg-25034	31	10	hiv	hiv	PROPN
mkg-25034	31	11	patients	patient	NOUN
mkg-25034	31	12	,	,	PUNCT
mkg-25034	31	13	were	be	AUX
mkg-25034	31	14	resistant	resistant	ADJ
mkg-25034	31	15	to	to	ADP
mkg-25034	31	16	c.	c.	NOUN
mkg-25034	31	17	albicans	albican	NOUN
mkg-25034	31	18	.	.	PUNCT
mkg-25034	32	1	one	one	NUM
mkg-25034	32	2	-	-	PUNCT
mkg-25034	32	3	third	third	NOUN
mkg-25034	32	4	of	of	ADP
mkg-25034	32	5	c.	c.	NOUN
mkg-25034	32	6	albicans	albican	NOUN
mkg-25034	32	7	hiv	hiv	PROPN
mkg-25034	32	8	isolates	isolate	NOUN
mkg-25034	32	9	were	be	AUX
mkg-25034	32	10	resistant	resistant	ADJ
mkg-25034	32	11	to	to	ADP
mkg-25034	32	12	several	several	ADJ
mkg-25034	32	13	antifungals.7	antifungals.7	NOUN
mkg-25034	32	14	mohamadi	mohamadi	NOUN
mkg-25034	32	15	et	et	PROPN
mkg-25034	32	16	al.8	al.8	PROPN
mkg-25034	32	17	revealed	reveal	VERB
mkg-25034	32	18	that	that	SCONJ
mkg-25034	32	19	c.	c.	NOUN
mkg-25034	32	20	albicans	albican	NOUN
mkg-25034	32	21	remains	remain	VERB
mkg-25034	32	22	the	the	DET
mkg-25034	32	23	most	most	ADV
mkg-25034	32	24	common	common	ADJ
mkg-25034	32	25	species	specie	NOUN
mkg-25034	32	26	that	that	PRON
mkg-25034	32	27	rapidly	rapidly	ADV
mkg-25034	32	28	developed	develop	VERB
mkg-25034	32	29	into	into	ADP
mkg-25034	32	30	fluconazole	fluconazole	NOUN
mkg-25034	32	31	,	,	PUNCT
mkg-25034	32	32	ketoconazole	ketoconazole	NOUN
mkg-25034	32	33	,	,	PUNCT
mkg-25034	32	34	and	and	CCONJ
mkg-25034	32	35	nystatin	nystatin	NOUN
mkg-25034	32	36	resistant	resistant	ADJ
mkg-25034	32	37	.	.	PUNCT
mkg-25034	33	1	the	the	DET
mkg-25034	33	2	resistance	resistance	NOUN
mkg-25034	33	3	of	of	ADP
mkg-25034	33	4	these	these	DET
mkg-25034	33	5	antifungals	antifungal	NOUN
mkg-25034	33	6	has	have	VERB
mkg-25034	33	7	an	an	DET
mkg-25034	33	8	impact	impact	NOUN
mkg-25034	33	9	on	on	ADP
mkg-25034	33	10	dehydration	dehydration	NOUN
mkg-25034	33	11	,	,	PUNCT
mkg-25034	33	12	malnutrition	malnutrition	NOUN
mkg-25034	33	13	,	,	PUNCT
mkg-25034	33	14	and	and	CCONJ
mkg-25034	33	15	increased	increase	VERB
mkg-25034	33	16	hiv	hiv	PROPN
mkg-25034	33	17	infection	infection	NOUN
mkg-25034	33	18	.	.	PUNCT
mkg-25034	34	1	it	it	PRON
mkg-25034	34	2	is	be	AUX
mkg-25034	34	3	often	often	ADV
mkg-25034	34	4	reported	report	VERB
mkg-25034	34	5	in	in	ADP
mkg-25034	34	6	cases	case	NOUN
mkg-25034	34	7	of	of	ADP
mkg-25034	34	8	esophageal	esophageal	ADJ
mkg-25034	34	9	and	and	CCONJ
mkg-25034	34	10	oropharyngeal	oropharyngeal	NOUN
mkg-25034	34	11	candidiasis	candidiasis	NOUN
mkg-25034	34	12	.	.	PUNCT
mkg-25034	35	1	monroy	monroy	NOUN
mkg-25034	35	2	-	-	PUNCT
mkg-25034	35	3	pérez	pérez	NOUN
mkg-25034	35	4	et	et	PROPN
mkg-25034	35	5	al.9	al.9	PROPN
mkg-25034	35	6	reported	report	VERB
mkg-25034	35	7	that	that	DET
mkg-25034	35	8	fluconazole	fluconazole	NOUN
mkg-25034	35	9	,	,	PUNCT
mkg-25034	35	10	ketoconazole	ketoconazole	NOUN
mkg-25034	35	11	,	,	PUNCT
mkg-25034	35	12	and	and	CCONJ
mkg-25034	35	13	nystatin	nystatin	NOUN
mkg-25034	35	14	have	have	VERB
mkg-25034	35	15	varying	vary	VERB
mkg-25034	35	16	susceptibility	susceptibility	NOUN
mkg-25034	35	17	to	to	ADP
mkg-25034	35	18	c.	c.	NOUN
mkg-25034	35	19	albicans	albican	NOUN
mkg-25034	35	20	.	.	PUNCT
mkg-25034	36	1	however	however	ADV
mkg-25034	36	2	,	,	PUNCT
mkg-25034	36	3	these	these	DET
mkg-25034	36	4	three	three	NUM
mkg-25034	36	5	antifungals	antifungal	NOUN
mkg-25034	36	6	have	have	VERB
mkg-25034	36	7	the	the	DET
mkg-25034	36	8	same	same	ADJ
mkg-25034	36	9	principle	principle	ADJ
mkg-25034	36	10	action	action	NOUN
mkg-25034	36	11	for	for	ADP
mkg-25034	36	12	inhibiting	inhibit	VERB
mkg-25034	36	13	the	the	DET
mkg-25034	36	14	development	development	NOUN
mkg-25034	36	15	of	of	ADP
mkg-25034	36	16	c.	c.	NOUN
mkg-25034	36	17	albicans	albican	NOUN
mkg-25034	36	18	by	by	ADP
mkg-25034	36	19	damaging	damage	VERB
mkg-25034	36	20	the	the	DET
mkg-25034	36	21	cell	cell	NOUN
mkg-25034	36	22	walls	wall	NOUN
mkg-25034	36	23	and	and	CCONJ
mkg-25034	36	24	inhibiting	inhibit	VERB
mkg-25034	36	25	synthesis	synthesis	NOUN
mkg-25034	36	26	protein.10	protein.10	NOUN
mkg-25034	36	27	susceptibility	susceptibility	NOUN
mkg-25034	36	28	of	of	ADP
mkg-25034	36	29	fluconazole	fluconazole	NOUN
mkg-25034	36	30	,	,	PUNCT
mkg-25034	36	31	ketoconazole	ketoconazole	NOUN
mkg-25034	36	32	,	,	PUNCT
mkg-25034	36	33	and	and	CCONJ
mkg-25034	36	34	nystatin	nystatin	NOUN
mkg-25034	36	35	to	to	ADP
mkg-25034	36	36	c.	c.	NOUN
mkg-25034	36	37	albicans	albican	NOUN
mkg-25034	36	38	in	in	ADP
mkg-25034	36	39	hiv	hiv	PROPN
mkg-25034	36	40	/	/	SYM
mkg-25034	36	41	aids	aid	NOUN
mkg-25034	36	42	patients	patient	NOUN
mkg-25034	36	43	can	can	AUX
mkg-25034	36	44	be	be	AUX
mkg-25034	36	45	used	use	VERB
mkg-25034	36	46	as	as	ADP
mkg-25034	36	47	a	a	DET
mkg-25034	36	48	reference	reference	NOUN
mkg-25034	36	49	for	for	ADP
mkg-25034	36	50	determining	determine	VERB
mkg-25034	36	51	relevant	relevant	ADJ
mkg-25034	36	52	and	and	CCONJ
mkg-25034	36	53	appropriate	appropriate	ADJ
mkg-25034	36	54	doses	dose	NOUN
mkg-25034	36	55	for	for	ADP
mkg-25034	36	56	hiv	hiv	PROPN
mkg-25034	36	57	/	/	SYM
mkg-25034	36	58	aids	aids	PROPN
mkg-25034	36	59	oral	oral	ADJ
mkg-25034	36	60	candidiasis	candidiasis	NOUN
mkg-25034	36	61	,	,	PUNCT
mkg-25034	36	62	which	which	PRON
mkg-25034	36	63	can	can	AUX
mkg-25034	36	64	reduce	reduce	VERB
mkg-25034	36	65	the	the	DET
mkg-25034	36	66	prevalence	prevalence	NOUN
mkg-25034	36	67	of	of	ADP
mkg-25034	36	68	resistance	resistance	NOUN
mkg-25034	36	69	.	.	PUNCT
mkg-25034	37	1	this	this	DET
mkg-25034	37	2	study	study	NOUN
mkg-25034	37	3	evaluated	evaluate	VERB
mkg-25034	37	4	the	the	DET
mkg-25034	37	5	susceptibility	susceptibility	NOUN
mkg-25034	37	6	of	of	ADP
mkg-25034	37	7	antifungals	antifungal	NOUN
mkg-25034	37	8	to	to	ADP
mkg-25034	37	9	oral	oral	ADJ
mkg-25034	37	10	c.	c.	NOUN
mkg-25034	37	11	albicans	albican	NOUN
mkg-25034	37	12	isolates	isolate	NOUN
mkg-25034	37	13	from	from	ADP
mkg-25034	37	14	hiv	hiv	PROPN
mkg-25034	37	15	/	/	SYM
mkg-25034	37	16	aids	aids	PROPN
mkg-25034	37	17	patients	patient	NOUN
mkg-25034	37	18	.	.	PUNCT
mkg-25034	38	1	materials	material	NOUN
mkg-25034	38	2	and	and	CCONJ
mkg-25034	38	3	methods	method	NOUN
mkg-25034	38	4	the	the	DET
mkg-25034	38	5	research	research	NOUN
mkg-25034	38	6	was	be	AUX
mkg-25034	38	7	approved	approve	VERB
mkg-25034	38	8	ethical	ethical	ADJ
mkg-25034	38	9	clearance	clearance	NOUN
mkg-25034	38	10	by	by	ADP
mkg-25034	38	11	the	the	DET
mkg-25034	38	12	faculty	faculty	NOUN
mkg-25034	38	13	of	of	ADP
mkg-25034	38	14	dentistry	dentistry	NOUN
mkg-25034	38	15	,	,	PUNCT
mkg-25034	38	16	universitas	universita	NOUN
mkg-25034	38	17	syiah	syiah	PROPN
mkg-25034	38	18	kuala	kuala	PROPN
mkg-25034	38	19	,	,	PUNCT
mkg-25034	38	20	banda	banda	PROPN
mkg-25034	38	21	aceh	aceh	PROPN
mkg-25034	38	22	,	,	PUNCT
mkg-25034	38	23	indonesia	indonesia	PROPN
mkg-25034	38	24	,	,	PUNCT
mkg-25034	38	25	no.187	no.187	PROPN
mkg-25034	38	26	/	/	SYM
mkg-25034	38	27	ke	ke	NOUN
mkg-25034	38	28	/	/	SYM
mkg-25034	38	29	fkg/2020	fkg/2020	NOUN
mkg-25034	38	30	.	.	PUNCT
mkg-25034	39	1	saliva	saliva	NOUN
mkg-25034	39	2	was	be	AUX
mkg-25034	39	3	collected	collect	VERB
mkg-25034	39	4	from	from	ADP
mkg-25034	39	5	98	98	NUM
mkg-25034	39	6	people	people	NOUN
mkg-25034	39	7	with	with	ADP
mkg-25034	39	8	hiv	hiv	PROPN
mkg-25034	39	9	/	/	SYM
mkg-25034	39	10	aids	aids	PROPN
mkg-25034	39	11	at	at	ADP
mkg-25034	39	12	the	the	DET
mkg-25034	39	13	aids	aids	PROPN
mkg-25034	39	14	center	center	PROPN
mkg-25034	39	15	of	of	ADP
mkg-25034	39	16	cipto	cipto	PROPN
mkg-25034	39	17	mangunkusumo	mangunkusumo	PROPN
mkg-25034	39	18	hospital	hospital	PROPN
mkg-25034	39	19	(	(	PUNCT
mkg-25034	39	20	rscm	rscm	NOUN
mkg-25034	39	21	)	)	PUNCT
mkg-25034	39	22	,	,	PUNCT
mkg-25034	39	23	jakarta	jakarta	PROPN
mkg-25034	39	24	,	,	PUNCT
mkg-25034	39	25	indonesia	indonesia	PROPN
mkg-25034	39	26	.	.	PUNCT
mkg-25034	40	1	the	the	DET
mkg-25034	40	2	isolation	isolation	NOUN
mkg-25034	40	3	and	and	CCONJ
mkg-25034	40	4	characterization	characterization	NOUN
mkg-25034	40	5	of	of	ADP
mkg-25034	40	6	candida	candida	PROPN
mkg-25034	40	7	species	specie	NOUN
mkg-25034	40	8	from	from	ADP
mkg-25034	40	9	the	the	DET
mkg-25034	40	10	samples	sample	NOUN
mkg-25034	40	11	were	be	AUX
mkg-25034	40	12	carried	carry	VERB
mkg-25034	40	13	out	out	ADP
mkg-25034	40	14	at	at	ADP
mkg-25034	40	15	the	the	DET
mkg-25034	40	16	microbiology	microbiology	NOUN
mkg-25034	40	17	laboratory	laboratory	NOUN
mkg-25034	40	18	,	,	PUNCT
mkg-25034	40	19	faculty	faculty	NOUN
mkg-25034	40	20	of	of	ADP
mkg-25034	40	21	medicine	medicine	NOUN
mkg-25034	40	22	,	,	PUNCT
mkg-25034	40	23	university	university	NOUN
mkg-25034	40	24	of	of	ADP
mkg-25034	40	25	indonesia	indonesia	PROPN
mkg-25034	40	26	.	.	PUNCT
mkg-25034	41	1	criteria	criterion	NOUN
mkg-25034	41	2	for	for	ADP
mkg-25034	41	3	inclusion	inclusion	NOUN
mkg-25034	41	4	were	be	AUX
mkg-25034	41	5	patients	patient	NOUN
mkg-25034	41	6	with	with	ADP
mkg-25034	41	7	hiv	hiv	PROPN
mkg-25034	41	8	/	/	SYM
mkg-25034	41	9	aids	aids	PROPN
mkg-25034	41	10	who	who	PRON
mkg-25034	41	11	had	have	AUX
mkg-25034	41	12	not	not	PART
mkg-25034	41	13	used	use	VERB
mkg-25034	41	14	antifungal	antifungal	ADJ
mkg-25034	41	15	drugs	drug	NOUN
mkg-25034	41	16	for	for	ADP
mkg-25034	41	17	the	the	DET
mkg-25034	41	18	previous	previous	ADJ
mkg-25034	41	19	week	week	NOUN
mkg-25034	41	20	,	,	PUNCT
mkg-25034	41	21	were	be	AUX
mkg-25034	41	22	communicative	communicative	ADJ
mkg-25034	41	23	and	and	CCONJ
mkg-25034	41	24	were	be	AUX
mkg-25034	41	25	cooperative	cooperative	ADJ
mkg-25034	41	26	.	.	PUNCT
mkg-25034	42	1	the	the	DET
mkg-25034	42	2	patients	patient	NOUN
mkg-25034	42	3	included	include	VERB
mkg-25034	42	4	male	male	ADJ
mkg-25034	42	5	and	and	CCONJ
mkg-25034	42	6	female	female	ADJ
mkg-25034	42	7	patients	patient	NOUN
mkg-25034	42	8	.	.	PUNCT
mkg-25034	43	1	meanwhile	meanwhile	ADV
mkg-25034	43	2	,	,	PUNCT
mkg-25034	43	3	the	the	DET
mkg-25034	43	4	exclusion	exclusion	NOUN
mkg-25034	43	5	criteria	criterion	NOUN
mkg-25034	43	6	included	include	VERB
mkg-25034	43	7	people	people	NOUN
mkg-25034	43	8	living	live	VERB
mkg-25034	43	9	with	with	ADP
mkg-25034	43	10	hiv	hiv	PROPN
mkg-25034	43	11	/	/	SYM
mkg-25034	43	12	aids	aids	PROPN
mkg-25034	43	13	who	who	PRON
mkg-25034	43	14	have	have	AUX
mkg-25034	43	15	refused	refuse	VERB
mkg-25034	43	16	to	to	PART
mkg-25034	43	17	be	be	AUX
mkg-25034	43	18	research	research	NOUN
mkg-25034	43	19	subjects	subject	NOUN
mkg-25034	43	20	,	,	PUNCT
mkg-25034	43	21	who	who	PRON
mkg-25034	43	22	have	have	AUX
mkg-25034	43	23	used	use	VERB
mkg-25034	43	24	antifungal	antifungal	ADJ
mkg-25034	43	25	drugs	drug	NOUN
mkg-25034	43	26	for	for	ADP
mkg-25034	43	27	the	the	DET
mkg-25034	43	28	past	past	ADJ
mkg-25034	43	29	week	week	NOUN
mkg-25034	43	30	,	,	PUNCT
mkg-25034	43	31	were	be	AUX
mkg-25034	43	32	non	non	ADJ
mkg-25034	43	33	-	-	ADJ
mkg-25034	43	34	communicative	communicative	ADJ
mkg-25034	43	35	and	and	CCONJ
mkg-25034	43	36	were	be	AUX
mkg-25034	43	37	non	non	ADJ
mkg-25034	43	38	-	-	ADJ
mkg-25034	43	39	cooperative	cooperative	ADJ
mkg-25034	43	40	.	.	PUNCT
mkg-25034	44	1	the	the	DET
mkg-25034	44	2	subjects	subject	NOUN
mkg-25034	44	3	were	be	AUX
mkg-25034	44	4	asked	ask	VERB
mkg-25034	44	5	to	to	PART
mkg-25034	44	6	sign	sign	VERB
mkg-25034	44	7	an	an	DET
mkg-25034	44	8	informed	informed	ADJ
mkg-25034	44	9	consent	consent	NOUN
mkg-25034	44	10	,	,	PUNCT
mkg-25034	44	11	and	and	CCONJ
mkg-25034	44	12	questionnaire	questionnaire	NOUN
mkg-25034	44	13	sheets	sheet	NOUN
mkg-25034	44	14	were	be	AUX
mkg-25034	44	15	filled	fill	VERB
mkg-25034	44	16	in	in	ADP
mkg-25034	44	17	with	with	ADP
mkg-25034	44	18	the	the	DET
mkg-25034	44	19	subjects	subject	NOUN
mkg-25034	44	20	’	'	PUNCT
mkg-25034	44	21	demographic	demographic	ADJ
mkg-25034	44	22	data	datum	NOUN
mkg-25034	44	23	obtained	obtain	VERB
mkg-25034	44	24	from	from	ADP
mkg-25034	44	25	interviews	interview	NOUN
mkg-25034	44	26	.	.	PUNCT
mkg-25034	45	1	interviews	interview	NOUN
mkg-25034	45	2	were	be	AUX
mkg-25034	45	3	conducted	conduct	VERB
mkg-25034	45	4	before	before	ADP
mkg-25034	45	5	sampling	sample	VERB
mkg-25034	45	6	,	,	PUNCT
mkg-25034	45	7	and	and	CCONJ
mkg-25034	45	8	the	the	DET
mkg-25034	45	9	medical	medical	ADJ
mkg-25034	45	10	records	record	NOUN
mkg-25034	45	11	of	of	ADP
mkg-25034	45	12	subjects	subject	NOUN
mkg-25034	45	13	were	be	AUX
mkg-25034	45	14	obtained	obtain	VERB
mkg-25034	45	15	from	from	ADP
mkg-25034	45	16	the	the	DET
mkg-25034	45	17	rscm	rscm	NOUN
mkg-25034	45	18	’s	’s	PART
mkg-25034	45	19	aids	aids	PROPN
mkg-25034	45	20	clinic	clinic	PROPN
mkg-25034	45	21	,	,	PUNCT
mkg-25034	45	22	jakarta	jakarta	PROPN
mkg-25034	45	23	,	,	PUNCT
mkg-25034	45	24	indonesia	indonesia	PROPN
mkg-25034	45	25	.	.	PUNCT
mkg-25034	46	1	the	the	DET
mkg-25034	46	2	researcher	researcher	NOUN
mkg-25034	46	3	applied	apply	VERB
mkg-25034	46	4	the	the	DET
mkg-25034	46	5	sampling	sample	VERB
mkg-25034	46	6	procedure	procedure	NOUN
mkg-25034	46	7	to	to	ADP
mkg-25034	46	8	people	people	NOUN
mkg-25034	46	9	with	with	ADP
mkg-25034	46	10	hiv	hiv	PROPN
mkg-25034	46	11	/	/	SYM
mkg-25034	46	12	aids	aid	NOUN
mkg-25034	46	13	using	use	VERB
mkg-25034	46	14	personal	personal	ADJ
mkg-25034	46	15	protective	protective	ADJ
mkg-25034	46	16	equipment	equipment	NOUN
mkg-25034	46	17	and	and	CCONJ
mkg-25034	46	18	precautions	precaution	NOUN
mkg-25034	46	19	,	,	PUNCT
mkg-25034	46	20	such	such	ADJ
mkg-25034	46	21	as	as	ADP
mkg-25034	46	22	gloves	glove	NOUN
mkg-25034	46	23	and	and	CCONJ
mkg-25034	46	24	masks	mask	NOUN
mkg-25034	46	25	,	,	PUNCT
mkg-25034	46	26	hand	hand	NOUN
mkg-25034	46	27	hygiene	hygiene	NOUN
mkg-25034	46	28	and	and	CCONJ
mkg-25034	46	29	sterility	sterility	NOUN
mkg-25034	46	30	,	,	PUNCT
mkg-25034	46	31	disposing	dispose	VERB
mkg-25034	46	32	of	of	ADP
mkg-25034	46	33	medical	medical	ADJ
mkg-25034	46	34	waste	waste	NOUN
mkg-25034	46	35	contaminated	contaminate	VERB
mkg-25034	46	36	with	with	ADP
mkg-25034	46	37	the	the	DET
mkg-25034	46	38	saliva	saliva	NOUN
mkg-25034	46	39	of	of	ADP
mkg-25034	46	40	research	research	NOUN
mkg-25034	46	41	subjects	subject	NOUN
mkg-25034	46	42	,	,	PUNCT
mkg-25034	46	43	and	and	CCONJ
mkg-25034	46	44	applying	apply	VERB
mkg-25034	46	45	laboratory	laboratory	NOUN
mkg-25034	46	46	work	work	NOUN
mkg-25034	46	47	safety	safety	NOUN
mkg-25034	46	48	procedures	procedure	NOUN
mkg-25034	46	49	.	.	PUNCT
mkg-25034	47	1	the	the	DET
mkg-25034	47	2	following	follow	VERB
mkg-25034	47	3	oral	oral	ADJ
mkg-25034	47	4	rinse	rinse	NOUN
mkg-25034	47	5	technique	technique	NOUN
mkg-25034	47	6	was	be	AUX
mkg-25034	47	7	used	use	VERB
mkg-25034	47	8	to	to	PART
mkg-25034	47	9	collect	collect	VERB
mkg-25034	47	10	the	the	DET
mkg-25034	47	11	saliva	saliva	NOUN
mkg-25034	47	12	:	:	PUNCT
mkg-25034	47	13	the	the	DET
mkg-25034	47	14	subjects	subject	NOUN
mkg-25034	47	15	were	be	AUX
mkg-25034	47	16	instructed	instruct	VERB
mkg-25034	47	17	to	to	PART
mkg-25034	47	18	rinse	rinse	VERB
mkg-25034	47	19	their	their	PRON
mkg-25034	47	20	mouths	mouth	NOUN
mkg-25034	47	21	in	in	ADP
mkg-25034	47	22	10	10	NUM
mkg-25034	47	23	ml	ml	NOUN
mkg-25034	47	24	of	of	ADP
mkg-25034	47	25	phosphate	phosphate	ADJ
mkg-25034	47	26	buffer	buffer	NOUN
mkg-25034	47	27	saline	saline	NOUN
mkg-25034	47	28	(	(	PUNCT
mkg-25034	47	29	pbs	pbs	PROPN
mkg-25034	47	30	)	)	PUNCT
mkg-25034	47	31	(	(	PUNCT
mkg-25034	47	32	sigmaaldrich	sigmaaldrich	ADV
mkg-25034	47	33	,	,	PUNCT
mkg-25034	47	34	darmstadt	darmstadt	PROPN
mkg-25034	47	35	,	,	PUNCT
mkg-25034	47	36	germany	germany	PROPN
mkg-25034	47	37	)	)	PUNCT
mkg-25034	47	38	for	for	ADP
mkg-25034	47	39	15	15	NUM
mkg-25034	47	40	sec	sec	PROPN
mkg-25034	47	41	.	.	PUNCT
mkg-25034	48	1	the	the	DET
mkg-25034	48	2	saliva	saliva	NOUN
mkg-25034	48	3	was	be	AUX
mkg-25034	48	4	then	then	ADV
mkg-25034	48	5	expectorated	expectorate	VERB
mkg-25034	48	6	into	into	ADP
mkg-25034	48	7	sterile	sterile	ADJ
mkg-25034	48	8	containers	container	NOUN
mkg-25034	48	9	and	and	CCONJ
mkg-25034	48	10	stored	store	VERB
mkg-25034	48	11	at	at	ADP
mkg-25034	48	12	-25	-25	PROPN
mkg-25034	48	13	°	°	PROPN
mkg-25034	48	14	c.11	c.11	NOUN
mkg-25034	48	15	next	next	ADV
mkg-25034	48	16	,	,	PUNCT
mkg-25034	48	17	the	the	DET
mkg-25034	48	18	oral	oral	ADJ
mkg-25034	48	19	saliva	saliva	NOUN
mkg-25034	48	20	specimen	speciman	NOUN
mkg-25034	48	21	was	be	AUX
mkg-25034	48	22	cultured	cultured	ADJ
mkg-25034	48	23	on	on	ADP
mkg-25034	48	24	mycobiotic	mycobiotic	ADJ
mkg-25034	48	25	®	®	NOUN
mkg-25034	48	26	agar	agar	NOUN
mkg-25034	48	27	at	at	ADP
mkg-25034	48	28	35	35	NUM
mkg-25034	48	29	°	°	ADP
mkg-25034	48	30	c	c	NOUN
mkg-25034	48	31	for	for	ADP
mkg-25034	48	32	48	48	NUM
mkg-25034	48	33	h	h	NOUN
mkg-25034	48	34	for	for	SCONJ
mkg-25034	48	35	identified	identify	VERB
mkg-25034	48	36	a	a	DET
mkg-25034	48	37	candida	candida	PROPN
mkg-25034	48	38	species	specie	NOUN
mkg-25034	48	39	.	.	PUNCT
mkg-25034	49	1	12	12	NUM
mkg-25034	49	2	the	the	DET
mkg-25034	49	3	suspensions	suspension	NOUN
mkg-25034	49	4	of	of	ADP
mkg-25034	49	5	c.	c.	NOUN
mkg-25034	49	6	albicans	albican	NOUN
mkg-25034	49	7	cultured	cultured	ADJ
mkg-25034	49	8	on	on	ADP
mkg-25034	49	9	the	the	DET
mkg-25034	49	10	mycobiotic	mycobiotic	ADJ
mkg-25034	49	11	®	®	NOUN
mkg-25034	49	12	agar	agar	NOUN
mkg-25034	49	13	medium	medium	NOUN
mkg-25034	49	14	using	use	VERB
mkg-25034	49	15	0.85	0.85	NUM
mkg-25034	49	16	%	%	NOUN
mkg-25034	49	17	nacl	nacl	NOUN
mkg-25034	49	18	and	and	CCONJ
mkg-25034	49	19	adjusted	adjust	VERB
mkg-25034	49	20	to	to	ADP
mkg-25034	49	21	mcfarland	mcfarland	PROPN
mkg-25034	49	22	2	2	NUM
mkg-25034	49	23	(	(	PUNCT
mkg-25034	49	24	6	6	NUM
mkg-25034	49	25	x	x	SYM
mkg-25034	49	26	108	108	NUM
mkg-25034	49	27	cfu	cfu	NOUN
mkg-25034	49	28	/	/	SYM
mkg-25034	49	29	ml).13	ml).13	NOUN
mkg-25034	49	30	then	then	ADV
mkg-25034	49	31	,	,	PUNCT
mkg-25034	49	32	100	100	NUM
mkg-25034	49	33	μl	μl	ADP
mkg-25034	49	34	of	of	ADP
mkg-25034	49	35	candida	candida	PROPN
mkg-25034	49	36	suspension	suspension	NOUN
mkg-25034	49	37	in	in	ADP
mkg-25034	49	38	0.85	0.85	NUM
mkg-25034	49	39	%	%	NOUN
mkg-25034	49	40	nacl	nacl	NOUN
mkg-25034	49	41	was	be	AUX
mkg-25034	49	42	mixed	mix	VERB
mkg-25034	49	43	to	to	PART
mkg-25034	49	44	api	api	VERB
mkg-25034	49	45	20	20	NUM
mkg-25034	49	46	liquid	liquid	ADJ
mkg-25034	49	47	medium	medium	NOUN
mkg-25034	49	48	.	.	PUNCT
mkg-25034	50	1	then	then	ADV
mkg-25034	50	2	homogenization	homogenization	NOUN
mkg-25034	50	3	was	be	AUX
mkg-25034	50	4	carried	carry	VERB
mkg-25034	50	5	out	out	ADP
mkg-25034	50	6	.	.	PUNCT
mkg-25034	51	1	subsequently	subsequently	ADV
mkg-25034	51	2	,	,	PUNCT
mkg-25034	51	3	200	200	NUM
mkg-25034	51	4	μl	μl	ADV
mkg-25034	51	5	was	be	AUX
mkg-25034	51	6	taken	take	VERB
mkg-25034	51	7	and	and	CCONJ
mkg-25034	51	8	placed	place	VERB
mkg-25034	51	9	into	into	ADP
mkg-25034	51	10	a	a	DET
mkg-25034	51	11	test	test	NOUN
mkg-25034	51	12	vial	vial	NOUN
mkg-25034	51	13	.	.	PUNCT
mkg-25034	52	1	a	a	DET
mkg-25034	52	2	fermentation	fermentation	NOUN
mkg-25034	52	3	assay	assay	NOUN
mkg-25034	52	4	was	be	AUX
mkg-25034	52	5	conducted	conduct	VERB
mkg-25034	52	6	on	on	ADP
mkg-25034	52	7	several	several	ADJ
mkg-25034	52	8	carbohydrates	carbohydrate	NOUN
mkg-25034	52	9	in	in	ADP
mkg-25034	52	10	parallel	parallel	NOUN
mkg-25034	52	11	.	.	PUNCT
mkg-25034	53	1	after	after	ADP
mkg-25034	53	2	48	48	NUM
mkg-25034	53	3	h	h	NOUN
mkg-25034	53	4	of	of	ADP
mkg-25034	53	5	incubating	incubate	VERB
mkg-25034	53	6	at	at	ADP
mkg-25034	53	7	30oc	30oc	NUM
mkg-25034	53	8	,	,	PUNCT
mkg-25034	53	9	a	a	DET
mkg-25034	53	10	well	well	ADV
mkg-25034	53	11	-	-	PUNCT
mkg-25034	53	12	observed	observe	VERB
mkg-25034	53	13	growth	growth	NOUN
mkg-25034	53	14	was	be	AUX
mkg-25034	53	15	taken	take	VERB
mkg-25034	53	16	randomly	randomly	ADV
mkg-25034	53	17	.	.	PUNCT
mkg-25034	54	1	a	a	DET
mkg-25034	54	2	positive	positive	ADJ
mkg-25034	54	3	reaction	reaction	NOUN
mkg-25034	54	4	was	be	AUX
mkg-25034	54	5	characterised	characterise	VERB
mkg-25034	54	6	by	by	ADP
mkg-25034	54	7	turbidity	turbidity	NOUN
mkg-25034	54	8	in	in	ADP
mkg-25034	54	9	each	each	DET
mkg-25034	54	10	well	well	ADV
mkg-25034	54	11	observed	observe	VERB
mkg-25034	54	12	after	after	ADP
mkg-25034	54	13	incubation	incubation	NOUN
mkg-25034	54	14	at	at	ADP
mkg-25034	54	15	30oc	30oc	NUM
mkg-25034	54	16	for	for	ADP
mkg-25034	54	17	48	48	NUM
mkg-25034	54	18	h.9	h.9	NOUN
mkg-25034	54	19	the	the	DET
mkg-25034	54	20	fungus	fungus	PROPN
mkg-25034	54	21	atb	atb	PROPN
mkg-25034	54	22	®	®	PROPN
mkg-25034	54	23	commercial	commercial	ADJ
mkg-25034	54	24	kit	kit	NOUN
mkg-25034	54	25	was	be	AUX
mkg-25034	54	26	used	use	VERB
mkg-25034	54	27	to	to	PART
mkg-25034	54	28	evaluate	evaluate	VERB
mkg-25034	54	29	the	the	DET
mkg-25034	54	30	susceptibility	susceptibility	NOUN
mkg-25034	54	31	test	test	NOUN
mkg-25034	54	32	,	,	PUNCT
mkg-25034	54	33	with	with	ADP
mkg-25034	54	34	the	the	DET
mkg-25034	54	35	maximal	maximal	ADJ
mkg-25034	54	36	assay	assay	NOUN
mkg-25034	54	37	in	in	ADP
mkg-25034	54	38	128	128	NUM
mkg-25034	54	39	μg	μg	NOUN
mkg-25034	54	40	/	/	SYM
mkg-25034	54	41	ml	ml	PROPN
mkg-25034	54	42	.	.	PUNCT
mkg-25034	55	1	a	a	DET
mkg-25034	55	2	20	20	NUM
mkg-25034	55	3	μl	μl	ADP
mkg-25034	55	4	suspension	suspension	NOUN
mkg-25034	55	5	of	of	ADP
mkg-25034	55	6	c.	c.	NOUN
mkg-25034	55	7	albicans	albican	NOUN
mkg-25034	55	8	in	in	ADP
mkg-25034	55	9	0.85	0.85	NUM
mkg-25034	55	10	%	%	NOUN
mkg-25034	55	11	nacl	nacl	NOUN
mkg-25034	55	12	was	be	AUX
mkg-25034	55	13	added	add	VERB
mkg-25034	55	14	to	to	ADP
mkg-25034	55	15	the	the	DET
mkg-25034	55	16	fungus	fungus	PROPN
mkg-25034	55	17	atb	atb	PROPN
mkg-25034	55	18	®	®	NOUN
mkg-25034	55	19	media	medium	NOUN
mkg-25034	55	20	.	.	PUNCT
mkg-25034	56	1	after	after	ADP
mkg-25034	56	2	homogenisation	homogenisation	NOUN
mkg-25034	56	3	,	,	PUNCT
mkg-25034	56	4	each	each	PRON
mkg-25034	56	5	well	well	ADV
mkg-25034	56	6	was	be	AUX
mkg-25034	56	7	inoculated	inoculate	VERB
mkg-25034	56	8	with	with	ADP
mkg-25034	56	9	135	135	NUM
mkg-25034	56	10	μl	μl	ADP
mkg-25034	56	11	of	of	ADP
mkg-25034	56	12	homogeneous	homogeneous	ADJ
mkg-25034	56	13	inoculums	inoculum	NOUN
mkg-25034	56	14	and	and	CCONJ
mkg-25034	56	15	incubated	incubate	VERB
mkg-25034	56	16	at	at	ADP
mkg-25034	56	17	37	37	NUM
mkg-25034	56	18	°	°	ADP
mkg-25034	56	19	c	c	NOUN
mkg-25034	56	20	for	for	ADP
mkg-25034	56	21	24	24	NUM
mkg-25034	56	22	h.	h.	NOUN
mkg-25034	56	23	the	the	DET
mkg-25034	56	24	growth	growth	NOUN
mkg-25034	56	25	of	of	ADP
mkg-25034	56	26	c.	c.	NOUN
mkg-25034	56	27	albicans	albican	NOUN
mkg-25034	56	28	on	on	ADP
mkg-25034	56	29	the	the	DET
mkg-25034	56	30	strip	strip	NOUN
mkg-25034	56	31	was	be	AUX
mkg-25034	56	32	read	read	VERB
mkg-25034	56	33	visually	visually	ADV
mkg-25034	56	34	,	,	PUNCT
mkg-25034	56	35	according	accord	VERB
mkg-25034	56	36	to	to	ADP
mkg-25034	56	37	the	the	DET
mkg-25034	56	38	instructions	instruction	NOUN
mkg-25034	56	39	kit	kit	PROPN
mkg-25034	56	40	,	,	PUNCT
mkg-25034	56	41	with	with	ADP
mkg-25034	56	42	baseline	baseline	ADJ
mkg-25034	56	43	turbidity	turbidity	NOUN
mkg-25034	56	44	as	as	ADP
mkg-25034	56	45	the	the	DET
mkg-25034	56	46	indicator	indicator	NOUN
mkg-25034	56	47	of	of	ADP
mkg-25034	56	48	the	the	DET
mkg-25034	56	49	growth	growth	NOUN
mkg-25034	56	50	of	of	ADP
mkg-25034	56	51	c.	c.	NOUN
mkg-25034	56	52	albicans	albican	NOUN
mkg-25034	56	53	in	in	ADP
mkg-25034	56	54	fluconazole	fluconazole	NOUN
mkg-25034	56	55	,	,	PUNCT
mkg-25034	56	56	ketoconazole	ketoconazole	NOUN
mkg-25034	56	57	and	and	CCONJ
mkg-25034	56	58	nystatin	nystatin	NOUN
mkg-25034	56	59	in	in	ADP
mkg-25034	56	60	concentrations	concentration	NOUN
mkg-25034	56	61	of	of	ADP
mkg-25034	56	62	<	<	X
mkg-25034	56	63	1	1	NUM
mkg-25034	56	64	,	,	PUNCT
mkg-25034	56	65	2	2	NUM
mkg-25034	56	66	,	,	PUNCT
mkg-25034	56	67	4	4	NUM
mkg-25034	56	68	,	,	PUNCT
mkg-25034	56	69	64	64	NUM
mkg-25034	56	70	,	,	PUNCT
mkg-25034	56	71	and	and	CCONJ
mkg-25034	56	72	>	>	X
mkg-25034	56	73	128	128	NUM
mkg-25034	56	74	μg	μg	NOUN
mkg-25034	56	75	/	/	SYM
mkg-25034	56	76	ml	ml	NOUN
mkg-25034	56	77	,	,	PUNCT
mkg-25034	56	78	which	which	PRON
mkg-25034	56	79	was	be	AUX
mkg-25034	56	80	an	an	DET
mkg-25034	56	81	indicator	indicator	NOUN
mkg-25034	56	82	of	of	ADP
mkg-25034	56	83	susceptibility	susceptibility	NOUN
mkg-25034	56	84	(	(	PUNCT
mkg-25034	56	85	≤8	≤8	PROPN
mkg-25034	56	86	μg	μg	PROPN
mkg-25034	56	87	/	/	SYM
mkg-25034	56	88	ml	ml	PROPN
mkg-25034	56	89	)	)	PUNCT
mkg-25034	56	90	,	,	PUNCT
mkg-25034	56	91	susceptibility	susceptibility	NOUN
mkg-25034	56	92	-	-	PUNCT
mkg-25034	56	93	dose	dose	NOUN
mkg-25034	56	94	dependent	dependent	ADJ
mkg-25034	56	95	(	(	PUNCT
mkg-25034	56	96	s	s	NOUN
mkg-25034	56	97	-	-	PUNCT
mkg-25034	56	98	dd	dd	NOUN
mkg-25034	56	99	)	)	PUNCT
mkg-25034	56	100	(	(	PUNCT
mkg-25034	56	101	16–64	16–64	NUM
mkg-25034	56	102	μg	μg	PROPN
mkg-25034	56	103	/	/	SYM
mkg-25034	56	104	ml	ml	NOUN
mkg-25034	56	105	)	)	PUNCT
mkg-25034	56	106	and	and	CCONJ
mkg-25034	56	107	resistance	resistance	NOUN
mkg-25034	56	108	(	(	PUNCT
mkg-25034	56	109	>	>	SYM
mkg-25034	56	110	128	128	NUM
mkg-25034	56	111	μg/	μg/	NOUN
mkg-25034	56	112	ml	ml	NOUN
mkg-25034	56	113	)	)	PUNCT
mkg-25034	56	114	.	.	PUNCT
mkg-25034	57	1	the	the	DET
mkg-25034	57	2	growth	growth	NOUN
mkg-25034	57	3	of	of	ADP
mkg-25034	57	4	c.	c.	NOUN
mkg-25034	57	5	albicans	albican	NOUN
mkg-25034	57	6	characterised	characterise	VERB
mkg-25034	57	7	by	by	ADP
mkg-25034	57	8	turbidity	turbidity	NOUN
mkg-25034	57	9	relates	relate	VERB
mkg-25034	57	10	to	to	ADP
mkg-25034	57	11	the	the	DET
mkg-25034	57	12	atb	atb	PROPN
mkg-25034	57	13	®	®	PROPN
mkg-25034	57	14	kit	kit	NOUN
mkg-25034	57	15	:	:	PUNCT
mkg-25034	57	16	0	0	PUNCT
mkg-25034	58	1	(	(	PUNCT
mkg-25034	58	2	no	no	DET
mkg-25034	58	3	growth	growth	NOUN
mkg-25034	58	4	)	)	PUNCT
mkg-25034	58	5	,	,	PUNCT
mkg-25034	58	6	1	1	NUM
mkg-25034	58	7	(	(	PUNCT
mkg-25034	58	8	weak	weak	ADJ
mkg-25034	58	9	growth	growth	NOUN
mkg-25034	58	10	)	)	PUNCT
mkg-25034	58	11	,	,	PUNCT
mkg-25034	58	12	2	2	NUM
mkg-25034	58	13	(	(	PUNCT
mkg-25034	58	14	reduction	reduction	NOUN
mkg-25034	58	15	in	in	ADP
mkg-25034	58	16	growth	growth	NOUN
mkg-25034	58	17	)	)	PUNCT
mkg-25034	58	18	,	,	PUNCT
mkg-25034	58	19	3	3	X
mkg-25034	58	20	(	(	PUNCT
mkg-25034	58	21	growth	growth	NOUN
mkg-25034	58	22	reduced	reduce	VERB
mkg-25034	58	23	slightly	slightly	ADV
mkg-25034	58	24	)	)	PUNCT
mkg-25034	58	25	,	,	PUNCT
mkg-25034	58	26	and	and	CCONJ
mkg-25034	58	27	4	4	NUM
mkg-25034	58	28	(	(	PUNCT
mkg-25034	58	29	no	no	DET
mkg-25034	58	30	reduction	reduction	NOUN
mkg-25034	58	31	in	in	ADP
mkg-25034	58	32	growth).14	growth).14	PROPN
mkg-25034	58	33	the	the	DET
mkg-25034	58	34	kruskal	kruskal	PROPN
mkg-25034	58	35	–	–	PUNCT
mkg-25034	58	36	wallis	wallis	PROPN
mkg-25034	58	37	test	test	NOUN
mkg-25034	58	38	analysed	analyse	VERB
mkg-25034	58	39	the	the	DET
mkg-25034	58	40	data	datum	NOUN
mkg-25034	58	41	of	of	ADP
mkg-25034	58	42	susceptibility	susceptibility	NOUN
mkg-25034	58	43	,	,	PUNCT
mkg-25034	58	44	s	s	NOUN
mkg-25034	58	45	-	-	PUNCT
mkg-25034	58	46	dd	dd	NOUN
mkg-25034	58	47	,	,	PUNCT
mkg-25034	58	48	and	and	CCONJ
mkg-25034	58	49	fluconazole	fluconazole	NOUN
mkg-25034	58	50	-	-	PUNCT
mkg-25034	58	51	resistant	resistant	ADJ
mkg-25034	58	52	against	against	ADP
mkg-25034	58	53	c.	c.	NOUN
mkg-25034	58	54	albicans	albican	NOUN
mkg-25034	58	55	.	.	PUNCT
mkg-25034	59	1	the	the	DET
mkg-25034	59	2	significance	significance	NOUN
mkg-25034	59	3	limit	limit	NOUN
mkg-25034	59	4	of	of	ADP
mkg-25034	59	5	p<0.05	p<0.05	NOUN
mkg-25034	59	6	and	and	CCONJ
mkg-25034	59	7	the	the	DET
mkg-25034	59	8	correlation	correlation	NOUN
mkg-25034	59	9	coefficient	coefficient	NOUN
mkg-25034	59	10	(	(	PUNCT
mkg-25034	59	11	r	r	NOUN
mkg-25034	59	12	=	=	SYM
mkg-25034	59	13	1	1	X
mkg-25034	59	14	)	)	PUNCT
mkg-25034	59	15	was	be	AUX
mkg-25034	59	16	strongly	strongly	ADV
mkg-25034	59	17	correlated	correlate	VERB
mkg-25034	59	18	.	.	PUNCT
mkg-25034	60	1	results	result	NOUN
mkg-25034	60	2	data	datum	NOUN
mkg-25034	60	3	from	from	ADP
mkg-25034	60	4	study	study	NOUN
mkg-25034	60	5	subjects	subject	NOUN
mkg-25034	60	6	included	include	VERB
mkg-25034	60	7	in	in	ADP
mkg-25034	60	8	this	this	DET
mkg-25034	60	9	study	study	NOUN
mkg-25034	60	10	are	be	AUX
mkg-25034	60	11	shown	show	VERB
mkg-25034	60	12	in	in	ADP
mkg-25034	60	13	table	table	NOUN
mkg-25034	60	14	1	1	NUM
mkg-25034	60	15	,	,	PUNCT
mkg-25034	60	16	representing	represent	VERB
mkg-25034	60	17	age	age	NOUN
mkg-25034	60	18	group	group	NOUN
mkg-25034	60	19	,	,	PUNCT
mkg-25034	60	20	sex	sex	NOUN
mkg-25034	60	21	,	,	PUNCT
mkg-25034	60	22	history	history	NOUN
mkg-25034	60	23	of	of	ADP
mkg-25034	60	24	hiv	hiv	PROPN
mkg-25034	60	25	/	/	SYM
mkg-25034	60	26	aids	aids	PROPN
mkg-25034	60	27	transmission	transmission	NOUN
mkg-25034	60	28	,	,	PUNCT
mkg-25034	60	29	history	history	NOUN
mkg-25034	60	30	of	of	ADP
mkg-25034	60	31	antifungal	antifungal	ADJ
mkg-25034	60	32	agents	agent	NOUN
mkg-25034	60	33	and	and	CCONJ
mkg-25034	60	34	oral	oral	ADJ
mkg-25034	60	35	candidiasis	candidiasis	NOUN
mkg-25034	60	36	.	.	PUNCT
mkg-25034	61	1	these	these	DET
mkg-25034	61	2	indicators	indicator	NOUN
mkg-25034	61	3	could	could	AUX
mkg-25034	61	4	be	be	AUX
mkg-25034	61	5	the	the	DET
mkg-25034	61	6	reference	reference	NOUN
mkg-25034	61	7	for	for	ADP
mkg-25034	61	8	this	this	DET
mkg-25034	61	9	study	study	NOUN
mkg-25034	61	10	,	,	PUNCT
mkg-25034	61	11	which	which	PRON
mkg-25034	61	12	also	also	ADV
mkg-25034	61	13	correlated	correlate	VERB
mkg-25034	61	14	with	with	ADP
mkg-25034	61	15	candida	candida	PROPN
mkg-25034	61	16	species	specie	NOUN
mkg-25034	61	17	susceptibility	susceptibility	NOUN
mkg-25034	61	18	.	.	PUNCT
mkg-25034	62	1	c.	c.	NOUN
mkg-25034	62	2	albicans	albican	NOUN
mkg-25034	62	3	were	be	AUX
mkg-25034	62	4	found	find	VERB
mkg-25034	62	5	predominantly	predominantly	ADV
mkg-25034	62	6	in	in	ADP
mkg-25034	62	7	hiv	hiv	PROPN
mkg-25034	62	8	/	/	SYM
mkg-25034	62	9	aids	aids	PROPN
mkg-25034	62	10	subjects	subject	NOUN
mkg-25034	62	11	without	without	ADP
mkg-25034	62	12	a	a	DET
mkg-25034	62	13	history	history	NOUN
mkg-25034	62	14	of	of	ADP
mkg-25034	62	15	candidiasis	candidiasis	NOUN
mkg-25034	62	16	(	(	PUNCT
mkg-25034	62	17	table	table	NOUN
mkg-25034	62	18	2	2	NUM
mkg-25034	62	19	)	)	PUNCT
mkg-25034	62	20	.	.	PUNCT
mkg-25034	63	1	its	its	PRON
mkg-25034	63	2	antifungals	antifungal	NOUN
mkg-25034	63	3	were	be	AUX
mkg-25034	63	4	reported	report	VERB
mkg-25034	63	5	susceptible	susceptible	ADJ
mkg-25034	63	6	to	to	ADP
mkg-25034	63	7	c.	c.	NOUN
mkg-25034	63	8	albicans	albican	NOUN
mkg-25034	63	9	and	and	CCONJ
mkg-25034	63	10	other	other	ADJ
mkg-25034	63	11	candida	candida	PROPN
mkg-25034	63	12	species	specie	NOUN
mkg-25034	63	13	.	.	PUNCT
mkg-25034	64	1	the	the	DET
mkg-25034	64	2	data	datum	NOUN
mkg-25034	64	3	from	from	ADP
mkg-25034	64	4	table	table	NOUN
mkg-25034	64	5	2	2	NUM
mkg-25034	64	6	refer	refer	NOUN
mkg-25034	64	7	to	to	ADP
mkg-25034	64	8	an	an	DET
mkg-25034	64	9	in	in	X
mkg-25034	64	10	vitro	vitro	X
mkg-25034	64	11	assay	assay	ADV
mkg-25034	64	12	related	relate	VERB
mkg-25034	64	13	to	to	ADP
mkg-25034	64	14	antifungal	antifungal	ADJ
mkg-25034	64	15	susceptibility	susceptibility	NOUN
mkg-25034	64	16	to	to	ADP
mkg-25034	64	17	c.	c.	NOUN
mkg-25034	64	18	albicans	albican	NOUN
mkg-25034	64	19	,	,	PUNCT
mkg-25034	64	20	which	which	PRON
mkg-25034	64	21	were	be	AUX
mkg-25034	64	22	selected	select	VERB
mkg-25034	64	23	to	to	PART
mkg-25034	64	24	represent	represent	VERB
mkg-25034	64	25	the	the	DET
mkg-25034	64	26	dominant	dominant	ADJ
mkg-25034	64	27	population	population	NOUN
mkg-25034	64	28	of	of	ADP
mkg-25034	64	29	candida	candida	PROPN
mkg-25034	64	30	species	specie	NOUN
mkg-25034	64	31	from	from	ADP
mkg-25034	64	32	hiv	hiv	PROPN
mkg-25034	64	33	/	/	SYM
mkg-25034	64	34	aids	aids	PROPN
mkg-25034	64	35	subjects	subject	NOUN
mkg-25034	64	36	.	.	PUNCT
mkg-25034	65	1	table	table	NOUN
mkg-25034	65	2	3	3	NUM
mkg-25034	65	3	shows	show	VERB
mkg-25034	65	4	that	that	SCONJ
mkg-25034	65	5	the	the	DET
mkg-25034	65	6	three	three	NUM
mkg-25034	65	7	antifungal	antifungal	ADJ
mkg-25034	65	8	drugs	drug	NOUN
mkg-25034	65	9	have	have	VERB
mkg-25034	65	10	a	a	DET
mkg-25034	65	11	high	high	ADJ
mkg-25034	65	12	susceptibility	susceptibility	NOUN
mkg-25034	65	13	above	above	ADP
mkg-25034	65	14	80	80	NUM
mkg-25034	65	15	%	%	NOUN
mkg-25034	65	16	,	,	PUNCT
mkg-25034	65	17	but	but	CCONJ
mkg-25034	65	18	not	not	PART
mkg-25034	65	19	significantly	significantly	ADV
mkg-25034	65	20	dental	dental	ADJ
mkg-25034	65	21	journal	journal	NOUN
mkg-25034	65	22	(	(	PUNCT
mkg-25034	65	23	majalah	majalah	PROPN
mkg-25034	65	24	kedokteran	kedokteran	PROPN
mkg-25034	65	25	gigi	gigi	PROPN
mkg-25034	65	26	)	)	PUNCT
mkg-25034	66	1	p	p	X
mkg-25034	66	2	-	-	PUNCT
mkg-25034	66	3	issn	issn	NOUN
mkg-25034	66	4	:	:	PUNCT
mkg-25034	66	5	1978	1978	NUM
mkg-25034	66	6	-	-	SYM
mkg-25034	66	7	3728	3728	NUM
mkg-25034	66	8	;	;	PUNCT
mkg-25034	66	9	e	e	X
mkg-25034	66	10	-	-	PUNCT
mkg-25034	66	11	issn	issn	ADJ
mkg-25034	66	12	:	:	PUNCT
mkg-25034	66	13	2442	2442	NUM
mkg-25034	66	14	-	-	SYM
mkg-25034	66	15	9740	9740	NUM
mkg-25034	66	16	.	.	PUNCT
mkg-25034	67	1	accredited	accredit	VERB
mkg-25034	67	2	no	no	PRON
mkg-25034	67	3	.	.	PUNCT
mkg-25034	67	4	32a	32a	NOUN
mkg-25034	67	5	/	/	SYM
mkg-25034	67	6	e	e	NOUN
mkg-25034	67	7	/	/	SYM
mkg-25034	67	8	kpt/2017	kpt/2017	X
mkg-25034	67	9	.	.	PUNCT
mkg-25034	68	1	open	open	ADJ
mkg-25034	68	2	access	access	NOUN
mkg-25034	68	3	under	under	ADP
mkg-25034	68	4	cc	cc	NOUN
mkg-25034	68	5	-	-	PUNCT
mkg-25034	68	6	by	by	ADP
mkg-25034	68	7	-	-	PUNCT
mkg-25034	68	8	sa	sa	NOUN
mkg-25034	68	9	license	license	NOUN
mkg-25034	68	10	.	.	PUNCT
mkg-25034	69	1	available	available	ADJ
mkg-25034	69	2	at	at	ADP
mkg-25034	69	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	69	4	doi	doi	NOUN
mkg-25034	69	5	:	:	PUNCT
mkg-25034	69	6	10.20473	10.20473	NUM
mkg-25034	69	7	/	/	SYM
mkg-25034	69	8	j.djmkg.v54.i2.p82–86	j.djmkg.v54.i2.p82–86	ADJ
mkg-25034	69	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	69	10	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	NOUN
mkg-25034	69	11	84	84	NUM
mkg-25034	69	12	rezeki	rezeki	NOUN
mkg-25034	69	13	et	et	PROPN
mkg-25034	69	14	al./dent	al./dent	PROPN
mkg-25034	69	15	.	.	PUNCT
mkg-25034	70	1	j.	j.	PROPN
mkg-25034	70	2	(	(	PUNCT
mkg-25034	70	3	majalah	majalah	PROPN
mkg-25034	70	4	kedokteran	kedokteran	PROPN
mkg-25034	70	5	gigi	gigi	PROPN
mkg-25034	70	6	)	)	PUNCT
mkg-25034	70	7	2021	2021	NUM
mkg-25034	70	8	june	june	PROPN
mkg-25034	70	9	;	;	PUNCT
mkg-25034	70	10	54(2	54(2	NUM
mkg-25034	70	11	):	):	PUNCT
mkg-25034	70	12	82–86	82–86	NUM
mkg-25034	70	13	(	(	PUNCT
mkg-25034	70	14	p	p	X
mkg-25034	70	15	>	>	X
mkg-25034	70	16	0.05	0.05	NUM
mkg-25034	70	17	;	;	PUNCT
mkg-25034	70	18	0.628	0.628	NUM
mkg-25034	70	19	)	)	PUNCT
mkg-25034	70	20	,	,	PUNCT
mkg-25034	70	21	which	which	PRON
mkg-25034	70	22	means	mean	VERB
mkg-25034	70	23	that	that	SCONJ
mkg-25034	70	24	all	all	DET
mkg-25034	70	25	drugs	drug	NOUN
mkg-25034	70	26	have	have	VERB
mkg-25034	70	27	a	a	DET
mkg-25034	70	28	potential	potential	ADJ
mkg-25034	70	29	antifungal	antifungal	ADJ
mkg-25034	70	30	effect	effect	NOUN
mkg-25034	70	31	on	on	ADP
mkg-25034	70	32	c.	c.	NOUN
mkg-25034	70	33	albicans	albican	NOUN
mkg-25034	70	34	.	.	PUNCT
mkg-25034	71	1	three	three	NUM
mkg-25034	71	2	antifungal	antifungal	ADJ
mkg-25034	71	3	drug	drug	NOUN
mkg-25034	71	4	concentrations	concentration	NOUN
mkg-25034	71	5	showed	show	VERB
mkg-25034	71	6	significant	significant	ADJ
mkg-25034	71	7	differences	difference	NOUN
mkg-25034	71	8	in	in	ADP
mkg-25034	71	9	fluconazole	fluconazole	NOUN
mkg-25034	71	10	’s	’s	PART
mkg-25034	71	11	susceptibility	susceptibility	NOUN
mkg-25034	71	12	against	against	ADP
mkg-25034	71	13	c.	c.	NOUN
mkg-25034	71	14	albicans	albican	NOUN
mkg-25034	71	15	(	(	PUNCT
mkg-25034	71	16	p<0.05	p<0.05	NOUN
mkg-25034	71	17	;	;	PUNCT
mkg-25034	71	18	0.024	0.024	NUM
mkg-25034	71	19	)	)	PUNCT
mkg-25034	71	20	.	.	PUNCT
mkg-25034	72	1	it	it	PRON
mkg-25034	72	2	means	mean	VERB
mkg-25034	72	3	that	that	SCONJ
mkg-25034	72	4	the	the	DET
mkg-25034	72	5	concentration	concentration	NOUN
mkg-25034	72	6	of	of	ADP
mkg-25034	72	7	the	the	DET
mkg-25034	72	8	three	three	NUM
mkg-25034	72	9	drugs	drug	NOUN
mkg-25034	72	10	has	have	VERB
mkg-25034	72	11	a	a	DET
mkg-25034	72	12	strong	strong	ADJ
mkg-25034	72	13	influence	influence	NOUN
mkg-25034	72	14	on	on	ADP
mkg-25034	72	15	fungicidal	fungicidal	ADJ
mkg-25034	72	16	or	or	CCONJ
mkg-25034	72	17	fungistatic	fungistatic	ADJ
mkg-25034	72	18	properties	property	NOUN
mkg-25034	72	19	.	.	PUNCT
mkg-25034	73	1	the	the	DET
mkg-25034	73	2	subject	subject	ADJ
mkg-25034	73	3	status	status	NOUN
mkg-25034	73	4	was	be	AUX
mkg-25034	73	5	related	relate	VERB
mkg-25034	73	6	to	to	ADP
mkg-25034	73	7	susceptibility	susceptibility	NOUN
mkg-25034	73	8	,	,	PUNCT
mkg-25034	73	9	s	s	NOUN
mkg-25034	73	10	-	-	PUNCT
mkg-25034	73	11	dd	dd	NOUN
mkg-25034	73	12	,	,	PUNCT
mkg-25034	73	13	and	and	CCONJ
mkg-25034	73	14	resistance	resistance	NOUN
mkg-25034	73	15	of	of	ADP
mkg-25034	73	16	the	the	DET
mkg-25034	73	17	three	three	NUM
mkg-25034	73	18	antifungal	antifungal	ADJ
mkg-25034	73	19	drugs	drug	NOUN
mkg-25034	73	20	against	against	ADP
mkg-25034	73	21	c.	c.	NOUN
mkg-25034	73	22	albicans	albican	NOUN
mkg-25034	73	23	(	(	PUNCT
mkg-25034	73	24	p	p	X
mkg-25034	73	25	>	>	X
mkg-25034	73	26	0.05	0.05	NUM
mkg-25034	73	27	;	;	PUNCT
mkg-25034	73	28	0.175	0.175	NUM
mkg-25034	73	29	)	)	PUNCT
mkg-25034	73	30	.	.	PUNCT
mkg-25034	74	1	based	base	VERB
mkg-25034	74	2	on	on	ADP
mkg-25034	74	3	spearman	spearman	NOUN
mkg-25034	74	4	’s	’s	PART
mkg-25034	74	5	rho	rho	ADJ
mkg-25034	74	6	correlation	correlation	NOUN
mkg-25034	74	7	,	,	PUNCT
mkg-25034	74	8	drug	drug	NOUN
mkg-25034	74	9	status	status	NOUN
mkg-25034	74	10	(	(	PUNCT
mkg-25034	74	11	susceptibility	susceptibility	NOUN
mkg-25034	74	12	,	,	PUNCT
mkg-25034	74	13	s	s	NOUN
mkg-25034	74	14	-	-	PUNCT
mkg-25034	74	15	dd	dd	NOUN
mkg-25034	74	16	,	,	PUNCT
mkg-25034	74	17	and	and	CCONJ
mkg-25034	74	18	resistance	resistance	NOUN
mkg-25034	74	19	)	)	PUNCT
mkg-25034	74	20	has	have	VERB
mkg-25034	74	21	a	a	DET
mkg-25034	74	22	strong	strong	ADJ
mkg-25034	74	23	relationship	relationship	NOUN
mkg-25034	74	24	with	with	ADP
mkg-25034	74	25	the	the	DET
mkg-25034	74	26	concentration	concentration	NOUN
mkg-25034	74	27	of	of	ADP
mkg-25034	74	28	the	the	DET
mkg-25034	74	29	three	three	NUM
mkg-25034	74	30	groups	group	NOUN
mkg-25034	74	31	of	of	ADP
mkg-25034	74	32	antifungal	antifungal	ADJ
mkg-25034	74	33	drugs	drug	NOUN
mkg-25034	74	34	(	(	PUNCT
mkg-25034	74	35	r	r	NOUN
mkg-25034	74	36	=	=	NOUN
mkg-25034	74	37	0.820	0.820	NUM
mkg-25034	74	38	)	)	PUNCT
mkg-25034	74	39	.	.	PUNCT
mkg-25034	75	1	the	the	DET
mkg-25034	75	2	standard	standard	ADJ
mkg-25034	75	3	susceptibility	susceptibility	NOUN
mkg-25034	75	4	≤	≤	NUM
mkg-25034	75	5	8	8	NUM
mkg-25034	75	6	μg	μg	NOUN
mkg-25034	75	7	/	/	SYM
mkg-25034	75	8	ml	ml	PROPN
mkg-25034	75	9	,	,	PUNCT
mkg-25034	75	10	s	s	PART
mkg-25034	75	11	-	-	VERB
mkg-25034	75	12	dd	dd	VERB
mkg-25034	75	13	16	16	NUM
mkg-25034	75	14	-	-	SYM
mkg-25034	75	15	64	64	NUM
mkg-25034	75	16	μg	μg	NOUN
mkg-25034	75	17	/	/	SYM
mkg-25034	75	18	ml	ml	PROPN
mkg-25034	75	19	,	,	PUNCT
mkg-25034	75	20	and	and	CCONJ
mkg-25034	75	21	resistant	resistant	ADJ
mkg-25034	75	22	≥	≥	NOUN
mkg-25034	75	23	128	128	NUM
mkg-25034	75	24	μg	μg	NOUN
mkg-25034	75	25	/	/	SYM
mkg-25034	75	26	ml	ml	PROPN
mkg-25034	75	27	is	be	AUX
mkg-25034	75	28	based	base	VERB
mkg-25034	75	29	on	on	ADP
mkg-25034	75	30	the	the	DET
mkg-25034	75	31	atb	atb	PROPN
mkg-25034	75	32	®	®	PROPN
mkg-25034	75	33	fungus	fungus	PROPN
mkg-25034	75	34	kit	kit	PROPN
mkg-25034	75	35	.	.	PUNCT
mkg-25034	75	36	table	table	NOUN
mkg-25034	75	37	1	1	NUM
mkg-25034	75	38	.	.	PUNCT
mkg-25034	75	39	distribution	distribution	NOUN
mkg-25034	75	40	and	and	CCONJ
mkg-25034	75	41	frequency	frequency	NOUN
mkg-25034	75	42	characteristics	characteristic	NOUN
mkg-25034	75	43	of	of	ADP
mkg-25034	75	44	hiv	hiv	PROPN
mkg-25034	75	45	/	/	SYM
mkg-25034	75	46	aids	aids	PROPN
mkg-25034	75	47	subjects	subject	NOUN
mkg-25034	75	48	characteristics	characteristic	NOUN
mkg-25034	75	49	n	n	PRON
mkg-25034	75	50	%	%	NOUN
mkg-25034	75	51	gender	gender	NOUN
mkg-25034	75	52	female	female	NOUN
mkg-25034	75	53	10	10	NUM
mkg-25034	75	54	10	10	NUM
mkg-25034	75	55	male	male	NOUN
mkg-25034	75	56	88	88	NUM
mkg-25034	75	57	90	90	NUM
mkg-25034	75	58	age	age	NOUN
mkg-25034	75	59	(	(	PUNCT
mkg-25034	75	60	year	year	NOUN
mkg-25034	75	61	)	)	PUNCT
mkg-25034	76	1	20–29	20–29	NUM
mkg-25034	76	2	47	47	NUM
mkg-25034	77	1	48	48	NUM
mkg-25034	77	2	30–39	30–39	NUM
mkg-25034	77	3	40	40	NUM
mkg-25034	77	4	41	41	NUM
mkg-25034	77	5	40–49	40–49	NUM
mkg-25034	77	6	10	10	NUM
mkg-25034	77	7	10	10	NUM
mkg-25034	77	8	50–59	50–59	NUM
mkg-25034	77	9	1	1	NUM
mkg-25034	77	10	1	1	NUM
mkg-25034	77	11	risk	risk	NOUN
mkg-25034	77	12	factors	factor	NOUN
mkg-25034	77	13	for	for	ADP
mkg-25034	77	14	hiv	hiv	PROPN
mkg-25034	77	15	transmission	transmission	NOUN
mkg-25034	77	16	intravenous	intravenous	ADJ
mkg-25034	77	17	drug	drug	NOUN
mkg-25034	77	18	users	user	NOUN
mkg-25034	77	19	(	(	PUNCT
mkg-25034	77	20	ivdu	ivdu	PROPN
mkg-25034	77	21	)	)	PUNCT
mkg-25034	77	22	61	61	NUM
mkg-25034	77	23	69	69	NUM
mkg-25034	77	24	homosexual	homosexual	ADJ
mkg-25034	77	25	intercourse	intercourse	NOUN
mkg-25034	77	26	1	1	NUM
mkg-25034	77	27	1	1	NUM
mkg-25034	77	28	heterosexual	heterosexual	ADJ
mkg-25034	77	29	intercourse	intercourse	NOUN
mkg-25034	77	30	22	22	NUM
mkg-25034	77	31	22	22	NUM
mkg-25034	77	32	ivdu	ivdu	NOUN
mkg-25034	77	33	and	and	CCONJ
mkg-25034	77	34	homosexual	homosexual	ADJ
mkg-25034	77	35	intercourse	intercourse	NOUN
mkg-25034	77	36	1	1	NUM
mkg-25034	77	37	1	1	NUM
mkg-25034	77	38	ivdu	ivdu	NOUN
mkg-25034	77	39	and	and	CCONJ
mkg-25034	77	40	heterosexual	heterosexual	ADJ
mkg-25034	77	41	intercourse	intercourse	NOUN
mkg-25034	77	42	5	5	NUM
mkg-25034	77	43	5	5	NUM
mkg-25034	77	44	ivdu	ivdu	NOUN
mkg-25034	77	45	and	and	CCONJ
mkg-25034	77	46	tattoo	tattoo	ADV
mkg-25034	77	47	/	/	SYM
mkg-25034	77	48	piercing	pierce	VERB
mkg-25034	77	49	2	2	NUM
mkg-25034	77	50	2	2	NUM
mkg-25034	77	51	history	history	NOUN
mkg-25034	77	52	of	of	ADP
mkg-25034	77	53	antifungal	antifungal	ADJ
mkg-25034	77	54	agents	agent	NOUN
mkg-25034	77	55	fluconazole	fluconazole	VERB
mkg-25034	77	56	no	no	DET
mkg-25034	77	57	59	59	NUM
mkg-25034	77	58	60	60	NUM
mkg-25034	78	1	yes	yes	NOUN
mkg-25034	78	2	39	39	NUM
mkg-25034	78	3	40	40	NUM
mkg-25034	78	4	nystatin	nystatin	NOUN
mkg-25034	78	5	no	no	DET
mkg-25034	78	6	38	38	NUM
mkg-25034	78	7	39	39	NUM
mkg-25034	79	1	yes	yes	NOUN
mkg-25034	79	2	60	60	NUM
mkg-25034	79	3	61	61	NUM
mkg-25034	79	4	ketoconazole	ketoconazole	NOUN
mkg-25034	79	5	no	no	DET
mkg-25034	79	6	96	96	NUM
mkg-25034	79	7	98	98	NUM
mkg-25034	80	1	yes	yes	INTJ
mkg-25034	80	2	2	2	NUM
mkg-25034	80	3	2	2	NUM
mkg-25034	80	4	oral	oral	ADJ
mkg-25034	80	5	candidiasis	candidiasis	NOUN
mkg-25034	80	6	no	no	DET
mkg-25034	80	7	57	57	NUM
mkg-25034	80	8	58	58	NUM
mkg-25034	81	1	yes	yes	INTJ
mkg-25034	81	2	41	41	NUM
mkg-25034	81	3	42	42	NUM
mkg-25034	81	4	table	table	NOUN
mkg-25034	81	5	2	2	NUM
mkg-25034	81	6	.	.	NOUN
mkg-25034	81	7	susceptibility	susceptibility	NOUN
mkg-25034	81	8	and	and	CCONJ
mkg-25034	81	9	resistance	resistance	NOUN
mkg-25034	81	10	antifungal	antifungal	ADJ
mkg-25034	81	11	on	on	ADP
mkg-25034	81	12	the	the	DET
mkg-25034	81	13	candida	candida	PROPN
mkg-25034	81	14	species	specie	NOUN
mkg-25034	81	15	and	and	CCONJ
mkg-25034	81	16	oral	oral	ADJ
mkg-25034	81	17	candidiasis	candidiasis	NOUN
mkg-25034	81	18	history	history	NOUN
mkg-25034	81	19	in	in	ADP
mkg-25034	81	20	hiv	hiv	PROPN
mkg-25034	81	21	/	/	SYM
mkg-25034	81	22	aids	aids	PROPN
mkg-25034	81	23	patients	patient	NOUN
mkg-25034	82	1	candida	candida	PROPN
mkg-25034	82	2	species	specie	NOUN
mkg-25034	82	3	n	n	PRON
mkg-25034	82	4	%	%	NOUN
mkg-25034	82	5	fluconazole	fluconazole	NOUN
mkg-25034	82	6	ketoconazole	ketoconazole	NOUN
mkg-25034	82	7	nystatin	nystatin	PROPN
mkg-25034	82	8	oral	oral	ADJ
mkg-25034	82	9	candidiasis	candidiasis	NOUN
mkg-25034	82	10	history	history	NOUN
mkg-25034	82	11	susceptible	susceptible	ADJ
mkg-25034	82	12	resistant	resistant	ADJ
mkg-25034	82	13	susceptible	susceptible	ADJ
mkg-25034	82	14	resistant	resistant	ADJ
mkg-25034	82	15	susceptible	susceptible	ADJ
mkg-25034	82	16	resistant	resistant	ADJ
mkg-25034	83	1	yes	yes	INTJ
mkg-25034	83	2	no	no	DET
mkg-25034	83	3	c.	c.	NOUN
mkg-25034	83	4	albicans	albican	VERB
mkg-25034	83	5	93	93	NUM
mkg-25034	83	6	95	95	NUM
mkg-25034	83	7	80	80	NUM
mkg-25034	83	8	13	13	NUM
mkg-25034	83	9	81	81	NUM
mkg-25034	83	10	12	12	NUM
mkg-25034	83	11	80	80	NUM
mkg-25034	83	12	13	13	NUM
mkg-25034	83	13	39	39	NUM
mkg-25034	83	14	50	50	NUM
mkg-25034	83	15	c.	c.	NOUN
mkg-25034	83	16	dubliniensis	dubliniensis	NOUN
mkg-25034	83	17	2	2	NUM
mkg-25034	83	18	2	2	NUM
mkg-25034	83	19	2	2	NUM
mkg-25034	83	20	0	0	NUM
mkg-25034	83	21	1	1	NUM
mkg-25034	83	22	1	1	NUM
mkg-25034	83	23	2	2	NUM
mkg-25034	83	24	0	0	NUM
mkg-25034	83	25	1	1	NUM
mkg-25034	83	26	2	2	NUM
mkg-25034	83	27	c.	c.	NOUN
mkg-25034	83	28	guillermondii	guillermondii	NOUN
mkg-25034	83	29	1	1	NUM
mkg-25034	83	30	1	1	NUM
mkg-25034	83	31	1	1	NUM
mkg-25034	83	32	0	0	NUM
mkg-25034	83	33	1	1	NUM
mkg-25034	83	34	0	0	NUM
mkg-25034	83	35	1	1	NUM
mkg-25034	83	36	0	0	NUM
mkg-25034	83	37	1	1	NUM
mkg-25034	83	38	2	2	NUM
mkg-25034	83	39	c.	c.	NOUN
mkg-25034	83	40	famata	famata	VERB
mkg-25034	83	41	1	1	NUM
mkg-25034	83	42	1	1	NUM
mkg-25034	83	43	1	1	NUM
mkg-25034	83	44	0	0	NUM
mkg-25034	83	45	1	1	NUM
mkg-25034	83	46	0	0	NUM
mkg-25034	83	47	1	1	NUM
mkg-25034	83	48	0	0	NUM
mkg-25034	83	49	0	0	NUM
mkg-25034	83	50	2	2	NUM
mkg-25034	83	51	c.	c.	NOUN
mkg-25034	83	52	tropicalis	tropicali	VERB
mkg-25034	83	53	1	1	NUM
mkg-25034	83	54	1	1	NUM
mkg-25034	83	55	1	1	NUM
mkg-25034	83	56	0	0	NUM
mkg-25034	83	57	1	1	NUM
mkg-25034	83	58	0	0	NUM
mkg-25034	83	59	1	1	NUM
mkg-25034	83	60	0	0	NUM
mkg-25034	83	61	0	0	NUM
mkg-25034	83	62	1	1	NUM
mkg-25034	83	63	table	table	NOUN
mkg-25034	83	64	3	3	NUM
mkg-25034	83	65	.	.	PUNCT
mkg-25034	83	66	antifungal	antifungal	ADJ
mkg-25034	83	67	susceptibility	susceptibility	NOUN
mkg-25034	83	68	on	on	ADP
mkg-25034	83	69	c.	c.	NOUN
mkg-25034	83	70	albicans	albican	NOUN
mkg-25034	83	71	in	in	ADP
mkg-25034	83	72	hiv	hiv	PROPN
mkg-25034	83	73	/	/	SYM
mkg-25034	83	74	aids	aids	PROPN
mkg-25034	83	75	patients	patient	NOUN
mkg-25034	83	76	antifungals	antifungal	NOUN
mkg-25034	83	77	(	(	PUNCT
mkg-25034	83	78	μg	μg	NOUN
mkg-25034	83	79	/	/	SYM
mkg-25034	83	80	ml	ml	NOUN
mkg-25034	83	81	)	)	PUNCT
mkg-25034	83	82	fluconazole	fluconazole	NOUN
mkg-25034	83	83	ketoconazole	ketoconazole	NOUN
mkg-25034	83	84	nystatin	nystatin	NOUN
mkg-25034	83	85	p	p	NOUN
mkg-25034	83	86	-	-	PUNCT
mkg-25034	83	87	value	value	NOUN
mkg-25034	83	88	n	n	CCONJ
mkg-25034	83	89	%	%	NOUN
mkg-25034	83	90	status	status	NOUN
mkg-25034	83	91	turbidity	turbidity	NOUN
mkg-25034	83	92	n	n	CCONJ
mkg-25034	83	93	%	%	NOUN
mkg-25034	83	94	status	status	NOUN
mkg-25034	83	95	turbidity	turbidity	NOUN
mkg-25034	83	96	n	n	CCONJ
mkg-25034	83	97	%	%	NOUN
mkg-25034	83	98	status	status	NOUN
mkg-25034	83	99	turbidity	turbidity	NOUN
mkg-25034	83	100	1	1	NUM
mkg-25034	83	101	74	74	NUM
mkg-25034	83	102	80	80	NUM
mkg-25034	83	103	susceptible	susceptible	ADJ
mkg-25034	83	104	0	0	NUM
mkg-25034	83	105	75	75	NUM
mkg-25034	83	106	81	81	NUM
mkg-25034	83	107	susceptible	susceptible	ADJ
mkg-25034	83	108	0	0	NUM
mkg-25034	83	109	73	73	NUM
mkg-25034	83	110	79	79	NUM
mkg-25034	83	111	susceptible	susceptible	ADJ
mkg-25034	83	112	0	0	NUM
mkg-25034	83	113	*	*	PUNCT
mkg-25034	83	114	p>0.05	p>0.05	PROPN
mkg-25034	83	115	(	(	PUNCT
mkg-25034	83	116	0.628	0.628	NUM
mkg-25034	83	117	)	)	PUNCT
mkg-25034	83	118	2	2	NUM
mkg-25034	83	119	3	3	NUM
mkg-25034	83	120	3	3	NUM
mkg-25034	83	121	susceptible	susceptible	ADJ
mkg-25034	83	122	1	1	NUM
mkg-25034	83	123	1	1	NUM
mkg-25034	83	124	1	1	NUM
mkg-25034	83	125	susceptible	susceptible	ADJ
mkg-25034	83	126	1	1	NUM
mkg-25034	83	127	1	1	NUM
mkg-25034	83	128	1	1	NUM
mkg-25034	83	129	susceptible	susceptible	ADJ
mkg-25034	83	130	1	1	NUM
mkg-25034	83	131	4	4	NUM
mkg-25034	83	132	3	3	NUM
mkg-25034	83	133	3	3	NUM
mkg-25034	83	134	susceptible	susceptible	ADJ
mkg-25034	83	135	1	1	NUM
mkg-25034	83	136	1	1	NUM
mkg-25034	83	137	1	1	NUM
mkg-25034	83	138	susceptible	susceptible	ADJ
mkg-25034	83	139	1	1	NUM
mkg-25034	83	140	1	1	NUM
mkg-25034	83	141	1	1	NUM
mkg-25034	83	142	susceptible	susceptible	ADJ
mkg-25034	83	143	1	1	NUM
mkg-25034	83	144	64	64	NUM
mkg-25034	83	145	1	1	NUM
mkg-25034	83	146	1	1	NUM
mkg-25034	83	147	s	s	PROPN
mkg-25034	83	148	-	-	PUNCT
mkg-25034	83	149	dd	dd	ADJ
mkg-25034	83	150	2	2	NUM
mkg-25034	83	151	1	1	NUM
mkg-25034	83	152	1	1	NUM
mkg-25034	83	153	s	s	NOUN
mkg-25034	83	154	-	-	PUNCT
mkg-25034	83	155	dd	dd	ADJ
mkg-25034	83	156	2	2	NUM
mkg-25034	83	157	1	1	NUM
mkg-25034	83	158	1	1	NUM
mkg-25034	83	159	s	s	NOUN
mkg-25034	83	160	-	-	PUNCT
mkg-25034	83	161	dd	dd	ADJ
mkg-25034	83	162	2	2	NUM
mkg-25034	83	163	128	128	NUM
mkg-25034	83	164	12	12	NUM
mkg-25034	83	165	13	13	NUM
mkg-25034	83	166	resistant	resistant	ADJ
mkg-25034	83	167	3	3	NUM
mkg-25034	83	168	15	15	NUM
mkg-25034	83	169	16	16	NUM
mkg-25034	83	170	resistant	resistant	ADJ
mkg-25034	83	171	3	3	NUM
mkg-25034	83	172	17	17	NUM
mkg-25034	83	173	18	18	NUM
mkg-25034	83	174	resistant	resistant	ADJ
mkg-25034	83	175	3	3	NUM
mkg-25034	83	176	*	*	NOUN
mkg-25034	83	177	kruskal	kruskal	PROPN
mkg-25034	83	178	–	–	PUNCT
mkg-25034	83	179	wallis	wallis	PROPN
mkg-25034	83	180	test	test	NOUN
mkg-25034	83	181	and	and	CCONJ
mkg-25034	83	182	spearman	spearman	NOUN
mkg-25034	83	183	’s	’s	PART
mkg-25034	83	184	rho	rho	ADJ
mkg-25034	83	185	correlation	correlation	NOUN
mkg-25034	83	186	;	;	PUNCT
mkg-25034	83	187	s	s	X
mkg-25034	83	188	-	-	PUNCT
mkg-25034	83	189	dd	dd	ADJ
mkg-25034	83	190	(	(	PUNCT
mkg-25034	83	191	susceptibility	susceptibility	NOUN
mkg-25034	83	192	-	-	PUNCT
mkg-25034	83	193	dose	dose	NOUN
mkg-25034	83	194	dependent	dependent	NOUN
mkg-25034	83	195	)	)	PUNCT
mkg-25034	83	196	;	;	PUNCT
mkg-25034	83	197	susceptible	susceptible	ADJ
mkg-25034	83	198	≤	≤	NUM
mkg-25034	83	199	8	8	NUM
mkg-25034	83	200	μg	μg	NOUN
mkg-25034	83	201	/	/	SYM
mkg-25034	83	202	ml	ml	PROPN
mkg-25034	83	203	,	,	PUNCT
mkg-25034	83	204	s	s	PART
mkg-25034	83	205	-	-	VERB
mkg-25034	83	206	dd	dd	VERB
mkg-25034	83	207	16	16	NUM
mkg-25034	83	208	-	-	SYM
mkg-25034	83	209	64	64	NUM
mkg-25034	83	210	μg	μg	PROPN
mkg-25034	83	211	/	/	SYM
mkg-25034	83	212	ml	ml	PROPN
mkg-25034	83	213	,	,	PUNCT
mkg-25034	83	214	resistant	resistant	ADJ
mkg-25034	83	215	≥	≥	NOUN
mkg-25034	83	216	128	128	NUM
mkg-25034	83	217	μg	μg	NOUN
mkg-25034	83	218	/	/	SYM
mkg-25034	83	219	ml	ml	PROPN
mkg-25034	83	220	,	,	PUNCT
mkg-25034	83	221	and	and	CCONJ
mkg-25034	83	222	250	250	NUM
mkg-25034	83	223	μg	μg	NOUN
mkg-25034	83	224	/	/	SYM
mkg-25034	83	225	ml	ml	ADV
mkg-25034	83	226	not	not	PART
mkg-25034	83	227	recommended	recommend	VERB
mkg-25034	83	228	:	:	PUNCT
mkg-25034	83	229	turbidity	turbidity	NOUN
mkg-25034	83	230	indicator	indicator	NOUN
mkg-25034	83	231	,	,	PUNCT
mkg-25034	83	232	0	0	NUM
mkg-25034	83	233	(	(	PUNCT
mkg-25034	83	234	no	no	DET
mkg-25034	83	235	growth	growth	NOUN
mkg-25034	83	236	)	)	PUNCT
mkg-25034	83	237	,	,	PUNCT
mkg-25034	83	238	1	1	NUM
mkg-25034	83	239	(	(	PUNCT
mkg-25034	83	240	weak	weak	ADJ
mkg-25034	83	241	growth	growth	NOUN
mkg-25034	83	242	)	)	PUNCT
mkg-25034	83	243	,	,	PUNCT
mkg-25034	83	244	2	2	NUM
mkg-25034	83	245	(	(	PUNCT
mkg-25034	83	246	reduction	reduction	NOUN
mkg-25034	83	247	in	in	ADP
mkg-25034	83	248	growth	growth	NOUN
mkg-25034	83	249	)	)	PUNCT
mkg-25034	83	250	,	,	PUNCT
mkg-25034	83	251	3	3	X
mkg-25034	83	252	(	(	PUNCT
mkg-25034	83	253	growth	growth	NOUN
mkg-25034	83	254	reduced	reduce	VERB
mkg-25034	83	255	slightly	slightly	ADV
mkg-25034	83	256	)	)	PUNCT
mkg-25034	83	257	,	,	PUNCT
mkg-25034	83	258	4	4	NUM
mkg-25034	83	259	(	(	PUNCT
mkg-25034	83	260	no	no	DET
mkg-25034	83	261	reduction	reduction	NOUN
mkg-25034	83	262	in	in	ADP
mkg-25034	83	263	growth	growth	NOUN
mkg-25034	83	264	)	)	PUNCT
mkg-25034	83	265	.	.	PUNCT
mkg-25034	84	1	dental	dental	ADJ
mkg-25034	84	2	journal	journal	NOUN
mkg-25034	84	3	(	(	PUNCT
mkg-25034	84	4	majalah	majalah	PROPN
mkg-25034	84	5	kedokteran	kedokteran	PROPN
mkg-25034	84	6	gigi	gigi	PROPN
mkg-25034	84	7	)	)	PUNCT
mkg-25034	85	1	p	p	X
mkg-25034	85	2	-	-	PUNCT
mkg-25034	85	3	issn	issn	NOUN
mkg-25034	85	4	:	:	PUNCT
mkg-25034	85	5	1978	1978	NUM
mkg-25034	85	6	-	-	SYM
mkg-25034	85	7	3728	3728	NUM
mkg-25034	85	8	;	;	PUNCT
mkg-25034	85	9	e	e	X
mkg-25034	85	10	-	-	PUNCT
mkg-25034	85	11	issn	issn	ADJ
mkg-25034	85	12	:	:	PUNCT
mkg-25034	85	13	2442	2442	NUM
mkg-25034	85	14	-	-	SYM
mkg-25034	85	15	9740	9740	NUM
mkg-25034	85	16	.	.	PUNCT
mkg-25034	86	1	accredited	accredit	VERB
mkg-25034	86	2	no	no	PRON
mkg-25034	86	3	.	.	PUNCT
mkg-25034	86	4	32a	32a	NOUN
mkg-25034	86	5	/	/	SYM
mkg-25034	86	6	e	e	NOUN
mkg-25034	86	7	/	/	SYM
mkg-25034	86	8	kpt/2017	kpt/2017	X
mkg-25034	86	9	.	.	PUNCT
mkg-25034	87	1	open	open	ADJ
mkg-25034	87	2	access	access	NOUN
mkg-25034	87	3	under	under	ADP
mkg-25034	87	4	cc	cc	NOUN
mkg-25034	87	5	-	-	PUNCT
mkg-25034	87	6	by	by	ADP
mkg-25034	87	7	-	-	PUNCT
mkg-25034	87	8	sa	sa	NOUN
mkg-25034	87	9	license	license	NOUN
mkg-25034	87	10	.	.	PUNCT
mkg-25034	88	1	available	available	ADJ
mkg-25034	88	2	at	at	ADP
mkg-25034	88	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	88	4	doi	doi	NOUN
mkg-25034	88	5	:	:	PUNCT
mkg-25034	88	6	10.20473	10.20473	NUM
mkg-25034	88	7	/	/	SYM
mkg-25034	88	8	j.djmkg.v54.i2.p82–86	j.djmkg.v54.i2.p82–86	ADJ
mkg-25034	88	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	88	10	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	NOUN
mkg-25034	88	11	85rezeki	85rezeki	PROPN
mkg-25034	88	12	et	et	PROPN
mkg-25034	88	13	al./dent	al./dent	PROPN
mkg-25034	88	14	.	.	PUNCT
mkg-25034	89	1	j.	j.	PROPN
mkg-25034	89	2	(	(	PUNCT
mkg-25034	89	3	majalah	majalah	PROPN
mkg-25034	89	4	kedokteran	kedokteran	PROPN
mkg-25034	89	5	gigi	gigi	PROPN
mkg-25034	89	6	)	)	PUNCT
mkg-25034	89	7	2021	2021	NUM
mkg-25034	89	8	june	june	PROPN
mkg-25034	89	9	;	;	PUNCT
mkg-25034	89	10	54(2	54(2	NUM
mkg-25034	89	11	):	):	PUNCT
mkg-25034	89	12	82–86	82–86	NUM
mkg-25034	89	13	discussion	discussion	NOUN
mkg-25034	89	14	this	this	DET
mkg-25034	89	15	research	research	NOUN
mkg-25034	89	16	reported	report	VERB
mkg-25034	89	17	that	that	SCONJ
mkg-25034	89	18	subjects	subject	NOUN
mkg-25034	89	19	without	without	ADP
mkg-25034	89	20	candidiasis	candidiasis	NOUN
mkg-25034	89	21	are	be	AUX
mkg-25034	89	22	more	more	ADV
mkg-25034	89	23	dominant	dominant	ADJ
mkg-25034	89	24	than	than	ADP
mkg-25034	89	25	with	with	ADP
mkg-25034	89	26	oral	oral	ADJ
mkg-25034	89	27	candidiasis	candidiasis	NOUN
mkg-25034	89	28	.	.	PUNCT
mkg-25034	90	1	these	these	DET
mkg-25034	90	2	subjects	subject	NOUN
mkg-25034	90	3	have	have	VERB
mkg-25034	90	4	susceptibility	susceptibility	NOUN
mkg-25034	90	5	and	and	CCONJ
mkg-25034	90	6	resistance	resistance	NOUN
mkg-25034	90	7	to	to	ADP
mkg-25034	90	8	fluconazole	fluconazole	NOUN
mkg-25034	90	9	,	,	PUNCT
mkg-25034	90	10	ketoconazole	ketoconazole	NOUN
mkg-25034	90	11	,	,	PUNCT
mkg-25034	90	12	and	and	CCONJ
mkg-25034	90	13	nystatin	nystatin	NOUN
mkg-25034	90	14	in	in	ADP
mkg-25034	90	15	low	low	ADJ
mkg-25034	90	16	.	.	PUNCT
mkg-25034	91	1	generally	generally	ADV
mkg-25034	91	2	,	,	PUNCT
mkg-25034	91	3	these	these	DET
mkg-25034	91	4	antifungals	antifungal	NOUN
mkg-25034	91	5	have	have	VERB
mkg-25034	91	6	a	a	DET
mkg-25034	91	7	vulnerability	vulnerability	NOUN
mkg-25034	91	8	to	to	ADP
mkg-25034	91	9	the	the	DET
mkg-25034	91	10	oral	oral	ADJ
mkg-25034	91	11	candida	candida	PROPN
mkg-25034	91	12	species	specie	NOUN
mkg-25034	91	13	,	,	PUNCT
mkg-25034	91	14	mainly	mainly	ADV
mkg-25034	91	15	c.	c.	NOUN
mkg-25034	91	16	albicans	albican	NOUN
mkg-25034	91	17	.	.	PUNCT
mkg-25034	92	1	the	the	DET
mkg-25034	92	2	presence	presence	NOUN
mkg-25034	92	3	of	of	ADP
mkg-25034	92	4	c.	c.	NOUN
mkg-25034	92	5	albicans	albican	NOUN
mkg-25034	92	6	in	in	ADP
mkg-25034	92	7	the	the	DET
mkg-25034	92	8	oral	oral	ADJ
mkg-25034	92	9	candidiasis	candidiasis	NOUN
mkg-25034	92	10	of	of	ADP
mkg-25034	92	11	hiv	hiv	PROPN
mkg-25034	92	12	patients	patient	NOUN
mkg-25034	92	13	is	be	AUX
mkg-25034	92	14	confirmed	confirm	VERB
mkg-25034	92	15	by	by	ADP
mkg-25034	92	16	patil	patil	PROPN
mkg-25034	92	17	et	et	PROPN
mkg-25034	92	18	al.15	al.15	NOUN
mkg-25034	92	19	who	who	PRON
mkg-25034	92	20	found	find	VERB
mkg-25034	92	21	95.2	95.2	NUM
mkg-25034	92	22	%	%	NOUN
mkg-25034	92	23	of	of	ADP
mkg-25034	92	24	c.	c.	NOUN
mkg-25034	92	25	albicans	albican	NOUN
mkg-25034	92	26	cases	case	NOUN
mkg-25034	92	27	leading	lead	VERB
mkg-25034	92	28	to	to	ADP
mkg-25034	92	29	oropharyngeal	oropharyngeal	ADJ
mkg-25034	92	30	candidiasis	candidiasis	NOUN
mkg-25034	92	31	in	in	ADP
mkg-25034	92	32	hiv	hiv	PROPN
mkg-25034	92	33	/	/	SYM
mkg-25034	92	34	aids	aids	PROPN
mkg-25034	92	35	.	.	PUNCT
mkg-25034	93	1	this	this	DET
mkg-25034	93	2	study	study	NOUN
mkg-25034	93	3	indicates	indicate	VERB
mkg-25034	93	4	that	that	SCONJ
mkg-25034	93	5	the	the	DET
mkg-25034	93	6	male	male	ADJ
mkg-25034	93	7	population	population	NOUN
mkg-25034	93	8	is	be	AUX
mkg-25034	93	9	higher	high	ADJ
mkg-25034	93	10	than	than	ADP
mkg-25034	93	11	the	the	DET
mkg-25034	93	12	female	female	ADJ
mkg-25034	93	13	population	population	NOUN
mkg-25034	93	14	with	with	ADP
mkg-25034	93	15	an	an	DET
mkg-25034	93	16	average	average	ADJ
mkg-25034	93	17	age	age	NOUN
mkg-25034	93	18	of	of	ADP
mkg-25034	93	19	20–29	20–29	NUM
mkg-25034	93	20	years	year	NOUN
mkg-25034	93	21	and	and	CCONJ
mkg-25034	93	22	ages	age	NOUN
mkg-25034	93	23	30–39	30–39	NUM
mkg-25034	93	24	(	(	PUNCT
mkg-25034	93	25	table	table	NOUN
mkg-25034	93	26	1	1	NUM
mkg-25034	93	27	)	)	PUNCT
mkg-25034	93	28	.	.	PUNCT
mkg-25034	94	1	the	the	DET
mkg-25034	94	2	most	most	ADV
mkg-25034	94	3	dominant	dominant	ADJ
mkg-25034	94	4	transmission	transmission	NOUN
mkg-25034	94	5	is	be	AUX
mkg-25034	94	6	through	through	ADP
mkg-25034	94	7	intravenous	intravenous	ADJ
mkg-25034	94	8	and	and	CCONJ
mkg-25034	94	9	heterosexual	heterosexual	ADJ
mkg-25034	94	10	injections	injection	NOUN
mkg-25034	94	11	.	.	PUNCT
mkg-25034	95	1	glick	glick	PROPN
mkg-25034	95	2	et	et	PROPN
mkg-25034	95	3	al.16	al.16	PROPN
mkg-25034	95	4	reports	report	VERB
mkg-25034	95	5	that	that	SCONJ
mkg-25034	95	6	men	man	NOUN
mkg-25034	95	7	who	who	PRON
mkg-25034	95	8	have	have	VERB
mkg-25034	95	9	sex	sex	NOUN
mkg-25034	95	10	with	with	ADP
mkg-25034	95	11	men	man	NOUN
mkg-25034	95	12	(	(	PUNCT
mkg-25034	95	13	msm	msm	NOUN
mkg-25034	95	14	)	)	PUNCT
mkg-25034	95	15	have	have	VERB
mkg-25034	95	16	higher	high	ADJ
mkg-25034	95	17	rates	rate	NOUN
mkg-25034	95	18	of	of	ADP
mkg-25034	95	19	hiv	hiv	PROPN
mkg-25034	95	20	and	and	CCONJ
mkg-25034	95	21	sexually	sexually	ADV
mkg-25034	95	22	transmitted	transmit	VERB
mkg-25034	95	23	infections	infection	NOUN
mkg-25034	95	24	(	(	PUNCT
mkg-25034	95	25	stis	stis	NOUN
mkg-25034	95	26	)	)	PUNCT
mkg-25034	95	27	than	than	ADP
mkg-25034	95	28	women	woman	NOUN
mkg-25034	95	29	and	and	CCONJ
mkg-25034	95	30	other	other	ADJ
mkg-25034	95	31	heterosexual	heterosexual	ADJ
mkg-25034	95	32	men	man	NOUN
mkg-25034	95	33	.	.	PUNCT
mkg-25034	96	1	this	this	DET
mkg-25034	96	2	increased	increase	VERB
mkg-25034	96	3	risk	risk	NOUN
mkg-25034	96	4	persists	persist	VERB
mkg-25034	96	5	across	across	ADP
mkg-25034	96	6	all	all	DET
mkg-25034	96	7	age	age	NOUN
mkg-25034	96	8	groups	group	NOUN
mkg-25034	96	9	and	and	CCONJ
mkg-25034	96	10	reflects	reflect	VERB
mkg-25034	96	11	various	various	ADJ
mkg-25034	96	12	biological	biological	ADJ
mkg-25034	96	13	and	and	CCONJ
mkg-25034	96	14	behavioural	behavioural	ADJ
mkg-25034	96	15	factors	factor	NOUN
mkg-25034	96	16	,	,	PUNCT
mkg-25034	96	17	but	but	CCONJ
mkg-25034	96	18	there	there	PRON
mkg-25034	96	19	are	be	VERB
mkg-25034	96	20	some	some	DET
mkg-25034	96	21	direct	direct	ADJ
mkg-25034	96	22	comparisons	comparison	NOUN
mkg-25034	96	23	of	of	ADP
mkg-25034	96	24	sexual	sexual	ADJ
mkg-25034	96	25	behaviour	behaviour	NOUN
mkg-25034	96	26	patterns	pattern	NOUN
mkg-25034	96	27	between	between	ADP
mkg-25034	96	28	populations.16	populations.16	PROPN
mkg-25034	96	29	in	in	ADP
mkg-25034	96	30	this	this	DET
mkg-25034	96	31	research	research	NOUN
mkg-25034	96	32	,	,	PUNCT
mkg-25034	96	33	we	we	PRON
mkg-25034	96	34	found	find	VERB
mkg-25034	96	35	the	the	DET
mkg-25034	96	36	different	different	ADJ
mkg-25034	96	37	effects	effect	NOUN
mkg-25034	96	38	of	of	ADP
mkg-25034	96	39	three	three	NUM
mkg-25034	96	40	antifungal	antifungal	ADJ
mkg-25034	96	41	types	type	NOUN
mkg-25034	96	42	to	to	PART
mkg-25034	96	43	treat	treat	VERB
mkg-25034	96	44	oral	oral	ADJ
mkg-25034	96	45	candidiasis	candidiasis	NOUN
mkg-25034	96	46	on	on	ADP
mkg-25034	96	47	hiv	hiv	PROPN
mkg-25034	96	48	/	/	SYM
mkg-25034	96	49	aids	aids	PROPN
mkg-25034	96	50	subjects	subject	NOUN
mkg-25034	96	51	(	(	PUNCT
mkg-25034	96	52	table	table	NOUN
mkg-25034	96	53	3	3	NUM
mkg-25034	96	54	)	)	PUNCT
mkg-25034	96	55	.	.	PUNCT
mkg-25034	97	1	they	they	PRON
mkg-25034	97	2	have	have	VERB
mkg-25034	97	3	a	a	DET
mkg-25034	97	4	susceptibility	susceptibility	NOUN
mkg-25034	97	5	to	to	ADP
mkg-25034	97	6	preventing	prevent	VERB
mkg-25034	97	7	the	the	DET
mkg-25034	97	8	oral	oral	ADJ
mkg-25034	97	9	candidiasis	candidiasis	NOUN
mkg-25034	97	10	treatment	treatment	NOUN
mkg-25034	97	11	of	of	ADP
mkg-25034	97	12	subjects	subject	NOUN
mkg-25034	97	13	with	with	ADP
mkg-25034	97	14	hiv	hiv	PROPN
mkg-25034	97	15	/	/	SYM
mkg-25034	97	16	aids	aids	PROPN
mkg-25034	97	17	.	.	PUNCT
mkg-25034	98	1	the	the	DET
mkg-25034	98	2	oral	oral	ADJ
mkg-25034	98	3	candidiasis	candidiasis	NOUN
mkg-25034	98	4	prophylaxis	prophylaxis	NOUN
mkg-25034	98	5	used	use	VERB
mkg-25034	98	6	fluconazole	fluconazole	NOUN
mkg-25034	98	7	(	(	PUNCT
mkg-25034	98	8	200	200	NUM
mkg-25034	98	9	mg	mg	NUM
mkg-25034	98	10	/	/	SYM
mkg-25034	98	11	day	day	NOUN
mkg-25034	98	12	)	)	PUNCT
mkg-25034	98	13	with	with	ADP
mkg-25034	98	14	a	a	DET
mkg-25034	98	15	cd4	cd4	PROPN
mkg-25034	98	16	count	count	NOUN
mkg-25034	98	17	<	<	X
mkg-25034	98	18	100	100	NUM
mkg-25034	98	19	cells	cell	NOUN
mkg-25034	98	20	/	/	SYM
mkg-25034	98	21	μl	μl	ADP
mkg-25034	98	22	also	also	ADV
mkg-25034	98	23	in	in	ADP
mkg-25034	98	24	patients	patient	NOUN
mkg-25034	98	25	with	with	ADP
mkg-25034	98	26	cd4	cd4	PROPN
mkg-25034	98	27	100–200	100–200	NUM
mkg-25034	98	28	cells	cell	NOUN
mkg-25034	98	29	/	/	SYM
mkg-25034	98	30	μl	μl	NOUN
mkg-25034	98	31	.	.	PUNCT
mkg-25034	99	1	additionally	additionally	ADV
mkg-25034	99	2	,	,	PUNCT
mkg-25034	99	3	long	long	ADJ
mkg-25034	99	4	-	-	PUNCT
mkg-25034	99	5	term	term	NOUN
mkg-25034	99	6	oral	oral	ADJ
mkg-25034	99	7	candidiasis	candidiasis	NOUN
mkg-25034	99	8	prophylaxis	prophylaxi	VERB
mkg-25034	99	9	with	with	ADP
mkg-25034	99	10	fluconazole	fluconazole	NOUN
mkg-25034	99	11	is	be	AUX
mkg-25034	99	12	likely	likely	ADJ
mkg-25034	99	13	to	to	PART
mkg-25034	99	14	lead	lead	VERB
mkg-25034	99	15	to	to	ADP
mkg-25034	99	16	resistance.17	resistance.17	PROPN
mkg-25034	99	17	based	base	VERB
mkg-25034	99	18	on	on	ADP
mkg-25034	99	19	the	the	DET
mkg-25034	99	20	characteristics	characteristic	NOUN
mkg-25034	99	21	analyses	analysis	NOUN
mkg-25034	99	22	of	of	ADP
mkg-25034	99	23	hiv	hiv	PROPN
mkg-25034	99	24	/	/	SYM
mkg-25034	99	25	aids	aids	PROPN
mkg-25034	99	26	,	,	PUNCT
mkg-25034	99	27	42	42	NUM
mkg-25034	99	28	%	%	NOUN
mkg-25034	99	29	of	of	ADP
mkg-25034	99	30	the	the	DET
mkg-25034	99	31	subjects	subject	NOUN
mkg-25034	99	32	had	have	VERB
mkg-25034	99	33	a	a	DET
mkg-25034	99	34	history	history	NOUN
mkg-25034	99	35	of	of	ADP
mkg-25034	99	36	candidiasis	candidiasis	NOUN
mkg-25034	99	37	,	,	PUNCT
mkg-25034	99	38	58	58	NUM
mkg-25034	99	39	%	%	NOUN
mkg-25034	99	40	had	have	VERB
mkg-25034	99	41	no	no	DET
mkg-25034	99	42	history	history	NOUN
mkg-25034	99	43	of	of	ADP
mkg-25034	99	44	candidiasis	candidiasis	NOUN
mkg-25034	99	45	.	.	PUNCT
mkg-25034	100	1	the	the	DET
mkg-25034	100	2	candida	candida	PROPN
mkg-25034	100	3	species	specie	NOUN
mkg-25034	100	4	cultures	culture	NOUN
mkg-25034	100	5	from	from	ADP
mkg-25034	100	6	the	the	DET
mkg-25034	100	7	98	98	NUM
mkg-25034	100	8	subjects	subject	NOUN
mkg-25034	100	9	showed	show	VERB
mkg-25034	100	10	95	95	NUM
mkg-25034	100	11	%	%	NOUN
mkg-25034	100	12	c.	c.	NOUN
mkg-25034	100	13	albicans	albican	NOUN
mkg-25034	100	14	,	,	PUNCT
mkg-25034	100	15	while	while	SCONJ
mkg-25034	100	16	the	the	DET
mkg-25034	100	17	rest	rest	NOUN
mkg-25034	100	18	were	be	AUX
mkg-25034	100	19	other	other	ADJ
mkg-25034	100	20	candida	candida	PROPN
mkg-25034	100	21	species	specie	NOUN
mkg-25034	100	22	.	.	PUNCT
mkg-25034	101	1	it	it	PRON
mkg-25034	101	2	is	be	AUX
mkg-25034	101	3	,	,	PUNCT
mkg-25034	101	4	therefore	therefore	ADV
mkg-25034	101	5	,	,	PUNCT
mkg-25034	101	6	explained	explain	VERB
mkg-25034	101	7	that	that	SCONJ
mkg-25034	101	8	in	in	ADP
mkg-25034	101	9	hiv	hiv	PROPN
mkg-25034	101	10	,	,	PUNCT
mkg-25034	101	11	oral	oral	ADJ
mkg-25034	101	12	candidiasis	candidiasis	NOUN
mkg-25034	101	13	is	be	AUX
mkg-25034	101	14	related	relate	VERB
mkg-25034	101	15	to	to	ADP
mkg-25034	101	16	the	the	DET
mkg-25034	101	17	history	history	NOUN
mkg-25034	101	18	of	of	ADP
mkg-25034	101	19	antifungal	antifungal	ADJ
mkg-25034	101	20	use	use	NOUN
mkg-25034	101	21	(	(	PUNCT
mkg-25034	101	22	table	table	NOUN
mkg-25034	101	23	1	1	NUM
mkg-25034	101	24	)	)	PUNCT
mkg-25034	101	25	.	.	PUNCT
mkg-25034	102	1	the	the	DET
mkg-25034	102	2	subjects	subject	NOUN
mkg-25034	102	3	had	have	VERB
mkg-25034	102	4	a	a	DET
mkg-25034	102	5	history	history	NOUN
mkg-25034	102	6	of	of	ADP
mkg-25034	102	7	antifungal	antifungal	ADJ
mkg-25034	102	8	use	use	NOUN
mkg-25034	102	9	with	with	ADP
mkg-25034	102	10	different	different	ADJ
mkg-25034	102	11	percentages	percentage	NOUN
mkg-25034	102	12	of	of	ADP
mkg-25034	102	13	antifungals	antifungal	NOUN
mkg-25034	102	14	.	.	PUNCT
mkg-25034	103	1	garcia	garcia	PROPN
mkg-25034	103	2	-	-	PUNCT
mkg-25034	103	3	cuesta	cuesta	PROPN
mkg-25034	103	4	et	et	NOUN
mkg-25034	103	5	al.18	al.18	PROPN
mkg-25034	103	6	explain	explain	VERB
mkg-25034	103	7	that	that	SCONJ
mkg-25034	103	8	the	the	DET
mkg-25034	103	9	oral	oral	ADJ
mkg-25034	103	10	antifungal	antifungal	NOUN
mkg-25034	103	11	of	of	ADP
mkg-25034	103	12	candidiasis	candidiasis	NOUN
mkg-25034	103	13	of	of	ADP
mkg-25034	103	14	a	a	DET
mkg-25034	103	15	patient	patient	NOUN
mkg-25034	103	16	with	with	ADP
mkg-25034	103	17	hiv	hiv	PROPN
mkg-25034	103	18	status	status	NOUN
mkg-25034	103	19	is	be	AUX
mkg-25034	103	20	often	often	ADV
mkg-25034	103	21	given	give	VERB
mkg-25034	103	22	several	several	ADJ
mkg-25034	103	23	antifungal	antifungal	ADJ
mkg-25034	103	24	types	type	NOUN
mkg-25034	103	25	to	to	PART
mkg-25034	103	26	prevent	prevent	VERB
mkg-25034	103	27	oral	oral	ADJ
mkg-25034	103	28	candida	candida	NOUN
mkg-25034	103	29	species	specie	NOUN
mkg-25034	103	30	symptoms	symptom	NOUN
mkg-25034	103	31	and	and	CCONJ
mkg-25034	103	32	infection	infection	NOUN
mkg-25034	103	33	.	.	PUNCT
mkg-25034	104	1	the	the	DET
mkg-25034	104	2	use	use	NOUN
mkg-25034	104	3	of	of	ADP
mkg-25034	104	4	an	an	DET
mkg-25034	104	5	antifungal	antifungal	ADJ
mkg-25034	104	6	mixture	mixture	NOUN
mkg-25034	104	7	to	to	PART
mkg-25034	104	8	maintain	maintain	VERB
mkg-25034	104	9	the	the	DET
mkg-25034	104	10	fungal	fungal	ADJ
mkg-25034	104	11	population	population	NOUN
mkg-25034	104	12	’s	’s	PART
mkg-25034	104	13	balance	balance	NOUN
mkg-25034	104	14	in	in	ADP
mkg-25034	104	15	the	the	DET
mkg-25034	104	16	oral	oral	ADJ
mkg-25034	104	17	cavity	cavity	NOUN
mkg-25034	104	18	can	can	AUX
mkg-25034	104	19	also	also	ADV
mkg-25034	104	20	help	help	VERB
mkg-25034	104	21	increase	increase	VERB
mkg-25034	104	22	the	the	DET
mkg-25034	104	23	mucosal	mucosal	ADJ
mkg-25034	104	24	oral	oral	ADJ
mkg-25034	104	25	defence	defence	NOUN
mkg-25034	104	26	system	system	NOUN
mkg-25034	104	27	to	to	PART
mkg-25034	104	28	prevent	prevent	VERB
mkg-25034	104	29	candida	candida	PROPN
mkg-25034	104	30	species	specie	NOUN
mkg-25034	104	31	’	'	PUNCT
mkg-25034	104	32	adhesion.19	adhesion.19	VERB
mkg-25034	104	33	the	the	DET
mkg-25034	104	34	development	development	NOUN
mkg-25034	104	35	of	of	ADP
mkg-25034	104	36	oral	oral	ADJ
mkg-25034	104	37	candidiasis	candidiasis	NOUN
mkg-25034	104	38	in	in	ADP
mkg-25034	104	39	hiv	hiv	PROPN
mkg-25034	104	40	/	/	SYM
mkg-25034	104	41	aids	aids	PROPN
mkg-25034	104	42	patients	patient	NOUN
mkg-25034	104	43	is	be	AUX
mkg-25034	104	44	highly	highly	ADV
mkg-25034	104	45	dependent	dependent	ADJ
mkg-25034	104	46	on	on	ADP
mkg-25034	104	47	the	the	DET
mkg-25034	104	48	history	history	NOUN
mkg-25034	104	49	of	of	ADP
mkg-25034	104	50	antifungal	antifungal	ADJ
mkg-25034	104	51	treatment	treatment	NOUN
mkg-25034	104	52	.	.	PUNCT
mkg-25034	105	1	it	it	PRON
mkg-25034	105	2	is	be	AUX
mkg-25034	105	3	reasonable	reasonable	ADJ
mkg-25034	105	4	to	to	PART
mkg-25034	105	5	suspect	suspect	VERB
mkg-25034	105	6	that	that	SCONJ
mkg-25034	105	7	some	some	DET
mkg-25034	105	8	subjects	subject	NOUN
mkg-25034	105	9	in	in	ADP
mkg-25034	105	10	this	this	DET
mkg-25034	105	11	study	study	NOUN
mkg-25034	105	12	have	have	AUX
mkg-25034	105	13	had	have	VERB
mkg-25034	105	14	proper	proper	ADJ
mkg-25034	105	15	oral	oral	ADJ
mkg-25034	105	16	candidiasis	candidiasis	NOUN
mkg-25034	105	17	treatment	treatment	NOUN
mkg-25034	105	18	.	.	PUNCT
mkg-25034	106	1	nevertheless	nevertheless	ADV
mkg-25034	106	2	,	,	PUNCT
mkg-25034	106	3	the	the	DET
mkg-25034	106	4	prevalence	prevalence	NOUN
mkg-25034	106	5	of	of	ADP
mkg-25034	106	6	c.	c.	NOUN
mkg-25034	106	7	albicans	albican	NOUN
mkg-25034	106	8	in	in	ADP
mkg-25034	106	9	hiv	hiv	PROPN
mkg-25034	106	10	is	be	AUX
mkg-25034	106	11	always	always	ADV
mkg-25034	106	12	associated	associate	VERB
mkg-25034	106	13	with	with	ADP
mkg-25034	106	14	resistance	resistance	NOUN
mkg-25034	106	15	to	to	ADP
mkg-25034	106	16	fluconazole.20	fluconazole.20	PROPN
mkg-25034	106	17	in	in	ADP
mkg-25034	106	18	general	general	ADJ
mkg-25034	106	19	,	,	PUNCT
mkg-25034	106	20	the	the	DET
mkg-25034	106	21	injection	injection	NOUN
mkg-25034	106	22	of	of	ADP
mkg-25034	106	23	narcotic	narcotic	ADJ
mkg-25034	106	24	drugs	drug	NOUN
mkg-25034	106	25	and	and	CCONJ
mkg-25034	106	26	heterosexual	heterosexual	ADJ
mkg-25034	106	27	relationships	relationship	NOUN
mkg-25034	106	28	tend	tend	VERB
mkg-25034	106	29	to	to	PART
mkg-25034	106	30	be	be	AUX
mkg-25034	106	31	experienced	experience	VERB
mkg-25034	106	32	by	by	ADP
mkg-25034	106	33	other	other	ADJ
mkg-25034	106	34	people	people	NOUN
mkg-25034	106	35	living	live	VERB
mkg-25034	106	36	with	with	ADP
mkg-25034	106	37	hiv	hiv	PROPN
mkg-25034	106	38	.	.	PUNCT
mkg-25034	107	1	these	these	DET
mkg-25034	107	2	trends	trend	NOUN
mkg-25034	107	3	indicate	indicate	VERB
mkg-25034	107	4	that	that	SCONJ
mkg-25034	107	5	the	the	DET
mkg-25034	107	6	susceptibility	susceptibility	NOUN
mkg-25034	107	7	population	population	NOUN
mkg-25034	107	8	is	be	AUX
mkg-25034	107	9	strongly	strongly	ADV
mkg-25034	107	10	related	relate	VERB
mkg-25034	107	11	to	to	ADP
mkg-25034	107	12	the	the	DET
mkg-25034	107	13	level	level	NOUN
mkg-25034	107	14	of	of	ADP
mkg-25034	107	15	resistance	resistance	NOUN
mkg-25034	107	16	to	to	ADP
mkg-25034	107	17	fluconazole	fluconazole	NOUN
mkg-25034	107	18	or	or	CCONJ
mkg-25034	107	19	other	other	ADJ
mkg-25034	107	20	antifungal	antifungal	ADJ
mkg-25034	107	21	drugs	drug	NOUN
mkg-25034	107	22	such	such	ADJ
mkg-25034	107	23	as	as	ADP
mkg-25034	107	24	nystatin	nystatin	NOUN
mkg-25034	107	25	and	and	CCONJ
mkg-25034	107	26	ketoconazole	ketoconazole	NOUN
mkg-25034	107	27	.	.	PUNCT
mkg-25034	108	1	maheshwari	maheshwari	PROPN
mkg-25034	108	2	et	et	PROPN
mkg-25034	108	3	al.21	al.21	PROPN
mkg-25034	108	4	reported	report	VERB
mkg-25034	108	5	that	that	SCONJ
mkg-25034	108	6	in	in	ADP
mkg-25034	108	7	general	general	ADJ
mkg-25034	108	8	hiv	hiv	PROPN
mkg-25034	108	9	-	-	PUNCT
mkg-25034	108	10	positive	positive	ADJ
mkg-25034	108	11	patients	patient	NOUN
mkg-25034	108	12	with	with	ADP
mkg-25034	108	13	cd4	cd4	PROPN
mkg-25034	108	14	+	+	NOUN
mkg-25034	108	15	cell	cell	NOUN
mkg-25034	108	16	counts	count	NOUN
mkg-25034	108	17	between	between	ADP
mkg-25034	108	18	200	200	NUM
mkg-25034	108	19	and	and	CCONJ
mkg-25034	108	20	400	400	NUM
mkg-25034	108	21	/	/	SYM
mkg-25034	108	22	μl	μl	PROPN
mkg-25034	108	23	had	have	VERB
mkg-25034	108	24	more	more	ADJ
mkg-25034	108	25	colonisation	colonisation	NOUN
mkg-25034	108	26	of	of	ADP
mkg-25034	108	27	c.	c.	NOUN
mkg-25034	108	28	albicans	albican	NOUN
mkg-25034	108	29	and	and	CCONJ
mkg-25034	108	30	c.	c.	NOUN
mkg-25034	108	31	dubliniensis	dubliniensis	NOUN
mkg-25034	108	32	.	.	PUNCT
mkg-25034	109	1	table	table	NOUN
mkg-25034	109	2	3	3	NUM
mkg-25034	109	3	shows	show	VERB
mkg-25034	109	4	that	that	SCONJ
mkg-25034	109	5	the	the	DET
mkg-25034	109	6	lowest	low	ADJ
mkg-25034	109	7	concentration	concentration	NOUN
mkg-25034	109	8	of	of	ADP
mkg-25034	109	9	fluconazole	fluconazole	NOUN
mkg-25034	109	10	has	have	VERB
mkg-25034	109	11	susceptibility	susceptibility	NOUN
mkg-25034	109	12	to	to	ADP
mkg-25034	109	13	oral	oral	ADJ
mkg-25034	109	14	c.	c.	NOUN
mkg-25034	109	15	albicans	albican	NOUN
mkg-25034	109	16	.	.	PUNCT
mkg-25034	110	1	in	in	ADP
mkg-25034	110	2	contrast	contrast	NOUN
mkg-25034	110	3	,	,	PUNCT
mkg-25034	110	4	the	the	DET
mkg-25034	110	5	highest	high	ADJ
mkg-25034	110	6	concentration	concentration	NOUN
mkg-25034	110	7	of	of	ADP
mkg-25034	110	8	fluconazole	fluconazole	NOUN
mkg-25034	110	9	is	be	AUX
mkg-25034	110	10	resistant	resistant	ADJ
mkg-25034	110	11	to	to	ADP
mkg-25034	110	12	the	the	DET
mkg-25034	110	13	antifungal	antifungal	NOUN
mkg-25034	110	14	of	of	ADP
mkg-25034	110	15	c.	c.	NOUN
mkg-25034	110	16	albicans	albican	VERB
mkg-25034	110	17	essence	essence	NOUN
mkg-25034	110	18	of	of	ADP
mkg-25034	110	19	hiv	hiv	PROPN
mkg-25034	110	20	/	/	SYM
mkg-25034	110	21	aids	aids	PROPN
mkg-25034	110	22	.	.	PUNCT
mkg-25034	111	1	thus	thus	ADV
mkg-25034	111	2	,	,	PUNCT
mkg-25034	111	3	fluconazole	fluconazole	NOUN
mkg-25034	111	4	toxicity	toxicity	NOUN
mkg-25034	111	5	to	to	ADP
mkg-25034	111	6	candida	candida	PROPN
mkg-25034	111	7	species	specie	NOUN
mkg-25034	111	8	at	at	ADP
mkg-25034	111	9	the	the	DET
mkg-25034	111	10	lowest	low	ADJ
mkg-25034	111	11	concentration	concentration	NOUN
mkg-25034	111	12	is	be	AUX
mkg-25034	111	13	becoming	become	VERB
mkg-25034	111	14	higher	high	ADJ
mkg-25034	111	15	.	.	PUNCT
mkg-25034	112	1	this	this	DET
mkg-25034	112	2	antifungal	antifungal	PROPN
mkg-25034	112	3	has	have	VERB
mkg-25034	112	4	the	the	DET
mkg-25034	112	5	ability	ability	NOUN
mkg-25034	112	6	to	to	PART
mkg-25034	112	7	prevent	prevent	VERB
mkg-25034	112	8	candida	candida	NOUN
mkg-25034	112	9	infections	infection	NOUN
mkg-25034	112	10	by	by	ADP
mkg-25034	112	11	inhibiting	inhibit	VERB
mkg-25034	112	12	dna	dna	ADJ
mkg-25034	112	13	synthesis	synthesis	NOUN
mkg-25034	112	14	and	and	CCONJ
mkg-25034	112	15	ergosterol	ergosterol	NOUN
mkg-25034	112	16	biosynthesis	biosynthesis	NOUN
mkg-25034	112	17	in	in	ADP
mkg-25034	112	18	fungal	fungal	ADJ
mkg-25034	112	19	cell	cell	NOUN
mkg-25034	112	20	membranes	membrane	NOUN
mkg-25034	112	21	,	,	PUNCT
mkg-25034	112	22	changing	change	VERB
mkg-25034	112	23	cell	cell	NOUN
mkg-25034	112	24	surface	surface	NOUN
mkg-25034	112	25	hydrophobicity	hydrophobicity	NOUN
mkg-25034	112	26	,	,	PUNCT
mkg-25034	112	27	and	and	CCONJ
mkg-25034	112	28	influencing	influence	VERB
mkg-25034	112	29	the	the	DET
mkg-25034	112	30	synthesis	synthesis	NOUN
mkg-25034	112	31	of	of	ADP
mkg-25034	112	32	triglycerides	triglyceride	NOUN
mkg-25034	112	33	and	and	CCONJ
mkg-25034	112	34	phospholipids.22	phospholipids.22	VERB
mkg-25034	112	35	based	base	VERB
mkg-25034	112	36	on	on	ADP
mkg-25034	112	37	this	this	DET
mkg-25034	112	38	study	study	NOUN
mkg-25034	112	39	,	,	PUNCT
mkg-25034	112	40	resistance	resistance	NOUN
mkg-25034	112	41	occurs	occur	VERB
mkg-25034	112	42	due	due	ADJ
mkg-25034	112	43	to	to	ADP
mkg-25034	112	44	intense	intense	ADJ
mkg-25034	112	45	administration	administration	NOUN
mkg-25034	112	46	with	with	ADP
mkg-25034	112	47	varying	vary	VERB
mkg-25034	112	48	doses	dose	NOUN
mkg-25034	112	49	.	.	PUNCT
mkg-25034	113	1	this	this	DET
mkg-25034	113	2	finding	finding	NOUN
mkg-25034	113	3	concurs	concur	VERB
mkg-25034	113	4	with	with	ADP
mkg-25034	113	5	previous	previous	ADJ
mkg-25034	113	6	research	research	NOUN
mkg-25034	113	7	showing	show	VERB
mkg-25034	113	8	that	that	SCONJ
mkg-25034	113	9	resistance	resistance	NOUN
mkg-25034	113	10	occurred	occur	VERB
mkg-25034	113	11	,	,	PUNCT
mkg-25034	113	12	on	on	ADP
mkg-25034	113	13	average	average	ADJ
mkg-25034	113	14	,	,	PUNCT
mkg-25034	113	15	in	in	ADP
mkg-25034	113	16	minimal	minimal	ADJ
mkg-25034	113	17	inhibition	inhibition	NOUN
mkg-25034	113	18	concentration	concentration	NOUN
mkg-25034	113	19	(	(	PUNCT
mkg-25034	113	20	mic	mic	NOUN
mkg-25034	113	21	)	)	PUNCT
mkg-25034	113	22	of	of	ADP
mkg-25034	113	23	fluconazole	fluconazole	NOUN
mkg-25034	113	24	concentrations	concentration	NOUN
mkg-25034	113	25	of	of	ADP
mkg-25034	113	26	up	up	ADP
mkg-25034	113	27	to	to	PART
mkg-25034	113	28	three	three	NUM
mkg-25034	113	29	times	time	NOUN
mkg-25034	113	30	due	due	ADJ
mkg-25034	113	31	to	to	ADP
mkg-25034	113	32	longterm	longterm	VERB
mkg-25034	113	33	treatment.23	treatment.23	PROPN
mkg-25034	113	34	patil	patil	PROPN
mkg-25034	113	35	et	et	PROPN
mkg-25034	113	36	al.24	al.24	PROPN
mkg-25034	113	37	reported	report	VERB
mkg-25034	113	38	that	that	SCONJ
mkg-25034	113	39	the	the	DET
mkg-25034	113	40	subject	subject	NOUN
mkg-25034	113	41	’s	’s	PART
mkg-25034	113	42	decreased	decrease	VERB
mkg-25034	113	43	resistance	resistance	NOUN
mkg-25034	113	44	could	could	AUX
mkg-25034	113	45	support	support	VERB
mkg-25034	113	46	oral	oral	ADJ
mkg-25034	113	47	candidiasis	candidiasis	NOUN
mkg-25034	113	48	development	development	NOUN
mkg-25034	113	49	.	.	PUNCT
mkg-25034	114	1	as	as	ADV
mkg-25034	114	2	many	many	ADJ
mkg-25034	114	3	as	as	ADP
mkg-25034	114	4	95	95	NUM
mkg-25034	114	5	%	%	NOUN
mkg-25034	114	6	of	of	ADP
mkg-25034	114	7	c.	c.	NOUN
mkg-25034	114	8	albicans	albican	NOUN
mkg-25034	114	9	cases	case	NOUN
mkg-25034	114	10	were	be	AUX
mkg-25034	114	11	reported	report	VERB
mkg-25034	114	12	as	as	ADP
mkg-25034	114	13	a	a	DET
mkg-25034	114	14	trigger	trigger	NOUN
mkg-25034	114	15	factor	factor	NOUN
mkg-25034	114	16	for	for	ADP
mkg-25034	114	17	oral	oral	ADJ
mkg-25034	114	18	candidiasis	candidiasis	NOUN
mkg-25034	114	19	.	.	PUNCT
mkg-25034	115	1	the	the	DET
mkg-25034	115	2	oral	oral	ADJ
mkg-25034	115	3	candida	candida	PROPN
mkg-25034	115	4	species	specie	NOUN
mkg-25034	115	5	’	'	PUNCT
mkg-25034	115	6	resistance	resistance	NOUN
mkg-25034	115	7	was	be	AUX
mkg-25034	115	8	reported	report	VERB
mkg-25034	115	9	to	to	PART
mkg-25034	115	10	be	be	AUX
mkg-25034	115	11	less	less	ADJ
mkg-25034	115	12	than	than	ADP
mkg-25034	115	13	sensitive	sensitive	ADJ
mkg-25034	115	14	,	,	PUNCT
mkg-25034	115	15	but	but	CCONJ
mkg-25034	115	16	it	it	PRON
mkg-25034	115	17	can	can	AUX
mkg-25034	115	18	threaten	threaten	VERB
mkg-25034	115	19	oral	oral	ADJ
mkg-25034	115	20	candidiasis	candidiasis	NOUN
mkg-25034	115	21	if	if	SCONJ
mkg-25034	115	22	hiv	hiv	PROPN
mkg-25034	115	23	/	/	SYM
mkg-25034	115	24	aids	aids	PROPN
mkg-25034	115	25	infection	infection	NOUN
mkg-25034	115	26	persists.24	persists.24	NOUN
mkg-25034	115	27	this	this	DET
mkg-25034	115	28	study	study	NOUN
mkg-25034	115	29	found	find	VERB
mkg-25034	115	30	that	that	SCONJ
mkg-25034	115	31	susceptibility	susceptibility	NOUN
mkg-25034	115	32	frequency	frequency	NOUN
mkg-25034	115	33	is	be	AUX
mkg-25034	115	34	higher	high	ADJ
mkg-25034	115	35	than	than	ADP
mkg-25034	115	36	that	that	PRON
mkg-25034	115	37	of	of	ADP
mkg-25034	115	38	resistance	resistance	NOUN
mkg-25034	115	39	,	,	PUNCT
mkg-25034	115	40	so	so	SCONJ
mkg-25034	115	41	these	these	DET
mkg-25034	115	42	antifungals	antifungal	NOUN
mkg-25034	115	43	are	be	AUX
mkg-25034	115	44	recommended	recommend	VERB
mkg-25034	115	45	to	to	PART
mkg-25034	115	46	prevent	prevent	VERB
mkg-25034	115	47	oral	oral	ADJ
mkg-25034	115	48	candidiasis	candidiasis	NOUN
mkg-25034	115	49	in	in	ADP
mkg-25034	115	50	hiv	hiv	PROPN
mkg-25034	115	51	/	/	SYM
mkg-25034	115	52	aids	aids	PROPN
mkg-25034	115	53	.	.	PUNCT
mkg-25034	116	1	the	the	DET
mkg-25034	116	2	antifungal	antifungal	ADJ
mkg-25034	116	3	drugs	drug	NOUN
mkg-25034	116	4	used	use	VERB
mkg-25034	116	5	in	in	ADP
mkg-25034	116	6	this	this	DET
mkg-25034	116	7	research	research	NOUN
mkg-25034	116	8	have	have	VERB
mkg-25034	116	9	different	different	ADJ
mkg-25034	116	10	susceptibility	susceptibility	NOUN
mkg-25034	116	11	and	and	CCONJ
mkg-25034	116	12	resistance	resistance	NOUN
mkg-25034	116	13	properties	property	NOUN
mkg-25034	116	14	.	.	PUNCT
mkg-25034	117	1	however	however	ADV
mkg-25034	117	2	,	,	PUNCT
mkg-25034	117	3	they	they	PRON
mkg-25034	117	4	have	have	VERB
mkg-25034	117	5	the	the	DET
mkg-25034	117	6	same	same	ADJ
mkg-25034	117	7	tendency	tendency	NOUN
mkg-25034	117	8	to	to	PART
mkg-25034	117	9	suppress	suppress	VERB
mkg-25034	117	10	the	the	DET
mkg-25034	117	11	growth	growth	NOUN
mkg-25034	117	12	of	of	ADP
mkg-25034	117	13	c.	c.	NOUN
mkg-25034	117	14	albicans	albican	NOUN
mkg-25034	117	15	,	,	PUNCT
mkg-25034	117	16	as	as	SCONJ
mkg-25034	117	17	shown	show	VERB
mkg-25034	117	18	in	in	ADP
mkg-25034	117	19	tables	table	NOUN
mkg-25034	117	20	2	2	NUM
mkg-25034	117	21	and	and	CCONJ
mkg-25034	117	22	3	3	NUM
mkg-25034	117	23	.	.	PUNCT
mkg-25034	118	1	it	it	PRON
mkg-25034	118	2	is	be	AUX
mkg-25034	118	3	indicated	indicate	VERB
mkg-25034	118	4	that	that	SCONJ
mkg-25034	118	5	fluconazole	fluconazole	NOUN
mkg-25034	118	6	,	,	PUNCT
mkg-25034	118	7	ketoconazole	ketoconazole	NOUN
mkg-25034	118	8	,	,	PUNCT
mkg-25034	118	9	and	and	CCONJ
mkg-25034	118	10	nystatin	nystatin	NOUN
mkg-25034	118	11	have	have	VERB
mkg-25034	118	12	a	a	DET
mkg-25034	118	13	high	high	ADJ
mkg-25034	118	14	susceptibility	susceptibility	NOUN
mkg-25034	118	15	,	,	PUNCT
mkg-25034	118	16	with	with	ADP
mkg-25034	118	17	an	an	DET
mkg-25034	118	18	average	average	NOUN
mkg-25034	118	19	above	above	ADP
mkg-25034	118	20	80	80	NUM
mkg-25034	118	21	%	%	NOUN
mkg-25034	118	22	.	.	PUNCT
mkg-25034	119	1	these	these	DET
mkg-25034	119	2	antifungals	antifungal	NOUN
mkg-25034	119	3	have	have	VERB
mkg-25034	119	4	a	a	DET
mkg-25034	119	5	substantial	substantial	ADJ
mkg-25034	119	6	effect	effect	NOUN
mkg-25034	119	7	on	on	ADP
mkg-25034	119	8	c.	c.	NOUN
mkg-25034	119	9	albicans	albican	NOUN
mkg-25034	119	10	,	,	PUNCT
mkg-25034	119	11	both	both	PRON
mkg-25034	119	12	fungicidal	fungicidal	NOUN
mkg-25034	119	13	and	and	CCONJ
mkg-25034	119	14	fungistatic	fungistatic	NOUN
mkg-25034	119	15	.	.	PUNCT
mkg-25034	120	1	other	other	ADJ
mkg-25034	120	2	findings	finding	NOUN
mkg-25034	120	3	from	from	ADP
mkg-25034	120	4	this	this	DET
mkg-25034	120	5	study	study	NOUN
mkg-25034	120	6	are	be	AUX
mkg-25034	120	7	that	that	SCONJ
mkg-25034	120	8	the	the	DET
mkg-25034	120	9	three	three	NUM
mkg-25034	120	10	drugs	drug	NOUN
mkg-25034	120	11	’	'	PUNCT
mkg-25034	120	12	susceptibility	susceptibility	NOUN
mkg-25034	120	13	and	and	CCONJ
mkg-25034	120	14	resistance	resistance	NOUN
mkg-25034	120	15	.	.	PUNCT
mkg-25034	121	1	whaley	whaley	PROPN
mkg-25034	121	2	et	et	PROPN
mkg-25034	121	3	al.25	al.25	PROPN
mkg-25034	121	4	reported	report	VERB
mkg-25034	121	5	that	that	SCONJ
mkg-25034	121	6	in	in	ADP
mkg-25034	121	7	the	the	DET
mkg-25034	121	8	treatment	treatment	NOUN
mkg-25034	121	9	of	of	ADP
mkg-25034	121	10	hiv	hiv	PROPN
mkg-25034	121	11	,	,	PUNCT
mkg-25034	121	12	the	the	DET
mkg-25034	121	13	administration	administration	NOUN
mkg-25034	121	14	of	of	ADP
mkg-25034	121	15	azole	azole	PROPN
mkg-25034	121	16	groups	group	NOUN
mkg-25034	121	17	could	could	AUX
mkg-25034	121	18	cause	cause	VERB
mkg-25034	121	19	c.	c.	NOUN
mkg-25034	121	20	albicans	albican	NOUN
mkg-25034	121	21	resistance	resistance	NOUN
mkg-25034	121	22	or	or	CCONJ
mkg-25034	121	23	trigger	trigger	VERB
mkg-25034	121	24	the	the	DET
mkg-25034	121	25	development	development	NOUN
mkg-25034	121	26	of	of	ADP
mkg-25034	121	27	non	non	ADJ
mkg-25034	121	28	-	-	ADJ
mkg-25034	121	29	c.	c.	ADJ
mkg-25034	121	30	albicans	albican	NOUN
mkg-25034	121	31	species	specie	NOUN
mkg-25034	121	32	,	,	PUNCT
mkg-25034	121	33	such	such	ADJ
mkg-25034	121	34	as	as	ADP
mkg-25034	121	35	c.	c.	PROPN
mkg-25034	121	36	glabrata	glabrata	PROPN
mkg-25034	121	37	and	and	CCONJ
mkg-25034	121	38	c.	c.	PROPN
mkg-25034	121	39	krusei	krusei	PROPN
mkg-25034	121	40	,	,	PUNCT
mkg-25034	121	41	which	which	PRON
mkg-25034	121	42	intrinsically	intrinsically	ADV
mkg-25034	121	43	cause	cause	VERB
mkg-25034	121	44	resistance	resistance	NOUN
mkg-25034	121	45	.	.	PUNCT
mkg-25034	122	1	the	the	DET
mkg-25034	122	2	opposition	opposition	NOUN
mkg-25034	122	3	to	to	ADP
mkg-25034	122	4	one	one	NUM
mkg-25034	122	5	of	of	ADP
mkg-25034	122	6	the	the	DET
mkg-25034	122	7	azole	azole	ADJ
mkg-25034	122	8	antifungal	antifungal	ADJ
mkg-25034	122	9	drugs	drug	NOUN
mkg-25034	122	10	is	be	AUX
mkg-25034	122	11	often	often	ADV
mkg-25034	122	12	associated	associate	VERB
mkg-25034	122	13	with	with	ADP
mkg-25034	122	14	other	other	ADJ
mkg-25034	122	15	azole	azole	ADJ
mkg-25034	122	16	resistance.25	resistance.25	NOUN
mkg-25034	122	17	period	period	NOUN
mkg-25034	122	18	exposure	exposure	NOUN
mkg-25034	122	19	is	be	AUX
mkg-25034	122	20	a	a	DET
mkg-25034	122	21	risk	risk	NOUN
mkg-25034	122	22	factor	factor	NOUN
mkg-25034	122	23	in	in	ADP
mkg-25034	122	24	fluconazole	fluconazole	NOUN
mkg-25034	122	25	resistance	resistance	NOUN
mkg-25034	122	26	.	.	PUNCT
mkg-25034	123	1	refractory	refractory	NOUN
mkg-25034	123	2	oropharyngeal	oropharyngeal	NOUN
mkg-25034	123	3	candidiasis	candidiasis	NOUN
mkg-25034	123	4	of	of	ADP
mkg-25034	123	5	treatment	treatment	NOUN
mkg-25034	123	6	by	by	ADP
mkg-25034	123	7	fluconazole	fluconazole	NOUN
mkg-25034	123	8	is	be	AUX
mkg-25034	123	9	most	most	ADV
mkg-25034	123	10	frequently	frequently	ADV
mkg-25034	123	11	used	use	VERB
mkg-25034	123	12	in	in	ADP
mkg-25034	123	13	hiv.8	hiv.8	PROPN
mkg-25034	123	14	the	the	DET
mkg-25034	123	15	tracing	tracing	NOUN
mkg-25034	123	16	of	of	ADP
mkg-25034	123	17	the	the	DET
mkg-25034	123	18	possible	possible	ADJ
mkg-25034	123	19	history	history	NOUN
mkg-25034	123	20	of	of	ADP
mkg-25034	123	21	antifungal	antifungal	ADJ
mkg-25034	123	22	drug	drug	PROPN
mkg-25034	123	23	administration	administration	NOUN
mkg-25034	123	24	was	be	AUX
mkg-25034	123	25	obtained	obtain	VERB
mkg-25034	123	26	through	through	ADP
mkg-25034	123	27	periods	period	NOUN
mkg-25034	123	28	of	of	ADP
mkg-25034	123	29	hiv	hiv	PROPN
mkg-25034	123	30	infection	infection	NOUN
mkg-25034	123	31	and	and	CCONJ
mkg-25034	123	32	diagnosed	diagnose	VERB
mkg-25034	123	33	hiv	hiv	PROPN
mkg-25034	123	34	patients	patient	NOUN
mkg-25034	123	35	.	.	PUNCT
mkg-25034	124	1	the	the	DET
mkg-25034	124	2	higher	high	ADJ
mkg-25034	124	3	possibility	possibility	NOUN
mkg-25034	124	4	of	of	ADP
mkg-25034	124	5	opportunistic	opportunistic	ADJ
mkg-25034	124	6	infections	infection	NOUN
mkg-25034	124	7	impacts	impact	VERB
mkg-25034	124	8	oral	oral	ADJ
mkg-25034	124	9	candidiasis	candidiasis	NOUN
mkg-25034	124	10	with	with	ADP
mkg-25034	124	11	treatment	treatment	NOUN
mkg-25034	124	12	by	by	ADP
mkg-25034	124	13	antifungals	antifungal	NOUN
mkg-25034	124	14	,	,	PUNCT
mkg-25034	124	15	which	which	PRON
mkg-25034	124	16	then	then	ADV
mkg-25034	124	17	affects	affect	VERB
mkg-25034	124	18	susceptibility	susceptibility	NOUN
mkg-25034	124	19	.	.	PUNCT
mkg-25034	125	1	however	however	ADV
mkg-25034	125	2	,	,	PUNCT
mkg-25034	125	3	these	these	DET
mkg-25034	125	4	allegations	allegation	NOUN
mkg-25034	125	5	still	still	ADV
mkg-25034	125	6	need	need	VERB
mkg-25034	125	7	further	further	ADJ
mkg-25034	125	8	analysis	analysis	NOUN
mkg-25034	125	9	regarding	regard	VERB
mkg-25034	125	10	the	the	DET
mkg-25034	125	11	relationship	relationship	NOUN
mkg-25034	125	12	between	between	ADP
mkg-25034	125	13	the	the	DET
mkg-25034	125	14	length	length	NOUN
mkg-25034	125	15	of	of	ADP
mkg-25034	125	16	hiv	hiv	PROPN
mkg-25034	125	17	infection	infection	NOUN
mkg-25034	125	18	with	with	ADP
mkg-25034	125	19	a	a	DET
mkg-25034	125	20	history	history	NOUN
mkg-25034	125	21	of	of	ADP
mkg-25034	125	22	antifungal	antifungal	ADJ
mkg-25034	125	23	use	use	NOUN
mkg-25034	125	24	and	and	CCONJ
mkg-25034	125	25	susceptibility	susceptibility	NOUN
mkg-25034	125	26	based	base	VERB
mkg-25034	125	27	on	on	ADP
mkg-25034	125	28	more	more	ADV
mkg-25034	125	29	accurate	accurate	ADJ
mkg-25034	125	30	data	datum	NOUN
mkg-25034	125	31	.	.	PUNCT
mkg-25034	126	1	in	in	ADP
mkg-25034	126	2	this	this	DET
mkg-25034	126	3	study	study	NOUN
mkg-25034	126	4	,	,	PUNCT
mkg-25034	126	5	dental	dental	ADJ
mkg-25034	126	6	journal	journal	NOUN
mkg-25034	126	7	(	(	PUNCT
mkg-25034	126	8	majalah	majalah	PROPN
mkg-25034	126	9	kedokteran	kedokteran	PROPN
mkg-25034	126	10	gigi	gigi	PROPN
mkg-25034	126	11	)	)	PUNCT
mkg-25034	126	12	p	p	X
mkg-25034	126	13	-	-	PUNCT
mkg-25034	126	14	issn	issn	NOUN
mkg-25034	126	15	:	:	PUNCT
mkg-25034	126	16	1978	1978	NUM
mkg-25034	126	17	-	-	SYM
mkg-25034	126	18	3728	3728	NUM
mkg-25034	126	19	;	;	PUNCT
mkg-25034	126	20	e	e	X
mkg-25034	126	21	-	-	PUNCT
mkg-25034	126	22	issn	issn	ADJ
mkg-25034	126	23	:	:	PUNCT
mkg-25034	126	24	2442	2442	NUM
mkg-25034	126	25	-	-	SYM
mkg-25034	126	26	9740	9740	NUM
mkg-25034	126	27	.	.	PUNCT
mkg-25034	126	28	accredited	accredit	VERB
mkg-25034	126	29	no	no	PRON
mkg-25034	126	30	.	.	PUNCT
mkg-25034	126	31	32a	32a	NOUN
mkg-25034	126	32	/	/	SYM
mkg-25034	126	33	e	e	NOUN
mkg-25034	126	34	/	/	SYM
mkg-25034	126	35	kpt/2017	kpt/2017	X
mkg-25034	126	36	.	.	PUNCT
mkg-25034	127	1	open	open	ADJ
mkg-25034	127	2	access	access	NOUN
mkg-25034	127	3	under	under	ADP
mkg-25034	127	4	cc	cc	NOUN
mkg-25034	127	5	-	-	PUNCT
mkg-25034	127	6	by	by	ADP
mkg-25034	127	7	-	-	PUNCT
mkg-25034	127	8	sa	sa	NOUN
mkg-25034	127	9	license	license	NOUN
mkg-25034	127	10	.	.	PUNCT
mkg-25034	128	1	available	available	ADJ
mkg-25034	128	2	at	at	ADP
mkg-25034	128	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	128	4	doi	doi	NOUN
mkg-25034	128	5	:	:	PUNCT
mkg-25034	128	6	10.20473	10.20473	NUM
mkg-25034	128	7	/	/	SYM
mkg-25034	128	8	j.djmkg.v54.i2.p82–86	j.djmkg.v54.i2.p82–86	ADJ
mkg-25034	128	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	128	10	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	NOUN
mkg-25034	128	11	86	86	NUM
mkg-25034	128	12	rezeki	rezeki	NOUN
mkg-25034	128	13	et	et	PROPN
mkg-25034	128	14	al./dent	al./dent	PROPN
mkg-25034	128	15	.	.	PUNCT
mkg-25034	129	1	j.	j.	PROPN
mkg-25034	129	2	(	(	PUNCT
mkg-25034	129	3	majalah	majalah	PROPN
mkg-25034	129	4	kedokteran	kedokteran	PROPN
mkg-25034	129	5	gigi	gigi	PROPN
mkg-25034	129	6	)	)	PUNCT
mkg-25034	129	7	2021	2021	NUM
mkg-25034	129	8	june	june	PROPN
mkg-25034	129	9	;	;	PUNCT
mkg-25034	129	10	54(2	54(2	NUM
mkg-25034	129	11	):	):	PUNCT
mkg-25034	129	12	82–86	82–86	NUM
mkg-25034	129	13	the	the	DET
mkg-25034	129	14	susceptibility	susceptibility	NOUN
mkg-25034	129	15	test	test	NOUN
mkg-25034	129	16	was	be	AUX
mkg-25034	129	17	not	not	PART
mkg-25034	129	18	carried	carry	VERB
mkg-25034	129	19	out	out	ADP
mkg-25034	129	20	on	on	ADP
mkg-25034	129	21	other	other	ADJ
mkg-25034	129	22	candida	candida	PROPN
mkg-25034	129	23	species	specie	NOUN
mkg-25034	129	24	because	because	SCONJ
mkg-25034	129	25	the	the	DET
mkg-25034	129	26	population	population	NOUN
mkg-25034	129	27	was	be	AUX
mkg-25034	129	28	too	too	ADV
mkg-25034	129	29	small	small	ADJ
mkg-25034	129	30	.	.	PUNCT
mkg-25034	130	1	there	there	PRON
mkg-25034	130	2	was	be	VERB
mkg-25034	130	3	also	also	ADV
mkg-25034	130	4	no	no	DET
mkg-25034	130	5	antifungal	antifungal	ADJ
mkg-25034	130	6	combination	combination	NOUN
mkg-25034	130	7	to	to	PART
mkg-25034	130	8	test	test	VERB
mkg-25034	130	9	the	the	DET
mkg-25034	130	10	susceptibility	susceptibility	NOUN
mkg-25034	130	11	to	to	ADP
mkg-25034	130	12	c.	c.	NOUN
mkg-25034	130	13	albicans	albican	NOUN
mkg-25034	130	14	.	.	PUNCT
mkg-25034	131	1	it	it	PRON
mkg-25034	131	2	can	can	AUX
mkg-25034	131	3	be	be	AUX
mkg-25034	131	4	concluded	conclude	VERB
mkg-25034	131	5	that	that	SCONJ
mkg-25034	131	6	candida	candida	NOUN
mkg-25034	131	7	albicans	albican	NOUN
mkg-25034	131	8	was	be	AUX
mkg-25034	131	9	dominant	dominant	ADJ
mkg-25034	131	10	in	in	ADP
mkg-25034	131	11	the	the	DET
mkg-25034	131	12	saliva	saliva	NOUN
mkg-25034	131	13	of	of	ADP
mkg-25034	131	14	hiv	hiv	PROPN
mkg-25034	131	15	/	/	SYM
mkg-25034	131	16	aids	aids	PROPN
mkg-25034	131	17	patients	patient	NOUN
mkg-25034	131	18	.	.	PUNCT
mkg-25034	132	1	this	this	DET
mkg-25034	132	2	fungus	fungus	NOUN
mkg-25034	132	3	was	be	AUX
mkg-25034	132	4	effectively	effectively	ADV
mkg-25034	132	5	treated	treat	VERB
mkg-25034	132	6	by	by	ADP
mkg-25034	132	7	fluconazole	fluconazole	NOUN
mkg-25034	132	8	,	,	PUNCT
mkg-25034	132	9	ketoconazole	ketoconazole	NOUN
mkg-25034	132	10	,	,	PUNCT
mkg-25034	132	11	and	and	CCONJ
mkg-25034	132	12	nystatin	nystatin	NOUN
mkg-25034	132	13	.	.	PUNCT
mkg-25034	133	1	these	these	DET
mkg-25034	133	2	antifungals	antifungal	NOUN
mkg-25034	133	3	had	have	VERB
mkg-25034	133	4	high	high	ADJ
mkg-25034	133	5	susceptibility	susceptibility	NOUN
mkg-25034	133	6	at	at	ADP
mkg-25034	133	7	≤	≤	NOUN
mkg-25034	133	8	8	8	NUM
mkg-25034	133	9	μg	μg	NOUN
mkg-25034	133	10	/	/	SYM
mkg-25034	133	11	ml	ml	NOUN
mkg-25034	133	12	to	to	ADP
mkg-25034	133	13	c.	c.	NOUN
mkg-25034	133	14	albicans	albican	NOUN
mkg-25034	133	15	.	.	PUNCT
mkg-25034	134	1	references	reference	NOUN
mkg-25034	134	2	1	1	NUM
mkg-25034	134	3	.	.	PUNCT
mkg-25034	134	4	rahmawati	rahmawati	PROPN
mkg-25034	134	5	m.	m.	PROPN
mkg-25034	134	6	penangulangan	penangulangan	VERB
mkg-25034	134	7	hiv	hiv	PROPN
mkg-25034	134	8	/	/	SYM
mkg-25034	134	9	aids	aids	PROPN
mkg-25034	134	10	di	di	PROPN
mkg-25034	134	11	indonesia	indonesia	PROPN
mkg-25034	134	12	dalam	dalam	PROPN
mkg-25034	134	13	ancaman	ancaman	PROPN
mkg-25034	134	14	rkuhp	rkuhp	ADJ
mkg-25034	134	15	:	:	PUNCT
mkg-25034	135	1	proyeksi	proyeksi	PROPN
mkg-25034	135	2	dampak	dampak	NOUN
mkg-25034	135	3	kriminalisasi	kriminalisasi	PROPN
mkg-25034	135	4	perilaku	perilaku	PROPN
mkg-25034	135	5	beresiko	beresiko	PROPN
mkg-25034	135	6	transmisi	transmisi	VERB
mkg-25034	135	7	hiv	hiv	PROPN
mkg-25034	135	8	/	/	SYM
mkg-25034	135	9	aids	aids	PROPN
mkg-25034	135	10	dalam	dalam	PROPN
mkg-25034	135	11	rkuhp	rkuhp	PROPN
mkg-25034	135	12	terhadap	terhadap	PROPN
mkg-25034	135	13	penanggulangan	penanggulangan	PROPN
mkg-25034	135	14	hiv/	hiv/	PROPN
mkg-25034	135	15	aids	aids	PROPN
mkg-25034	135	16	di	di	X
mkg-25034	135	17	indonesia	indonesia	PROPN
mkg-25034	135	18	.	.	PUNCT
mkg-25034	136	1	jakarta	jakarta	PROPN
mkg-25034	136	2	:	:	PUNCT
mkg-25034	136	3	institute	institute	VERB
mkg-25034	136	4	for	for	ADP
mkg-25034	136	5	criminal	criminal	ADJ
mkg-25034	136	6	justice	justice	NOUN
mkg-25034	136	7	reform	reform	NOUN
mkg-25034	136	8	;	;	PUNCT
mkg-25034	136	9	2019	2019	NUM
mkg-25034	136	10	.	.	PUNCT
mkg-25034	137	1	p.	p.	NOUN
mkg-25034	138	1	7–8	7–8	NOUN
mkg-25034	138	2	.	.	PROPN
mkg-25034	138	3	2	2	NUM
mkg-25034	138	4	.	.	X
mkg-25034	138	5	anwar	anwar	PROPN
mkg-25034	138	6	kp	kp	PROPN
mkg-25034	138	7	,	,	PUNCT
mkg-25034	138	8	malik	malik	PROPN
mkg-25034	138	9	a	a	PRON
mkg-25034	138	10	,	,	PUNCT
mkg-25034	138	11	subhan	subhan	INTJ
mkg-25034	138	12	kh	kh	PROPN
mkg-25034	138	13	.	.	PROPN
mkg-25034	138	14	profile	profile	NOUN
mkg-25034	138	15	of	of	ADP
mkg-25034	138	16	candidiasis	candidiasis	NOUN
mkg-25034	138	17	in	in	ADP
mkg-25034	138	18	hiv	hiv	PROPN
mkg-25034	138	19	infected	infect	VERB
mkg-25034	138	20	patients	patient	NOUN
mkg-25034	138	21	.	.	PUNCT
mkg-25034	139	1	iran	iran	PROPN
mkg-25034	139	2	j	j	PROPN
mkg-25034	139	3	microbiol	microbiol	PROPN
mkg-25034	139	4	.	.	PUNCT
mkg-25034	140	1	2012	2012	NUM
mkg-25034	140	2	;	;	PUNCT
mkg-25034	140	3	4(4	4(4	NUM
mkg-25034	140	4	):	):	PUNCT
mkg-25034	140	5	204–9	204–9	NUM
mkg-25034	140	6	.	.	NOUN
mkg-25034	141	1	3	3	NUM
mkg-25034	141	2	.	.	X
mkg-25034	141	3	wilson	wilson	PROPN
mkg-25034	141	4	d.	d.	PROPN
mkg-25034	141	5	candida	candida	PROPN
mkg-25034	141	6	albicans	albican	NOUN
mkg-25034	141	7	.	.	PUNCT
mkg-25034	142	1	trends	trend	NOUN
mkg-25034	142	2	microbiol	microbiol	PROPN
mkg-25034	142	3	.	.	PUNCT
mkg-25034	143	1	2019	2019	NUM
mkg-25034	143	2	;	;	PUNCT
mkg-25034	144	1	27(2	27(2	NUM
mkg-25034	144	2	):	):	PUNCT
mkg-25034	144	3	188–9	188–9	NUM
mkg-25034	144	4	.	.	NOUN
mkg-25034	144	5	4	4	NUM
mkg-25034	144	6	.	.	X
mkg-25034	144	7	thompson	thompson	PROPN
mkg-25034	144	8	gr	gr	PROPN
mkg-25034	144	9	,	,	PUNCT
mkg-25034	144	10	patel	patel	PROPN
mkg-25034	144	11	pk	pk	PROPN
mkg-25034	144	12	,	,	PUNCT
mkg-25034	144	13	kirkpatrick	kirkpatrick	PROPN
mkg-25034	144	14	wr	wr	PROPN
mkg-25034	144	15	,	,	PUNCT
mkg-25034	144	16	westbrook	westbrook	PROPN
mkg-25034	144	17	sd	sd	PROPN
mkg-25034	144	18	,	,	PUNCT
mkg-25034	144	19	berg	berg	PROPN
mkg-25034	144	20	d	d	PROPN
mkg-25034	144	21	,	,	PUNCT
mkg-25034	144	22	erlandsen	erlandsen	PROPN
mkg-25034	144	23	j	j	PROPN
mkg-25034	144	24	,	,	PUNCT
mkg-25034	144	25	redding	redd	VERB
mkg-25034	144	26	sw	sw	PROPN
mkg-25034	144	27	,	,	PUNCT
mkg-25034	144	28	patterson	patterson	PROPN
mkg-25034	144	29	tf	tf	X
mkg-25034	144	30	.	.	PUNCT
mkg-25034	145	1	oropharyngeal	oropharyngeal	ADJ
mkg-25034	145	2	candidiasis	candidiasis	NOUN
mkg-25034	145	3	in	in	ADP
mkg-25034	145	4	the	the	DET
mkg-25034	145	5	era	era	NOUN
mkg-25034	145	6	of	of	ADP
mkg-25034	145	7	antiretroviral	antiretroviral	ADJ
mkg-25034	145	8	therapy	therapy	NOUN
mkg-25034	145	9	.	.	PUNCT
mkg-25034	146	1	oral	oral	ADJ
mkg-25034	146	2	surg	surg	NOUN
mkg-25034	146	3	oral	oral	ADJ
mkg-25034	146	4	med	med	ADJ
mkg-25034	146	5	oral	oral	ADJ
mkg-25034	146	6	pathol	pathol	NOUN
mkg-25034	146	7	oral	oral	ADJ
mkg-25034	146	8	radiol	radiol	NOUN
mkg-25034	146	9	endod	endod	PROPN
mkg-25034	146	10	.	.	PUNCT
mkg-25034	147	1	2010	2010	NUM
mkg-25034	147	2	;	;	PUNCT
mkg-25034	147	3	109(4	109(4	NUM
mkg-25034	147	4	):	):	PUNCT
mkg-25034	147	5	488–95	488–95	NUM
mkg-25034	147	6	.	.	PUNCT
mkg-25034	148	1	5	5	X
mkg-25034	148	2	.	.	X
mkg-25034	148	3	mulu	mulu	NOUN
mkg-25034	148	4	a	a	PRON
mkg-25034	148	5	,	,	PUNCT
mkg-25034	148	6	kassu	kassu	PROPN
mkg-25034	148	7	a	a	X
mkg-25034	148	8	,	,	PUNCT
mkg-25034	148	9	anagaw	anagaw	PROPN
mkg-25034	148	10	b	b	PROPN
mkg-25034	148	11	,	,	PUNCT
mkg-25034	148	12	moges	moge	NOUN
mkg-25034	148	13	b	b	NUM
mkg-25034	148	14	,	,	PUNCT
mkg-25034	148	15	gelaw	gelaw	NOUN
mkg-25034	148	16	a	a	NOUN
mkg-25034	148	17	,	,	PUNCT
mkg-25034	148	18	alemayehu	alemayehu	PROPN
mkg-25034	148	19	m	m	PROPN
mkg-25034	148	20	,	,	PUNCT
mkg-25034	148	21	belyhun	belyhun	PROPN
mkg-25034	148	22	y	y	PROPN
mkg-25034	148	23	,	,	PUNCT
mkg-25034	148	24	biadglegne	biadglegne	VERB
mkg-25034	148	25	f	f	PROPN
mkg-25034	148	26	,	,	PUNCT
mkg-25034	148	27	hurissa	hurissa	ADJ
mkg-25034	148	28	z	z	PROPN
mkg-25034	148	29	,	,	PUNCT
mkg-25034	148	30	moges	moge	NOUN
mkg-25034	148	31	f	f	NUM
mkg-25034	148	32	,	,	PUNCT
mkg-25034	148	33	isogai	isogai	PROPN
mkg-25034	148	34	e.	e.	PROPN
mkg-25034	148	35	frequent	frequent	ADJ
mkg-25034	148	36	detection	detection	NOUN
mkg-25034	148	37	of	of	ADP
mkg-25034	148	38	‘	'	PUNCT
mkg-25034	148	39	azole	azole	NOUN
mkg-25034	148	40	’	'	PUNCT
mkg-25034	148	41	resistant	resistant	ADJ
mkg-25034	148	42	candida	candida	NOUN
mkg-25034	148	43	species	specie	NOUN
mkg-25034	148	44	among	among	ADP
mkg-25034	148	45	late	late	ADJ
mkg-25034	148	46	presenting	present	VERB
mkg-25034	148	47	aids	aids	PROPN
mkg-25034	148	48	patients	patient	NOUN
mkg-25034	148	49	in	in	ADP
mkg-25034	148	50	northwest	northwest	PROPN
mkg-25034	148	51	ethiopia	ethiopia	PROPN
mkg-25034	148	52	.	.	PUNCT
mkg-25034	149	1	bmc	bmc	PROPN
mkg-25034	149	2	infect	infect	PROPN
mkg-25034	149	3	dis	dis	PROPN
mkg-25034	149	4	.	.	PUNCT
mkg-25034	150	1	2013	2013	NUM
mkg-25034	150	2	;	;	PUNCT
mkg-25034	150	3	13	13	NUM
mkg-25034	150	4	:	:	SYM
mkg-25034	150	5	82	82	NUM
mkg-25034	150	6	.	.	NOUN
mkg-25034	151	1	6	6	NUM
mkg-25034	151	2	.	.	NUM
mkg-25034	151	3	rodrigues	rodrigues	PROPN
mkg-25034	151	4	cf	cf	PROPN
mkg-25034	151	5	,	,	PUNCT
mkg-25034	151	6	rodrigues	rodrigue	VERB
mkg-25034	151	7	me	i	PRON
mkg-25034	151	8	,	,	PUNCT
mkg-25034	151	9	henriques	henrique	NOUN
mkg-25034	151	10	m.	m.	PROPN
mkg-25034	151	11	candida	candida	PROPN
mkg-25034	151	12	sp	sp	PROPN
mkg-25034	151	13	.	.	PROPN
mkg-25034	151	14	infections	infection	NOUN
mkg-25034	151	15	in	in	ADP
mkg-25034	151	16	patients	patient	NOUN
mkg-25034	151	17	with	with	ADP
mkg-25034	151	18	diabetes	diabetes	NOUN
mkg-25034	151	19	mellitus	mellitus	NOUN
mkg-25034	151	20	.	.	PUNCT
mkg-25034	152	1	j	j	PROPN
mkg-25034	152	2	clin	clin	PROPN
mkg-25034	152	3	med	med	PROPN
mkg-25034	152	4	.	.	PROPN
mkg-25034	152	5	2019	2019	NUM
mkg-25034	152	6	;	;	PUNCT
mkg-25034	152	7	8(1	8(1	NOUN
mkg-25034	152	8	):	):	PUNCT
mkg-25034	152	9	76	76	NUM
mkg-25034	152	10	.	.	PUNCT
mkg-25034	153	1	7	7	X
mkg-25034	153	2	.	.	NUM
mkg-25034	153	3	katiraee	katiraee	PROPN
mkg-25034	153	4	f	f	PROPN
mkg-25034	153	5	,	,	PUNCT
mkg-25034	153	6	teifoori	teifoori	NOUN
mkg-25034	153	7	f	f	NOUN
mkg-25034	153	8	,	,	PUNCT
mkg-25034	153	9	soltani	soltani	PROPN
mkg-25034	153	10	m.	m.	PROPN
mkg-25034	153	11	emergence	emergence	NOUN
mkg-25034	153	12	of	of	ADP
mkg-25034	153	13	azole	azole	NOUN
mkg-25034	153	14	-	-	PUNCT
mkg-25034	153	15	resistant	resistant	ADJ
mkg-25034	153	16	candida	candida	NOUN
mkg-25034	153	17	species	specie	NOUN
mkg-25034	153	18	in	in	ADP
mkg-25034	153	19	aids	aids	NOUN
mkg-25034	153	20	patients	patient	NOUN
mkg-25034	153	21	with	with	ADP
mkg-25034	153	22	oropharyngeal	oropharyngeal	ADJ
mkg-25034	153	23	candidiasis	candidiasis	NOUN
mkg-25034	153	24	in	in	ADP
mkg-25034	153	25	iran	iran	PROPN
mkg-25034	153	26	.	.	PUNCT
mkg-25034	154	1	curr	curr	PROPN
mkg-25034	154	2	med	med	PROPN
mkg-25034	154	3	mycol	mycol	NOUN
mkg-25034	154	4	.	.	PUNCT
mkg-25034	155	1	2015	2015	NUM
mkg-25034	155	2	;	;	PUNCT
mkg-25034	155	3	1(3	1(3	NUM
mkg-25034	155	4	):	):	PUNCT
mkg-25034	155	5	11–6	11–6	NUM
mkg-25034	155	6	.	.	NOUN
mkg-25034	155	7	8	8	NUM
mkg-25034	155	8	.	.	PUNCT
mkg-25034	156	1	mohamadi	mohamadi	PROPN
mkg-25034	156	2	j	j	PROPN
mkg-25034	156	3	,	,	PUNCT
mkg-25034	156	4	motaghi	motaghi	PROPN
mkg-25034	156	5	m	m	PROPN
mkg-25034	156	6	,	,	PUNCT
mkg-25034	156	7	panahi	panahi	PROPN
mkg-25034	156	8	j	j	PROPN
mkg-25034	156	9	,	,	PUNCT
mkg-25034	156	10	havasian	havasian	PROPN
mkg-25034	156	11	mr	mr	PROPN
mkg-25034	156	12	,	,	PUNCT
mkg-25034	156	13	delpisheh	delpisheh	ADJ
mkg-25034	156	14	a	a	PRON
mkg-25034	156	15	,	,	PUNCT
mkg-25034	156	16	azizian	azizian	PROPN
mkg-25034	156	17	m	m	PROPN
mkg-25034	156	18	,	,	PUNCT
mkg-25034	156	19	pakzad	pakzad	PROPN
mkg-25034	156	20	i.	i.	PROPN
mkg-25034	156	21	anti	anti	ADJ
mkg-25034	156	22	-	-	ADJ
mkg-25034	156	23	fungal	fungal	ADJ
mkg-25034	156	24	resistance	resistance	NOUN
mkg-25034	156	25	in	in	ADP
mkg-25034	156	26	candida	candida	PROPN
mkg-25034	156	27	isolated	isolate	VERB
mkg-25034	156	28	from	from	ADP
mkg-25034	156	29	oral	oral	ADJ
mkg-25034	156	30	and	and	CCONJ
mkg-25034	156	31	diaper	diaper	ADJ
mkg-25034	156	32	rash	rash	NOUN
mkg-25034	156	33	candidiasis	candidiasis	NOUN
mkg-25034	156	34	in	in	ADP
mkg-25034	156	35	neonates	neonate	NOUN
mkg-25034	156	36	.	.	PUNCT
mkg-25034	157	1	bioinformation	bioinformation	NOUN
mkg-25034	157	2	.	.	PUNCT
mkg-25034	158	1	2014	2014	NUM
mkg-25034	158	2	;	;	PUNCT
mkg-25034	158	3	10(11	10(11	NUM
mkg-25034	158	4	):	):	PUNCT
mkg-25034	158	5	667–70	667–70	PROPN
mkg-25034	158	6	.	.	PUNCT
mkg-25034	159	1	9	9	X
mkg-25034	159	2	.	.	X
mkg-25034	159	3	monroy	monroy	NOUN
mkg-25034	159	4	-	-	PUNCT
mkg-25034	159	5	pérez	pérez	NOUN
mkg-25034	159	6	e	e	NOUN
mkg-25034	159	7	,	,	PUNCT
mkg-25034	159	8	paniagua	paniagua	PROPN
mkg-25034	159	9	-	-	PUNCT
mkg-25034	159	10	contreras	contreras	PROPN
mkg-25034	159	11	gl	gl	PROPN
mkg-25034	159	12	,	,	PUNCT
mkg-25034	159	13	rodríguez	rodríguez	NOUN
mkg-25034	159	14	-	-	PUNCT
mkg-25034	159	15	purata	purata	NOUN
mkg-25034	159	16	p	p	X
mkg-25034	159	17	,	,	PUNCT
mkg-25034	159	18	vacapaniagua	vacapaniagua	NOUN
mkg-25034	159	19	f	f	NOUN
mkg-25034	159	20	,	,	PUNCT
mkg-25034	159	21	vázquez	vázquez	NOUN
mkg-25034	159	22	-	-	PUNCT
mkg-25034	159	23	villaseñor	villaseñor	NOUN
mkg-25034	159	24	m	m	PROPN
mkg-25034	159	25	,	,	PUNCT
mkg-25034	159	26	díaz	díaz	NOUN
mkg-25034	159	27	-	-	PUNCT
mkg-25034	159	28	velásquez	velásquez	NOUN
mkg-25034	159	29	c	c	PROPN
mkg-25034	159	30	,	,	PUNCT
mkg-25034	159	31	uribe	uribe	PROPN
mkg-25034	159	32	-	-	PUNCT
mkg-25034	159	33	garcía	garcía	PROPN
mkg-25034	159	34	a	a	X
mkg-25034	159	35	,	,	PUNCT
mkg-25034	159	36	vaca	vaca	PROPN
mkg-25034	159	37	s.	s.	PROPN
mkg-25034	159	38	high	high	ADJ
mkg-25034	159	39	virulence	virulence	NOUN
mkg-25034	159	40	and	and	CCONJ
mkg-25034	159	41	antifungal	antifungal	ADJ
mkg-25034	159	42	resistance	resistance	NOUN
mkg-25034	159	43	in	in	ADP
mkg-25034	159	44	clinical	clinical	ADJ
mkg-25034	159	45	strains	strain	NOUN
mkg-25034	159	46	of	of	ADP
mkg-25034	159	47	candida	candida	NOUN
mkg-25034	159	48	albicans	albican	NOUN
mkg-25034	159	49	.	.	PUNCT
mkg-25034	160	1	can	can	AUX
mkg-25034	160	2	j	j	PROPN
mkg-25034	160	3	infect	infect	VERB
mkg-25034	160	4	dis	dis	PROPN
mkg-25034	160	5	med	med	PROPN
mkg-25034	160	6	microbiol	microbiol	PROPN
mkg-25034	160	7	.	.	PUNCT
mkg-25034	161	1	2016	2016	NUM
mkg-25034	161	2	;	;	PUNCT
mkg-25034	161	3	2016	2016	NUM
mkg-25034	161	4	:	:	PUNCT
mkg-25034	161	5	5930489	5930489	NUM
mkg-25034	161	6	.	.	PUNCT
mkg-25034	162	1	10	10	NUM
mkg-25034	162	2	.	.	PUNCT
mkg-25034	163	1	hasim	hasim	PROPN
mkg-25034	163	2	s	s	PROPN
mkg-25034	163	3	,	,	PUNCT
mkg-25034	163	4	coleman	coleman	PROPN
mkg-25034	163	5	jj	jj	PROPN
mkg-25034	163	6	.	.	PROPN
mkg-25034	163	7	targeting	target	VERB
mkg-25034	163	8	the	the	DET
mkg-25034	163	9	fungal	fungal	ADJ
mkg-25034	163	10	cell	cell	NOUN
mkg-25034	163	11	wall	wall	NOUN
mkg-25034	163	12	:	:	PUNCT
mkg-25034	163	13	current	current	ADJ
mkg-25034	163	14	therapies	therapy	NOUN
mkg-25034	163	15	and	and	CCONJ
mkg-25034	163	16	implications	implication	NOUN
mkg-25034	163	17	for	for	ADP
mkg-25034	163	18	development	development	NOUN
mkg-25034	163	19	of	of	ADP
mkg-25034	163	20	alternative	alternative	ADJ
mkg-25034	163	21	antifungal	antifungal	ADJ
mkg-25034	163	22	agents	agent	NOUN
mkg-25034	163	23	.	.	PUNCT
mkg-25034	164	1	future	future	ADJ
mkg-25034	164	2	med	med	ADJ
mkg-25034	164	3	chem	chem	NOUN
mkg-25034	164	4	.	.	PUNCT
mkg-25034	165	1	2019	2019	NUM
mkg-25034	165	2	;	;	PUNCT
mkg-25034	165	3	11(8	11(8	NUM
mkg-25034	165	4	):	):	PUNCT
mkg-25034	165	5	869–83	869–83	NOUN
mkg-25034	165	6	.	.	PUNCT
mkg-25034	166	1	11	11	NUM
mkg-25034	166	2	.	.	PUNCT
mkg-25034	167	1	tellier	tellier	PROPN
mkg-25034	167	2	r	r	PROPN
mkg-25034	167	3	,	,	PUNCT
mkg-25034	167	4	li	li	PROPN
mkg-25034	167	5	y	y	PROPN
mkg-25034	167	6	,	,	PUNCT
mkg-25034	167	7	cowling	cowl	VERB
mkg-25034	167	8	bj	bj	NOUN
mkg-25034	167	9	,	,	PUNCT
mkg-25034	167	10	tang	tang	PROPN
mkg-25034	167	11	jw	jw	PROPN
mkg-25034	167	12	.	.	PROPN
mkg-25034	167	13	recognition	recognition	PROPN
mkg-25034	167	14	of	of	ADP
mkg-25034	167	15	aerosol	aerosol	NOUN
mkg-25034	167	16	transmission	transmission	NOUN
mkg-25034	167	17	of	of	ADP
mkg-25034	167	18	infectious	infectious	ADJ
mkg-25034	167	19	agents	agent	NOUN
mkg-25034	167	20	:	:	PUNCT
mkg-25034	167	21	a	a	DET
mkg-25034	167	22	commentary	commentary	NOUN
mkg-25034	167	23	.	.	PUNCT
mkg-25034	168	1	bmc	bmc	PROPN
mkg-25034	168	2	infect	infect	PROPN
mkg-25034	168	3	dis	dis	PROPN
mkg-25034	168	4	.	.	PUNCT
mkg-25034	169	1	2019	2019	NUM
mkg-25034	169	2	;	;	PUNCT
mkg-25034	169	3	19	19	NUM
mkg-25034	169	4	:	:	SYM
mkg-25034	169	5	101	101	NUM
mkg-25034	169	6	.	.	NOUN
mkg-25034	169	7	12	12	NUM
mkg-25034	169	8	.	.	PUNCT
mkg-25034	170	1	lozano	lozano	PROPN
mkg-25034	170	2	moraga	moraga	PROPN
mkg-25034	170	3	cp	cp	PROPN
mkg-25034	170	4	,	,	PUNCT
mkg-25034	170	5	rodríguez	rodríguez	PROPN
mkg-25034	170	6	martínez	martínez	PROPN
mkg-25034	170	7	ga	ga	PROPN
mkg-25034	170	8	,	,	PUNCT
mkg-25034	170	9	lefimil	lefimil	PROPN
mkg-25034	170	10	puente	puente	PROPN
mkg-25034	170	11	ca	can	AUX
mkg-25034	170	12	,	,	PUNCT
mkg-25034	170	13	morales	morale	VERB
mkg-25034	170	14	bozo	bozo	PROPN
mkg-25034	170	15	ic	ic	PROPN
mkg-25034	170	16	,	,	PUNCT
mkg-25034	170	17	urzúa	urzúa	PROPN
mkg-25034	170	18	orellana	orellana	PROPN
mkg-25034	170	19	br	br	PROPN
mkg-25034	170	20	.	.	PUNCT
mkg-25034	171	1	prevalence	prevalence	NOUN
mkg-25034	171	2	of	of	ADP
mkg-25034	171	3	candida	candida	PROPN
mkg-25034	171	4	albicans	albican	NOUN
mkg-25034	171	5	and	and	CCONJ
mkg-25034	171	6	carriage	carriage	NOUN
mkg-25034	171	7	of	of	ADP
mkg-25034	171	8	candida	candida	PROPN
mkg-25034	171	9	non	non	NOUN
mkg-25034	171	10	-	-	NOUN
mkg-25034	171	11	albicans	albican	NOUN
mkg-25034	171	12	in	in	ADP
mkg-25034	171	13	the	the	DET
mkg-25034	171	14	saliva	saliva	NOUN
mkg-25034	171	15	of	of	ADP
mkg-25034	171	16	preschool	preschool	ADJ
mkg-25034	171	17	children	child	NOUN
mkg-25034	171	18	,	,	PUNCT
mkg-25034	171	19	according	accord	VERB
mkg-25034	171	20	to	to	ADP
mkg-25034	171	21	their	their	PRON
mkg-25034	171	22	caries	carie	NOUN
mkg-25034	171	23	status	status	NOUN
mkg-25034	171	24	.	.	PUNCT
mkg-25034	172	1	acta	acta	PROPN
mkg-25034	172	2	odontol	odontol	PROPN
mkg-25034	172	3	scand	scand	PROPN
mkg-25034	172	4	.	.	PROPN
mkg-25034	173	1	2017	2017	NUM
mkg-25034	173	2	;	;	PUNCT
mkg-25034	174	1	75(1	75(1	NUM
mkg-25034	174	2	):	):	PUNCT
mkg-25034	174	3	30–5	30–5	NUM
mkg-25034	174	4	.	.	NOUN
mkg-25034	174	5	13	13	NUM
mkg-25034	174	6	.	.	X
mkg-25034	175	1	arastehfar	arastehfar	ADV
mkg-25034	175	2	a	a	X
mkg-25034	175	3	,	,	PUNCT
mkg-25034	175	4	daneshnia	daneshnia	PROPN
mkg-25034	175	5	f	f	PROPN
mkg-25034	175	6	,	,	PUNCT
mkg-25034	175	7	kord	kord	PROPN
mkg-25034	175	8	m	m	PROPN
mkg-25034	175	9	,	,	PUNCT
mkg-25034	175	10	roudbary	roudbary	PROPN
mkg-25034	175	11	m	m	NOUN
mkg-25034	175	12	,	,	PUNCT
mkg-25034	175	13	zarrinfar	zarrinfar	PROPN
mkg-25034	175	14	h	h	NOUN
mkg-25034	175	15	,	,	PUNCT
mkg-25034	175	16	fang	fang	PROPN
mkg-25034	175	17	w	w	PROPN
mkg-25034	175	18	,	,	PUNCT
mkg-25034	175	19	hashemi	hashemi	PROPN
mkg-25034	175	20	sj	sj	INTJ
mkg-25034	175	21	,	,	PUNCT
mkg-25034	175	22	najafzadeh	najafzadeh	PROPN
mkg-25034	175	23	mj	mj	PROPN
mkg-25034	175	24	,	,	PUNCT
mkg-25034	175	25	khodavaisy	khodavaisy	PROPN
mkg-25034	175	26	s	s	PROPN
mkg-25034	175	27	,	,	PUNCT
mkg-25034	175	28	pan	pan	PROPN
mkg-25034	175	29	w	w	PROPN
mkg-25034	175	30	,	,	PUNCT
mkg-25034	175	31	liao	liao	PROPN
mkg-25034	175	32	w	w	PROPN
mkg-25034	175	33	,	,	PUNCT
mkg-25034	175	34	badali	badali	VERB
mkg-25034	175	35	h	h	NOUN
mkg-25034	175	36	,	,	PUNCT
mkg-25034	175	37	rezaie	rezaie	PROPN
mkg-25034	175	38	s	s	PROPN
mkg-25034	175	39	,	,	PUNCT
mkg-25034	175	40	zomorodian	zomorodian	ADJ
mkg-25034	175	41	k	k	NOUN
mkg-25034	175	42	,	,	PUNCT
mkg-25034	175	43	hagen	hagen	PROPN
mkg-25034	175	44	f	f	PROPN
mkg-25034	175	45	,	,	PUNCT
mkg-25034	175	46	boekhout	boekhout	VERB
mkg-25034	175	47	t.	t.	NOUN
mkg-25034	175	48	comparison	comparison	NOUN
mkg-25034	175	49	of	of	ADP
mkg-25034	175	50	21	21	NUM
mkg-25034	175	51	-	-	PUNCT
mkg-25034	175	52	plex	plex	NOUN
mkg-25034	175	53	pcr	pcr	PROPN
mkg-25034	175	54	and	and	CCONJ
mkg-25034	175	55	api	api	PROPN
mkg-25034	175	56	20c	20c	PROPN
mkg-25034	175	57	aux	aux	X
mkg-25034	175	58	,	,	PUNCT
mkg-25034	175	59	maldi	maldi	PROPN
mkg-25034	175	60	-	-	PUNCT
mkg-25034	175	61	tof	tof	PROPN
mkg-25034	175	62	ms	ms	NOUN
mkg-25034	175	63	,	,	PUNCT
mkg-25034	175	64	and	and	CCONJ
mkg-25034	175	65	rdna	rdna	NOUN
mkg-25034	175	66	sequencing	sequence	VERB
mkg-25034	175	67	for	for	ADP
mkg-25034	175	68	a	a	DET
mkg-25034	175	69	wide	wide	ADJ
mkg-25034	175	70	range	range	NOUN
mkg-25034	175	71	of	of	ADP
mkg-25034	175	72	clinically	clinically	ADV
mkg-25034	175	73	isolated	isolate	VERB
mkg-25034	175	74	yeast	yeast	NOUN
mkg-25034	175	75	species	specie	NOUN
mkg-25034	175	76	:	:	PUNCT
mkg-25034	175	77	improved	improve	VERB
mkg-25034	175	78	identification	identification	NOUN
mkg-25034	175	79	by	by	ADP
mkg-25034	175	80	combining	combine	VERB
mkg-25034	175	81	21	21	NUM
mkg-25034	175	82	-	-	PUNCT
mkg-25034	175	83	plex	plex	NOUN
mkg-25034	175	84	pcr	pcr	PROPN
mkg-25034	175	85	and	and	CCONJ
mkg-25034	175	86	api	api	PROPN
mkg-25034	175	87	20c	20c	X
mkg-25034	175	88	aux	aux	X
mkg-25034	175	89	as	as	ADP
mkg-25034	175	90	an	an	DET
mkg-25034	175	91	alternative	alternative	ADJ
mkg-25034	175	92	strategy	strategy	NOUN
mkg-25034	175	93	for	for	ADP
mkg-25034	175	94	developing	develop	VERB
mkg-25034	175	95	countries	country	NOUN
mkg-25034	175	96	.	.	PUNCT
mkg-25034	176	1	front	front	ADJ
mkg-25034	176	2	cell	cell	NOUN
mkg-25034	176	3	infect	infect	VERB
mkg-25034	176	4	microbiol	microbiol	NOUN
mkg-25034	176	5	.	.	PUNCT
mkg-25034	177	1	2019	2019	NUM
mkg-25034	177	2	;	;	PUNCT
mkg-25034	177	3	9	9	NUM
mkg-25034	177	4	:	:	SYM
mkg-25034	177	5	21	21	NUM
mkg-25034	177	6	.	.	X
mkg-25034	178	1	14	14	NUM
mkg-25034	178	2	.	.	PUNCT
mkg-25034	179	1	zhang	zhang	PROPN
mkg-25034	179	2	l	l	PROPN
mkg-25034	179	3	,	,	PUNCT
mkg-25034	179	4	wang	wang	PROPN
mkg-25034	179	5	h	h	PROPN
mkg-25034	179	6	,	,	PUNCT
mkg-25034	179	7	xiao	xiao	PROPN
mkg-25034	179	8	m	m	PROPN
mkg-25034	179	9	,	,	PUNCT
mkg-25034	179	10	kudinha	kudinha	PROPN
mkg-25034	179	11	t	t	PROPN
mkg-25034	179	12	,	,	PUNCT
mkg-25034	179	13	mao	mao	NOUN
mkg-25034	179	14	l	l	NOUN
mkg-25034	179	15	-	-	PUNCT
mkg-25034	179	16	l	l	NOUN
mkg-25034	179	17	,	,	PUNCT
mkg-25034	179	18	zhao	zhao	PROPN
mkg-25034	179	19	h	h	NOUN
mkg-25034	179	20	-	-	PUNCT
mkg-25034	179	21	r	r	NOUN
mkg-25034	179	22	,	,	PUNCT
mkg-25034	179	23	kong	kong	PROPN
mkg-25034	179	24	f	f	PROPN
mkg-25034	179	25	,	,	PUNCT
mkg-25034	179	26	xu	xu	PROPN
mkg-25034	179	27	y	y	PROPN
mkg-25034	179	28	-	-	PROPN
mkg-25034	179	29	c.	c.	PROPN
mkg-25034	179	30	the	the	DET
mkg-25034	179	31	widely	widely	ADV
mkg-25034	179	32	used	use	VERB
mkg-25034	179	33	atb	atb	NOUN
mkg-25034	179	34	fungus	fungus	PROPN
mkg-25034	179	35	3	3	NUM
mkg-25034	179	36	automated	automate	VERB
mkg-25034	179	37	readings	reading	NOUN
mkg-25034	179	38	in	in	ADP
mkg-25034	179	39	china	china	PROPN
mkg-25034	179	40	and	and	CCONJ
mkg-25034	179	41	its	its	PRON
mkg-25034	179	42	misleading	misleading	ADJ
mkg-25034	179	43	high	high	ADJ
mkg-25034	179	44	mics	mic	NOUN
mkg-25034	179	45	of	of	ADP
mkg-25034	179	46	candida	candida	PROPN
mkg-25034	179	47	spp	spp	NOUN
mkg-25034	179	48	.	.	PUNCT
mkg-25034	180	1	to	to	ADP
mkg-25034	180	2	azoles	azole	NOUN
mkg-25034	180	3	:	:	PUNCT
mkg-25034	180	4	challenges	challenge	NOUN
mkg-25034	180	5	for	for	ADP
mkg-25034	180	6	developing	develop	VERB
mkg-25034	180	7	countries	country	NOUN
mkg-25034	180	8	’	'	PUNCT
mkg-25034	180	9	clinical	clinical	ADJ
mkg-25034	180	10	microbiology	microbiology	NOUN
mkg-25034	180	11	labs	lab	NOUN
mkg-25034	180	12	.	.	PUNCT
mkg-25034	181	1	plos	plos	PROPN
mkg-25034	181	2	one	one	NUM
mkg-25034	181	3	.	.	PUNCT
mkg-25034	181	4	2014	2014	NUM
mkg-25034	181	5	;	;	PUNCT
mkg-25034	181	6	9(12	9(12	NUM
mkg-25034	181	7	):	):	PUNCT
mkg-25034	181	8	e114004	e114004	PROPN
mkg-25034	181	9	.	.	NOUN
mkg-25034	181	10	15	15	NUM
mkg-25034	181	11	.	.	PUNCT
mkg-25034	182	1	patil	patil	PROPN
mkg-25034	182	2	s	s	PROPN
mkg-25034	182	3	,	,	PUNCT
mkg-25034	182	4	majumdar	majumdar	PROPN
mkg-25034	182	5	b	b	PROPN
mkg-25034	182	6	,	,	PUNCT
mkg-25034	182	7	sarode	sarode	PROPN
mkg-25034	182	8	sc	sc	PROPN
mkg-25034	182	9	,	,	PUNCT
mkg-25034	182	10	sarode	sarode	PROPN
mkg-25034	182	11	gs	gs	PROPN
mkg-25034	182	12	,	,	PUNCT
mkg-25034	182	13	awan	awan	PROPN
mkg-25034	182	14	kh	kh	PROPN
mkg-25034	182	15	.	.	PUNCT
mkg-25034	182	16	oropharyngeal	oropharyngeal	ADJ
mkg-25034	182	17	candidosis	candidosis	NOUN
mkg-25034	182	18	in	in	ADP
mkg-25034	182	19	hiv	hiv	PROPN
mkg-25034	182	20	-	-	PUNCT
mkg-25034	182	21	infected	infect	VERB
mkg-25034	182	22	patients	patient	NOUN
mkg-25034	182	23	-	-	PUNCT
mkg-25034	182	24	an	an	DET
mkg-25034	182	25	update	update	NOUN
mkg-25034	182	26	.	.	PUNCT
mkg-25034	183	1	front	front	ADJ
mkg-25034	183	2	microbiol	microbiol	NOUN
mkg-25034	183	3	.	.	PUNCT
mkg-25034	184	1	2018	2018	NUM
mkg-25034	184	2	;	;	PUNCT
mkg-25034	184	3	9	9	NUM
mkg-25034	184	4	:	:	SYM
mkg-25034	184	5	980	980	NUM
mkg-25034	184	6	.	.	NOUN
mkg-25034	184	7	16	16	NUM
mkg-25034	184	8	.	.	PUNCT
mkg-25034	185	1	glick	glick	PROPN
mkg-25034	185	2	sn	sn	PROPN
mkg-25034	185	3	,	,	PUNCT
mkg-25034	185	4	morris	morris	PROPN
mkg-25034	185	5	m	m	PROPN
mkg-25034	185	6	,	,	PUNCT
mkg-25034	185	7	foxman	foxman	PROPN
mkg-25034	185	8	b	b	PROPN
mkg-25034	185	9	,	,	PUNCT
mkg-25034	185	10	aral	aral	PROPN
mkg-25034	185	11	so	so	ADV
mkg-25034	185	12	,	,	PUNCT
mkg-25034	185	13	manhart	manhart	NOUN
mkg-25034	185	14	le	le	X
mkg-25034	185	15	,	,	PUNCT
mkg-25034	185	16	holmes	holmes	PROPN
mkg-25034	185	17	kk	kk	PROPN
mkg-25034	185	18	,	,	PUNCT
mkg-25034	185	19	golden	golden	PROPN
mkg-25034	185	20	mr	mr	PROPN
mkg-25034	185	21	.	.	PROPN
mkg-25034	185	22	a	a	DET
mkg-25034	185	23	comparison	comparison	NOUN
mkg-25034	185	24	of	of	ADP
mkg-25034	185	25	sexual	sexual	ADJ
mkg-25034	185	26	behavior	behavior	NOUN
mkg-25034	185	27	patterns	pattern	NOUN
mkg-25034	185	28	among	among	ADP
mkg-25034	185	29	men	man	NOUN
mkg-25034	185	30	who	who	PRON
mkg-25034	185	31	have	have	VERB
mkg-25034	185	32	sex	sex	NOUN
mkg-25034	185	33	with	with	ADP
mkg-25034	185	34	men	man	NOUN
mkg-25034	185	35	and	and	CCONJ
mkg-25034	185	36	heterosexual	heterosexual	ADJ
mkg-25034	185	37	men	man	NOUN
mkg-25034	185	38	and	and	CCONJ
mkg-25034	185	39	women	woman	NOUN
mkg-25034	185	40	.	.	PUNCT
mkg-25034	186	1	j	j	PROPN
mkg-25034	186	2	acquir	acquir	PROPN
mkg-25034	186	3	immune	immune	VERB
mkg-25034	186	4	defic	defic	ADJ
mkg-25034	186	5	syndr	syndr	NOUN
mkg-25034	186	6	.	.	PUNCT
mkg-25034	186	7	2012	2012	NUM
mkg-25034	186	8	;	;	PUNCT
mkg-25034	186	9	60(1	60(1	NUM
mkg-25034	186	10	):	):	PUNCT
mkg-25034	186	11	83–90	83–90	NUM
mkg-25034	186	12	.	.	PUNCT
mkg-25034	187	1	17	17	NUM
mkg-25034	187	2	.	.	PUNCT
mkg-25034	188	1	berkow	berkow	PROPN
mkg-25034	188	2	el	el	PROPN
mkg-25034	188	3	,	,	PUNCT
mkg-25034	188	4	lockhart	lockhart	PROPN
mkg-25034	188	5	sr	sr	PROPN
mkg-25034	188	6	.	.	PUNCT
mkg-25034	189	1	fluconazole	fluconazole	PROPN
mkg-25034	189	2	resistance	resistance	NOUN
mkg-25034	189	3	in	in	ADP
mkg-25034	189	4	candida	candida	PROPN
mkg-25034	189	5	species	specie	NOUN
mkg-25034	189	6	:	:	PUNCT
mkg-25034	189	7	a	a	DET
mkg-25034	189	8	current	current	ADJ
mkg-25034	189	9	perspective	perspective	NOUN
mkg-25034	189	10	.	.	PUNCT
mkg-25034	190	1	infect	infect	VERB
mkg-25034	190	2	drug	drug	NOUN
mkg-25034	190	3	resist	resist	NOUN
mkg-25034	190	4	.	.	PUNCT
mkg-25034	191	1	2017	2017	NUM
mkg-25034	191	2	;	;	PUNCT
mkg-25034	191	3	10	10	NUM
mkg-25034	191	4	:	:	PUNCT
mkg-25034	191	5	237–45	237–45	NOUN
mkg-25034	191	6	.	.	X
mkg-25034	191	7	18	18	NUM
mkg-25034	191	8	.	.	PUNCT
mkg-25034	192	1	garcia	garcia	PROPN
mkg-25034	192	2	-	-	PUNCT
mkg-25034	192	3	cuesta	cuesta	PROPN
mkg-25034	192	4	c	c	X
mkg-25034	192	5	,	,	PUNCT
mkg-25034	192	6	sarrion	sarrion	NOUN
mkg-25034	192	7	-	-	PUNCT
mkg-25034	192	8	pérez	pérez	NOUN
mkg-25034	192	9	m	m	PROPN
mkg-25034	192	10	-	-	PUNCT
mkg-25034	192	11	g	g	PROPN
mkg-25034	192	12	,	,	PUNCT
mkg-25034	192	13	bagán	bagán	NOUN
mkg-25034	192	14	j	j	PROPN
mkg-25034	192	15	v.	v.	ADP
mkg-25034	192	16	current	current	ADJ
mkg-25034	192	17	treatment	treatment	NOUN
mkg-25034	192	18	of	of	ADP
mkg-25034	192	19	oral	oral	ADJ
mkg-25034	192	20	candidiasis	candidiasis	NOUN
mkg-25034	192	21	:	:	PUNCT
mkg-25034	192	22	a	a	DET
mkg-25034	192	23	literature	literature	NOUN
mkg-25034	192	24	review	review	NOUN
mkg-25034	192	25	.	.	PUNCT
mkg-25034	193	1	j	j	PROPN
mkg-25034	193	2	clin	clin	PROPN
mkg-25034	193	3	exp	exp	PROPN
mkg-25034	193	4	dent	dent	NOUN
mkg-25034	193	5	.	.	PUNCT
mkg-25034	194	1	2014	2014	NUM
mkg-25034	194	2	;	;	PUNCT
mkg-25034	194	3	6(5	6(5	NUM
mkg-25034	194	4	):	):	PUNCT
mkg-25034	195	1	e576	e576	PROPN
mkg-25034	195	2	-	-	PUNCT
mkg-25034	195	3	82	82	NUM
mkg-25034	195	4	.	.	PROPN
mkg-25034	195	5	19	19	NUM
mkg-25034	195	6	.	.	PUNCT
mkg-25034	195	7	williams	williams	PROPN
mkg-25034	195	8	d	d	PROPN
mkg-25034	195	9	,	,	PUNCT
mkg-25034	195	10	lewis	lewis	PROPN
mkg-25034	195	11	m.	m.	NOUN
mkg-25034	195	12	pathogenesis	pathogenesis	PROPN
mkg-25034	195	13	and	and	CCONJ
mkg-25034	195	14	treatment	treatment	NOUN
mkg-25034	195	15	of	of	ADP
mkg-25034	195	16	oral	oral	ADJ
mkg-25034	195	17	candidosis	candidosis	NOUN
mkg-25034	195	18	.	.	PUNCT
mkg-25034	196	1	j	j	PROPN
mkg-25034	196	2	oral	oral	PROPN
mkg-25034	196	3	microbiol	microbiol	PROPN
mkg-25034	196	4	.	.	PUNCT
mkg-25034	197	1	2011	2011	NUM
mkg-25034	197	2	;	;	PUNCT
mkg-25034	197	3	3	3	NUM
mkg-25034	197	4	:	:	PUNCT
mkg-25034	197	5	1–11	1–11	PROPN
mkg-25034	197	6	.	.	PUNCT
mkg-25034	198	1	20	20	NUM
mkg-25034	198	2	.	.	PUNCT
mkg-25034	198	3	gaitán	gaitán	NOUN
mkg-25034	198	4	-	-	PUNCT
mkg-25034	198	5	cepeda	cepeda	PROPN
mkg-25034	198	6	la	la	PROPN
mkg-25034	198	7	,	,	PUNCT
mkg-25034	198	8	sánchez	sánchez	NOUN
mkg-25034	198	9	-	-	PUNCT
mkg-25034	198	10	vargas	vargas	PROPN
mkg-25034	198	11	o	o	NOUN
mkg-25034	198	12	,	,	PUNCT
mkg-25034	198	13	castillo	castillo	PROPN
mkg-25034	198	14	n.	n.	PROPN
mkg-25034	198	15	prevalence	prevalence	NOUN
mkg-25034	198	16	of	of	ADP
mkg-25034	198	17	oral	oral	ADJ
mkg-25034	198	18	candidiasis	candidiasis	NOUN
mkg-25034	198	19	in	in	ADP
mkg-25034	198	20	hiv	hiv	PROPN
mkg-25034	198	21	/	/	SYM
mkg-25034	198	22	aids	aids	PROPN
mkg-25034	198	23	children	child	NOUN
mkg-25034	198	24	in	in	ADP
mkg-25034	198	25	highly	highly	ADV
mkg-25034	198	26	active	active	ADJ
mkg-25034	198	27	antiretroviral	antiretroviral	ADJ
mkg-25034	198	28	therapy	therapy	NOUN
mkg-25034	198	29	era	era	NOUN
mkg-25034	198	30	.	.	PUNCT
mkg-25034	199	1	a	a	DET
mkg-25034	199	2	literature	literature	NOUN
mkg-25034	199	3	analysis	analysis	NOUN
mkg-25034	199	4	.	.	PUNCT
mkg-25034	200	1	int	int	NOUN
mkg-25034	200	2	j	j	PROPN
mkg-25034	200	3	std	std	PROPN
mkg-25034	200	4	aids	aids	PROPN
mkg-25034	200	5	.	.	PUNCT
mkg-25034	201	1	2015	2015	NUM
mkg-25034	201	2	;	;	PUNCT
mkg-25034	201	3	26(9	26(9	NUM
mkg-25034	201	4	):	):	PUNCT
mkg-25034	201	5	625–32	625–32	NUM
mkg-25034	201	6	.	.	PUNCT
mkg-25034	202	1	21	21	NUM
mkg-25034	202	2	.	.	PUNCT
mkg-25034	203	1	maheshwari	maheshwari	PROPN
mkg-25034	203	2	m	m	PROPN
mkg-25034	203	3	,	,	PUNCT
mkg-25034	203	4	kaur	kaur	PROPN
mkg-25034	203	5	r	r	PROPN
mkg-25034	203	6	,	,	PUNCT
mkg-25034	203	7	chadha	chadha	PROPN
mkg-25034	203	8	s.	s.	PROPN
mkg-25034	203	9	candida	candida	PROPN
mkg-25034	203	10	species	species	PROPN
mkg-25034	203	11	prevalence	prevalence	NOUN
mkg-25034	203	12	profile	profile	NOUN
mkg-25034	203	13	in	in	ADP
mkg-25034	203	14	hiv	hiv	PROPN
mkg-25034	203	15	seropositive	seropositive	ADJ
mkg-25034	203	16	patients	patient	NOUN
mkg-25034	203	17	from	from	ADP
mkg-25034	203	18	a	a	DET
mkg-25034	203	19	major	major	ADJ
mkg-25034	203	20	tertiary	tertiary	ADJ
mkg-25034	203	21	care	care	NOUN
mkg-25034	203	22	hospital	hospital	NOUN
mkg-25034	203	23	in	in	ADP
mkg-25034	203	24	new	new	PROPN
mkg-25034	203	25	delhi	delhi	PROPN
mkg-25034	203	26	,	,	PUNCT
mkg-25034	203	27	india	india	PROPN
mkg-25034	203	28	.	.	PUNCT
mkg-25034	204	1	j	j	PROPN
mkg-25034	204	2	pathog	pathog	PROPN
mkg-25034	204	3	.	.	PUNCT
mkg-25034	205	1	2016	2016	NUM
mkg-25034	205	2	;	;	PUNCT
mkg-25034	205	3	2016	2016	NUM
mkg-25034	205	4	:	:	PUNCT
mkg-25034	205	5	6204804	6204804	NUM
mkg-25034	205	6	.	.	PUNCT
mkg-25034	206	1	22	22	NUM
mkg-25034	206	2	.	.	PUNCT
mkg-25034	207	1	brito	brito	PROPN
mkg-25034	207	2	gnb	gnb	PROPN
mkg-25034	207	3	,	,	PUNCT
mkg-25034	207	4	inocêncio	inocêncio	PROPN
mkg-25034	207	5	ac	ac	PROPN
mkg-25034	207	6	,	,	PUNCT
mkg-25034	207	7	querido	querido	NOUN
mkg-25034	207	8	smr	smr	NOUN
mkg-25034	207	9	,	,	PUNCT
mkg-25034	207	10	jorge	jorge	NOUN
mkg-25034	207	11	aoc	aoc	PROPN
mkg-25034	207	12	,	,	PUNCT
mkg-25034	207	13	koga	koga	PROPN
mkg-25034	207	14	-	-	PUNCT
mkg-25034	207	15	ito	ito	PROPN
mkg-25034	207	16	cy	cy	PROPN
mkg-25034	207	17	.	.	PROPN
mkg-25034	208	1	in	in	ADP
mkg-25034	208	2	vitro	vitro	X
mkg-25034	208	3	antifungal	antifungal	ADJ
mkg-25034	208	4	susceptibility	susceptibility	NOUN
mkg-25034	208	5	of	of	ADP
mkg-25034	208	6	candida	candida	PROPN
mkg-25034	208	7	spp	spp	PROPN
mkg-25034	208	8	.	.	PUNCT
mkg-25034	209	1	oral	oral	ADJ
mkg-25034	209	2	isolates	isolate	NOUN
mkg-25034	209	3	from	from	ADP
mkg-25034	209	4	hiv	hiv	PROPN
mkg-25034	209	5	-	-	PUNCT
mkg-25034	209	6	positive	positive	ADJ
mkg-25034	209	7	patients	patient	NOUN
mkg-25034	209	8	and	and	CCONJ
mkg-25034	209	9	control	control	NOUN
mkg-25034	209	10	individuals	individual	NOUN
mkg-25034	209	11	.	.	PUNCT
mkg-25034	210	1	braz	braz	PROPN
mkg-25034	210	2	oral	oral	PROPN
mkg-25034	210	3	res	re	NOUN
mkg-25034	210	4	.	.	PUNCT
mkg-25034	210	5	2011	2011	NUM
mkg-25034	210	6	;	;	PUNCT
mkg-25034	210	7	25(1	25(1	NUM
mkg-25034	210	8	):	):	PUNCT
mkg-25034	210	9	28–33	28–33	NUM
mkg-25034	210	10	.	.	NOUN
mkg-25034	210	11	23	23	NUM
mkg-25034	210	12	.	.	PUNCT
mkg-25034	211	1	butts	butts	NOUN
mkg-25034	211	2	a	a	PRON
mkg-25034	211	3	,	,	PUNCT
mkg-25034	211	4	reitler	reitler	NOUN
mkg-25034	211	5	p	p	NOUN
mkg-25034	211	6	,	,	PUNCT
mkg-25034	211	7	nishimoto	nishimoto	NOUN
mkg-25034	211	8	at	at	ADP
mkg-25034	211	9	,	,	PUNCT
mkg-25034	211	10	dejarnette	dejarnette	NOUN
mkg-25034	211	11	c	c	PROPN
mkg-25034	211	12	,	,	PUNCT
mkg-25034	211	13	estredge	estredge	VERB
mkg-25034	211	14	lr	lr	NOUN
mkg-25034	211	15	,	,	PUNCT
mkg-25034	211	16	peters	peters	PROPN
mkg-25034	211	17	tl	tl	PROPN
mkg-25034	211	18	,	,	PUNCT
mkg-25034	211	19	veve	veve	PROPN
mkg-25034	211	20	mp	mp	PROPN
mkg-25034	211	21	,	,	PUNCT
mkg-25034	211	22	rogers	rogers	PROPN
mkg-25034	211	23	pd	pd	PROPN
mkg-25034	211	24	,	,	PUNCT
mkg-25034	211	25	palmer	palmer	PROPN
mkg-25034	211	26	ge	ge	PROPN
mkg-25034	211	27	.	.	PUNCT
mkg-25034	212	1	a	a	DET
mkg-25034	212	2	systematic	systematic	ADJ
mkg-25034	212	3	screen	screen	NOUN
mkg-25034	212	4	reveals	reveal	VERB
mkg-25034	212	5	a	a	DET
mkg-25034	212	6	diverse	diverse	ADJ
mkg-25034	212	7	collection	collection	NOUN
mkg-25034	212	8	of	of	ADP
mkg-25034	212	9	medications	medication	NOUN
mkg-25034	212	10	that	that	PRON
mkg-25034	212	11	induce	induce	VERB
mkg-25034	212	12	antifungal	antifungal	ADJ
mkg-25034	212	13	resistance	resistance	NOUN
mkg-25034	212	14	in	in	ADP
mkg-25034	212	15	candida	candida	PROPN
mkg-25034	212	16	species	specie	NOUN
mkg-25034	212	17	.	.	PUNCT
mkg-25034	213	1	antimicrob	antimicrob	PROPN
mkg-25034	213	2	agents	agents	PROPN
mkg-25034	213	3	chemother	chemother	PROPN
mkg-25034	213	4	.	.	PUNCT
mkg-25034	214	1	2019	2019	NUM
mkg-25034	214	2	;	;	PUNCT
mkg-25034	214	3	63(5	63(5	NOUN
mkg-25034	214	4	):	):	PUNCT
mkg-25034	214	5	e00054	e00054	NOUN
mkg-25034	214	6	-	-	PUNCT
mkg-25034	214	7	19	19	NUM
mkg-25034	214	8	.	.	NOUN
mkg-25034	214	9	24	24	NUM
mkg-25034	214	10	.	.	PUNCT
mkg-25034	215	1	patil	patil	PROPN
mkg-25034	215	2	s	s	PROPN
mkg-25034	215	3	,	,	PUNCT
mkg-25034	215	4	rao	rao	NOUN
mkg-25034	215	5	rs	rs	NOUN
mkg-25034	215	6	,	,	PUNCT
mkg-25034	215	7	majumdar	majumdar	PROPN
mkg-25034	215	8	b	b	PROPN
mkg-25034	215	9	,	,	PUNCT
mkg-25034	215	10	anil	anil	PROPN
mkg-25034	215	11	s.	s.	PROPN
mkg-25034	215	12	clinical	clinical	ADJ
mkg-25034	215	13	appearance	appearance	NOUN
mkg-25034	215	14	of	of	ADP
mkg-25034	215	15	oral	oral	ADJ
mkg-25034	215	16	candida	candida	NOUN
mkg-25034	215	17	infection	infection	NOUN
mkg-25034	215	18	and	and	CCONJ
mkg-25034	215	19	therapeutic	therapeutic	ADJ
mkg-25034	215	20	strategies	strategy	NOUN
mkg-25034	215	21	.	.	PUNCT
mkg-25034	216	1	front	front	ADJ
mkg-25034	216	2	microbiol	microbiol	PROPN
mkg-25034	216	3	.	.	PUNCT
mkg-25034	217	1	2015	2015	NUM
mkg-25034	217	2	;	;	PUNCT
mkg-25034	217	3	6	6	NUM
mkg-25034	217	4	:	:	SYM
mkg-25034	217	5	1391	1391	NUM
mkg-25034	217	6	.	.	X
mkg-25034	218	1	25	25	NUM
mkg-25034	218	2	.	.	X
mkg-25034	218	3	whaley	whaley	PROPN
mkg-25034	218	4	sg	sg	PROPN
mkg-25034	218	5	,	,	PUNCT
mkg-25034	218	6	berkow	berkow	PROPN
mkg-25034	218	7	el	el	PROPN
mkg-25034	218	8	,	,	PUNCT
mkg-25034	218	9	rybak	rybak	PROPN
mkg-25034	218	10	jm	jm	PROPN
mkg-25034	218	11	,	,	PUNCT
mkg-25034	218	12	nishimoto	nishimoto	NOUN
mkg-25034	218	13	at	at	ADP
mkg-25034	218	14	,	,	PUNCT
mkg-25034	218	15	barker	barker	PROPN
mkg-25034	218	16	ks	ks	PROPN
mkg-25034	218	17	,	,	PUNCT
mkg-25034	218	18	rogers	rogers	PROPN
mkg-25034	218	19	pd	pd	PROPN
mkg-25034	218	20	.	.	PROPN
mkg-25034	218	21	azole	azole	PROPN
mkg-25034	218	22	antifungal	antifungal	PROPN
mkg-25034	218	23	resistance	resistance	NOUN
mkg-25034	218	24	in	in	ADP
mkg-25034	218	25	candida	candida	NOUN
mkg-25034	218	26	albicans	albican	NOUN
mkg-25034	218	27	and	and	CCONJ
mkg-25034	218	28	emerging	emerge	VERB
mkg-25034	218	29	non	non	ADJ
mkg-25034	218	30	-	-	ADJ
mkg-25034	218	31	albicans	albicans	ADJ
mkg-25034	218	32	candida	candida	PROPN
mkg-25034	218	33	species	specie	NOUN
mkg-25034	218	34	.	.	PUNCT
mkg-25034	219	1	front	front	ADJ
mkg-25034	219	2	microbiol	microbiol	PROPN
mkg-25034	219	3	.	.	PUNCT
mkg-25034	220	1	2016	2016	NUM
mkg-25034	220	2	;	;	PUNCT
mkg-25034	220	3	7	7	NUM
mkg-25034	220	4	:	:	SYM
mkg-25034	220	5	2173	2173	NUM
mkg-25034	220	6	.	.	PUNCT
mkg-25034	221	1	dental	dental	ADJ
mkg-25034	221	2	journal	journal	NOUN
mkg-25034	221	3	(	(	PUNCT
mkg-25034	221	4	majalah	majalah	PROPN
mkg-25034	221	5	kedokteran	kedokteran	PROPN
mkg-25034	221	6	gigi	gigi	PROPN
mkg-25034	221	7	)	)	PUNCT
mkg-25034	222	1	p	p	X
mkg-25034	222	2	-	-	PUNCT
mkg-25034	222	3	issn	issn	NOUN
mkg-25034	222	4	:	:	PUNCT
mkg-25034	222	5	1978	1978	NUM
mkg-25034	222	6	-	-	SYM
mkg-25034	222	7	3728	3728	NUM
mkg-25034	222	8	;	;	PUNCT
mkg-25034	222	9	e	e	X
mkg-25034	222	10	-	-	PUNCT
mkg-25034	222	11	issn	issn	ADJ
mkg-25034	222	12	:	:	PUNCT
mkg-25034	222	13	2442	2442	NUM
mkg-25034	222	14	-	-	SYM
mkg-25034	222	15	9740	9740	NUM
mkg-25034	222	16	.	.	PUNCT
mkg-25034	223	1	accredited	accredit	VERB
mkg-25034	223	2	no	no	PRON
mkg-25034	223	3	.	.	PUNCT
mkg-25034	223	4	32a	32a	NOUN
mkg-25034	223	5	/	/	SYM
mkg-25034	223	6	e	e	NOUN
mkg-25034	223	7	/	/	SYM
mkg-25034	223	8	kpt/2017	kpt/2017	X
mkg-25034	223	9	.	.	PUNCT
mkg-25034	224	1	open	open	ADJ
mkg-25034	224	2	access	access	NOUN
mkg-25034	224	3	under	under	ADP
mkg-25034	224	4	cc	cc	NOUN
mkg-25034	224	5	-	-	PUNCT
mkg-25034	224	6	by	by	ADP
mkg-25034	224	7	-	-	PUNCT
mkg-25034	224	8	sa	sa	NOUN
mkg-25034	224	9	license	license	NOUN
mkg-25034	224	10	.	.	PUNCT
mkg-25034	225	1	available	available	ADJ
mkg-25034	225	2	at	at	ADP
mkg-25034	225	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	225	4	doi	doi	NOUN
mkg-25034	225	5	:	:	PUNCT
mkg-25034	225	6	10.20473	10.20473	NUM
mkg-25034	225	7	/	/	SYM
mkg-25034	225	8	j.djmkg.v54.i2.p82–86	j.djmkg.v54.i2.p82–86	ADJ
mkg-25034	225	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-25034	225	10	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	http://dx.doi.org/10.20473/j.djmkg.v54.i2.p82-86	NOUN